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resumo 
 
 
A incidência de doenças cardiovasculares (CVD) tem vindo a aumentar de 
acordo com as estatísticas europeias e globais. Assim, o desenvolvimento de 
novos dispositivos analíticos, tais como os biossensores para avaliar o risco de 
CVD pode constituir uma ferramenta valiosa para a melhoria dos cuidados de 
saúde. Nos últimos anos, a nanotecnologia tem proporcionado a criação de 
novos materiais com excelentes propriedades eletrónicas que têm uma 
contribuição importante no mecanismo de transdução dos biossensores. 
Assim, nesta tese, foram desenvolvidos biossensores com uma configuração 
de transístores de efeito de campo com nanotubos de carbono de parede 
simples (NTFET) para deteção da proteína C-reactiva (CRP) em amostras 
biológicas, isto é, soro e saliva de um grupo de pacientes controlo e de outro 
com pacientes que sofrem de doenças que afetam os níveis de CRP (grupo de 
risco de CVD). A CRP é uma proteína de fase aguda que é conhecida como o 
melhor marcador validado para a deteção de risco de CVD, os nanotubos de 
parede simples (SWCNT) foram aplicados como parte do componente de 
transdução e a imunorreação, ou seja, a interação entre a CRP e o seu 
anticorpo específico, foi utilizada como mecanismo de reconhecimento 
molecular para a deteção da CRP. Após a microfabricação dos transístores de 
efeito de campo (FET), a seleção das variáveis mais importantes para a 
dispersão dos SWCNT, a montagem dos NTFET, e a aplicação dos NTFET a 
soluções padrão de CRP, verificou-se que os dispositivos respondem com 
precisão à CRP, tanto nas amostras de soro como nas de saliva, uma vez que 
os NTFET e a metodologia de referência (ELISA) determinaram níveis 
semelhantes de CRP. Por outro lado, uma forte correlação foi encontrada entre 
os níveis de CRP em soro e saliva determinados com os NTFET, o que 
significa que a saliva pode ser utilizada, com base numa amostragem não-
invasiva, como alternativa ao soro. Estes dispositivos conseguem ainda 
discriminar os pacientes do grupo de controlo e os do grupo de risco tendo por 
base os níveis de CRP na saliva, permitindo assim a determinação de um nível 
de corte para a CRP na saliva de 1900 ng L-1, que corresponde ao nível de 
corte estabelecido para a CRP no soro de 3 mg L-1, havendo assim a 
possibilidade de estabelecer uma nova gama de valores para os níveis de 
CRP na saliva. Tendo em conta os resultados obtidos a partir do perfil 
lipoproteico e dos hábitos de vida, concluiu-se que os pacientes do grupo de 
controlo e os do grupo de risco de CVD podem ser separados com base nos 
fatores de risco já estabelecidos na literatura e que contribuem para o 
desenvolvimento de CVD, tais como os triglicerídeos, a CRP do soro, o 
colesterol total, o colesterol LDL, o índice de massa corporal, a pontuação de 
Framingham, a hipertensão, a dislipidemia, e a diabetes mellitus. Assim, este 
trabalho relata o desenvolvimento de dispositivos de baixo custo, rápidos, 
descartáveis, e sem a presença de marcadores para a deteção da CRP, com 
base numa amostragem não-invasiva, para avaliação de risco de CVD 
podendo constituir um avanço nos cuidados de saúde. 
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abstract 
 
The incidence of cardiovascular diseases (CVD) has been increasing according 
to the European and global statistics. Thus, the development of new analytical 
devices, such as biosensors for assessing the risk of CVD could become a 
valuable approach for the improvement of healthcare service. In latest years, 
the nanotechnology has provided new materials with improved electronic 
properties which have an important contribution in the transduction mechanism 
of biosensors. Thus, in this thesis, biosensors based on field effect transistors 
with single-walled carbon nanotubes (NTFET) were developed for the detection 
of C-reactive protein (CRP) in clinical samples, that is, blood serum and saliva 
from a group of control patients and a group of CVD risk patients. CRP is an 
acute-phase protein, which is commonly known as the best validated biomarker 
for the assessment of CVD, the single-walled carbon nanotubes (SWCNT) 
were applied as transduction components, and the immunoreaction (interaction 
between the CRP antigen and the antibodies specific to CRP) was used as the 
mechanism of molecular recognition for the label-free detection of CRP. After 
the microfabrication of field effect transistors (FET), the screening of the most 
important variables for the dispersion of SWCNT, the assemblage of NTFET, 
and their application on standard solutions of CRP, it was found that NTFET 
respond accurately to CRP both in saliva and in serum samples, since similar 
CRP levels were found with the NTFET and the traditional methodology (ELISA 
technique). On the other hand, a strong correlation between salivary and serum 
CRP was found with NTFET, which means that saliva could be used, based on 
non-invasive sampling, as an alternative fluid to blood serum. It was also 
shown that NTFET could discriminate control patients from CVD risk patients, 
allowing the determination of a cut-off value for salivary CRP of 1900 ng L-1, 
which corresponds to the well established cut-off of 3 mg L-1 for CRP in serum, 
constituting an important finding for the possible establishment of a new range 
of CRP levels based on saliva. According to the data provided from the 
volunteer patients regarding their lipoprotein profile and lifestyle factors, it was 
concluded that the control and the CVD risk patients could be separated taking 
into account the various risk factors established in literature as strong 
contributors for developing a CVD, such as triglycerides, serum CRP, total 
cholesterol, LDL cholesterol, body mass index, Framingham risk score, 
hypertension, dyslipidemia, and diabetes mellitus. Thus, this work could 
provide an additional contribution to the understanding of the association of 
biomarkers levels in serum and saliva samples, and above all, cost-effective, 
rapid, label-free, and disposable NTFET were developed, based on a non-
invasive sampling, for the assessment of CVD risk, thus constituting a potential 
point-of-care technology. 
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carbone monofeuillet, protéine C-réactive, technique d’ELISA, transistors à 
effet de champ. 
résumé 
 
L’incidence des maladies cardiovasculaires (CVD) a augmentée selon les 
dernières statistiques européennes et mondiales. Ainsi, le développement de 
nouveaux appareils d’analyse, tels que les biocapteurs pour évaluer le risque 
de CVD pourrait être une approche intéressante pour l’amélioration des 
services de santé. Dans les dernières années, la nanotechnologie a fourni de 
nouveaux matériaux avec d’excellentes propriétés électroniques qui ont une 
contribution importante pour le mécanisme de transduction des biocapteurs. 
Ainsi, dans cette thèse, les biocapteurs basés sur des transistors à effet de 
champ avec des nanotubes de carbone monofeuillet (NTFET) ont été 
développés pour la détection de la protéine C-réactive (CRP) dans des 
échantillons de sérum et de salive d’un group de patients de contrôle et un 
autre groupe de patients avec un risque élevé de développer une CVD. La 
CRP est une protéine de phase aiguë qui est connu comme le meilleur 
biomarqueur validé pour la détection de CVD, les nanotubes de carbone 
monofeuillet (SWCNT) on été appliqués comme parti de l’élément de 
transduction, et la réaction immunologique (interaction entre l’antigène CRP et 
ses anticorps spécifiques) a été utilisée comme le mécanisme de 
reconnaissance moléculaire pour la détection de la CRP. Après la 
microfabrication des transistors à effet de champ (FET), la sélection des 
variables les plus importantes pour la dispersion des SWCNT, l’assemblage 
des NTFET, et leur application sur des solutions de CRP, il a été constaté que 
les dispositifs de NTFET on répondu précisément à la CRP tant dans les 
échantillons de sérum comme dans ceux de salive, une fois que les NTFET et 
la méthodologie traditionnelle (technique d’ELISA) ont déterminés des taux 
similaires de CRP. D’autre part, une forte corrélation entre la CRP de la salive 
et du sérum a été trouvée avec les NTFET, ce que signifie que la salive, qui 
demande un échantillonnage non-invasif, pourrait être utilisée comme une 
alternative au sérum. Il a été également démontré que les NTFET on la 
possibilité de discriminer les patients de contrôle des patients de risque de 
CVD, permettant la détermination d’un taux limite pour la CRP salivaire  de 
1900 ng L-1, qui correspond au taux limite de 3 mg L-1, celui-ci bien établi pour 
la CRP dans le sang, ce qui constitue un résultat important pour l’éventuelle 
création d’une nouvelle gamme de taux de CRP basée sur la salive. Selon les 
données fournies par les patients volontaires concernant leur profil de 
lipoprotéines et des facteurs de style de vie, les patients de contrôle et de 
risque de CVD ont étés séparé pris en compte les différents facteurs de risque 
établis dans la littérature comme contribuant fortement pour le développement 
de CVD, tels que les triglycérides, la CRP, le cholestérol total et LDL, l’indice 
de masse corporelle, le score de Framingham, l’hypertension, la dyslipidémie, 
et les diabètes. Ainsi, cette thèse rapporte le développement de dispositifs peu 
couteux, rapide, jetable et sans la présence de marqueurs pour la détection de 
la CRP, basées sur un échantillonnage non-invasif, pour l’évaluation du risque 
de CVD, pouvant être une percée dans les soins de santé. 
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1.1. Objectives 
 
The main objective of this thesis is the development of biosensors based on the field 
effect transistors (FET) configuration with a network of single-walled carbon nanotubes 
(SWCNT) for the assemblage of NTFET in order to detect C-reactive protein (CRP) in 
clinical samples, that is, blood serum and saliva, for the improvement of healthcare 
regarding the assessment of risk of cardiovascular diseases. 
SWCNT networks are applied as the transduction components, and the 
immunoreaction (interaction between CRP antigen and CRP specific antibody) is used as 
the mechanism of molecular recognition with label-free detection of CRP, which is an 
acute-phase protein, also being currently the best validated biomarker for the assessment 
of cardiovascular diseases. 
The scope of this thesis covers a wide range of scientific areas from the design of FET 
to their microfabrication and the exposure of NTFET to clinical samples. Therefore, the 
general objective can be divided into the following specific objectives: 
- design and microfabrication of various types of FET; 
- deposition of SWCNT on FET for the assemblage of NTFET, and the study of 
geometry parameters of NTFET; 
- comparison of the effectiveness on SWCNT dispersion in two types of dispersants: 
an organic solvent and a surfactant; 
- application of an experimental design, based on a full factorial design, to determine 
the most important variables to obtain uniform SWCNT dispersion; 
- characterization of NTFET regarding their analytical performance, based on 
measurements of current with applied voltage; 
- application of NTFET to CRP standard solutions, and the study of the best 
analytical calibration model for further use in the determination of CRP concentration in 
clinical samples; 
- application of NTFET to clinical samples, that is, blood serum and saliva, by 
invasive sampling and non-invasive sampling, respectively, and validation of NTFET by 
comparison of results with a traditional methodology based on enzyme-linked 
immunosorbent assay (ELISA); 
- establishment of the correlation of CRP with other factors of risk associated with 
the development of cardiovascular diseases (CVD), such as cholesterol (total, HDL, and 
LDL), triglycerides, Framingham risk score, and body mass index, as well as with stress, 
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hypertension, dyslipidemia, diabetes mellitus, family history of CVD, physical activity, and 
consumption of tobacco, alcohol, and coffee. 
 
 
1.2. Thesis outline 
 
The work presented in this thesis was disclosed in 5 posters at national and 
international meetings, 2 papers in conference proceedings, and 6 papers published and 
1 paper submitted in peer-reviewed international journals in the Science Citation Index 
(SCI®, Thomson ISI). This thesis contains 6 chapters organized as follows: 
 
- Chapter 1 provides the general and specific objectives of this thesis, as well as its 
organization in various chapters with reference to their contents; 
 
- Chapter 2 gives an introduction on various topics: characterization of carbon 
nanotubes (CNT) regarding their structure, properties, synthesis processes and 
applications, incorporation of nanomaterials, mainly CNT, on biosensing devices, 
molecular recognition of analytes through biosensors with dispersion of CNT, and 
functionalization methods of CNT. Furthermore, the theoretical principles of 
immunoreaction and operational principles of NTFET, as well as the characterization of 
CRP are also reported due to their importance on this PhD work. 
Chapter 2 is partially based on the following published papers: 
 
→ Justino C.I.L., Rocha-Santos T.A.P., Duarte A.C., 2013. Advances in 
point-of-care technologies with biosensors based on carbon nanotubes. 
Trends in Analytical Chemistry 45, 24-36. (IF: 6.351; Rank: 2/75; Q1, Area: 
Analytical Chemistry); 
→ Justino C.I.L., Rocha-Santos T.A.P., Cardoso S., Duarte A.C., 2013. 
Strategies for enhancing the analytical performance of nanomaterial-based 
sensors. Trends in Analytical Chemistry 47, 27-36. (IF: 6.351; Rank: 2/75; 
Q1, Area: Analytical Chemistry); 
→ Justino C.I.L., Rocha-Santos T.A.P., Duarte A.C., 2010. Review of 
analytical figures of merit of sensors and biosensors in clinical applications. 
Trends in Analytical Chemistry 29, 1172-1183. (IF: 6.351; Rank: 2/75; Q1, 
Area: Analytical Chemistry). 
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- Chapter 3 presents the experimental methodologies followed and the results obtained 
from the comparison on the effectiveness of the dispersion of single-walled carbon 
nanotubes (SWCNT) through their functionalization with sodium cholate (SC) and 
dimethylformamide (DMF). The most important variables for SWCNT dispersion were 
found after statistical analysis of data obtained by the application of an experimental 
design. The relationships between some experimental conditions related to the main steps 
(sonication and centrifugation) for the preparation of SWCNT solutions were also 
determined. 
Chapter 3 is partially based on the following published paper: 
 
→ Justino C.I.L., Freitas A.C., Rocha-Santos T.A.P., Duarte A.C., 2012. 
Screening of single-walled carbon nanotubes by optical fiber sensing. 
Talanta 89, 105-108. (IF: 3.498; Rank: 12/75; Q1, Area: Analytical 
Chemistry). 
 
- Chapter 4 describes the whole experimental methodology and the experimental 
conditions for the fabrication of various types of FET. 
Chapter 4 is partially based on the following published paper:  
 
→ Justino C.I.L., Rocha-Santos T.A.P., Amaral J.P., Cardoso S., Duarte 
A.C., 2013. Effects of geometry parameters of NTFET devices on the I-V 
measurements. Solid-State Electronics 81, 32-34. (IF: 1.482; Rank: 88/242; 
Q2, Area: Engineering, Electrical and Electronics). 
 
Chapter 5 reports the development of NTFET, with a back-gated and interdigitated 
configuration, and based on random networks of SWCNT, as immunosensors for the 
label-free detection of CRP in standard solutions and in clinical samples. Specifically, the 
assemblage of NTFET with the study of different geometry parameters (distance between 
electrodes, number of electrodes, and thickness of gold layer) on the device performance 
is reported, based on the characterization of NTFET by their output characteristics 
(current-voltage measurements). The selection of the NTFET type for sensing 
experiments is also reported. The experimental conditions followed and the results 
obtained from the study for finding the best calibration model obtained through the 
application of NTFET to CRP standard solutions are also provided. Methodologies tested 
and results obtained from the separation process of SWCNT networks found in a SWCNT 
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dispersion by electronic type, that is, in semiconducting and metallic SWCNT is also 
reported; semiconducting SWCNT were applied for the assemblage of NTFET in order to 
verify if better performance could be reached, in comparison to the use of SWCNT 
networks. Furthermore, the methodologies applied for the determination of the CRP 
concentration by NTFET in clinical samples (blood serum and saliva) and corresponding 
results are provided, together with the comparison of such results with those obtained 
from a traditional methodology (ELISA technique), for biosensor validation. Statistical 
analysis of such results was also performed, and the correlation of CRP with other risk 
factors such as cholesterol (total, HDL, and LDL), triglycerides, Framingham risk score, 
and body mass index, as well as with stress, hypertension, dyslipidemia, diabetes 
mellitus, family history of CVD, physical activity, and consumption of tobacco, alcohol, and 
coffee, was reported. 
Chapter 5 is partially based on the following published/submitted papers: 
 
→ Justino C.I.L., Freitas A.C., Amaral J.P., Rocha-Santos T.A.P., 
Cardoso S., Duarte A.C., 2013. Disposable immunosensors for C-reactive 
protein based on carbon nanotubes field effect transistors. Talanta 108, 
165-170. (IF: 3.498; Rank: 12/75; Q1, Area: Analytical Chemistry); 
→ Justino C.I.L., Rocha-Santos T.A.P., Amaral J.P., Cardoso S., Duarte 
A.C., 2013. Effects of geometry parameters of NTFET devices on the I-V 
measurements. Solid-State Electronics 81, 32-34. (IF: 1.482; Rank: 88/242; 
Q2, Area: Engineering, Electrical and Electronics); 
→ Justino C.I.L., Duarte K., Lucas S., Chaves P., Bettencourt P., Freitas 
A.C., Pereira R., Cardoso S., Duarte A.C., Rocha-Santos T.A.P., submitted. 
Assessment of cardiovascular disease risk using immunosensors for 
determination of C-reactive protein levels in serum and saliva. Bioanalysis. 
(IF: 3.253; Rank: 15/75; Q1, Area: Analytical Chemistry). 
 
- Chapter 6 outlines the concluding remarks concerning the various phases of this PhD 
work, highlighting the advantages of the developed NTFET for the improvement of clinical 
diagnosis. 
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In the latest decade, the use of analytical methodologies based on new materials from 
Nanoscience and Nanotechnology has been increasing and the study of nanostructures 
such as nanotubes, nanofibres, nanogaps, and quantum dots have contributed to 
significant advances in Chemistry, Biotechnology and Medicine. Particularly, in Analytical 
Chemistry, nanostructures have a high potential for the fabrication of sensors as useful 
and functional devices, due to their capabilities for improved sensitivity, increased speed 
of analysis, and cost-effectiveness, when compared to traditional devices, such as 
immunoassays (Lee et al., 2009; Vashist et al., 2011). Furthermore, the association of 
Nanotechnology with medical diagnostics, therapeutics, treatment, and monitoring has 
lead to the implementation of the concept of Nanomedicine in Science lexicon. 
Nanomedicine is related to a wide interdisciplinary scientific area which includes 
molecular biologists’, chemists’, physicians’, mathematicians’, engineers’, and computer 
scientists’ knowledge in order to face several analytical challenges (Kranz et al., 2011). In 
association with the field of Nanotechnology, the microelectronics technology further 
provides the use of powerful circuits and systems to promote the development of new 
miniaturized devices for molecular sensing, as reviewed by Carrara (2010) and some of 
these devices are implantable biosensors, as well as nanosensors for the monitoring of 
blood glucose (Cash and Clark, 2010) and for DNA detection (Dolatabadi et al., 2011). 
The incorporation of nanomaterials for the development of versatile tools used as 
diagnostic devices has been intensively attempted in order to improve healthcare. One of 
the first examples was the use of nanostructured materials in glucose sensors as a way to 
support the standard electrochemical detection of glucose, since nanomaterials provide 
higher surface areas and high electron transfer from enzyme to electrode (Cash and 
Clark, 2010). 
Large improvements in the detection and quantification of compounds such as 
proteins, neurotransmitters, and cancer biomarkers by biosensors have been reported 
due to the integration of Nanoscience and Nanotechnology, as reviewed by Justino et al. 
(2010; 2013a). For example, new nanostructured materials with various functional groups 
such as carboxyl and amine groups, or with metallic nanoclusters such as gold and silver, 
have been used for the improvement of signal transduction. Specifically, carbon 
nanotubes (CNT) have been the most used in several modern technologies and devices 
as transduction components for the improvement of biosensing systems, mainly due to 
their large surface area, high electrical conductivity, and electron transfer properties 
(Vashist et al., 2011; Balasubramanian, 2012). The association of CNT, either with other 
nanomaterials or with polymers in new nanostructured materials, have allowed the 
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production of new types of biosensors for applications in fields such as healthcare, 
environmental monitoring, and food safety. Concerning the healthcare field, some 
examples related to the detection of glucose used the association of CNT with 
nanoparticles of gold, silver, platinum, and silica and also composites of silica/iron oxide 
nanoparticles (Justino et al., 2013a) for sensing transducers. Also in this field, the 
development of biosensors with CNT for detection of diseases at an early stage has been 
mainly focused in their miniaturization and portability, sensitivity, fast response, real-time 
diagnosis, reducing sample volume, and non-invasive methods. According to the latest 
global CNT market report (Patel, 2011), the development of medical and healthcare 
devices has been one of the reasons for the increase of the production of CNT, which has 
involved 28 % of the global market demands on nanomaterials. Furthermore, the annual 
production capacity has been around 2500 t for the ten world major producers of single-
walled CNT (SWCNT) and multi-walled CNT (MWCNT), where 44 %, 29 %, and 24 % of 
such production is accounted for Asia-Pacific, North America and European Union, 
respectively. According to the same report (Patel, 2011), the CNT production is expected 
to reach 12800 t in 2016, demonstrating the relevance of these nanomaterials to several 
known applications. 
 
 
2.1. Characterization of carbon nanotubes (CNT) 
 
2.1.1. Bonding in carbon materials and structure of CNT 
 
Carbon atoms have the electronic configuration 1s22s22p2, and covalent bonds can be 
formed to produce various allotropic forms of carbon, such as diamond, graphite, 
graphene, fullerenes and CNT, through hybridization of orbitals due to the transfer of one 
of the 2s electrons to the 2p orbital. Figure 2.1 displays the structural forms of the carbon 
allotropes. 
 
Figure 2.1 Crystal structures of the allotropic forms of carbon: a) diamond, b) graphite, c) 
graphene, d) CNT, and e) C60 (Adapted and reprinted from Materials Today, 10, 
Katsnelson, Copyright (2007) with permission from Elsevier). 
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As claimed by Geim and Novoselov (2007), the dimensionality is one of the most 
defining material parameter, since different orders of the dimensional (D) crystal structure 
lead to different material properties. Concerning the graphene layer, it can be wrapped up 
into 0D fullerenes, rolled into 1D CNT, or stacked into 3D graphite, being the graphene 
itself the 2D form of carbon, as shown in Figure 2.2. 
 
Figure 2.2 Graphene layer as the basis of carbon materials (Reprinted by permission from 
Macmillan Publishers Ltd: Nature Materials (Geim and Novoselov), copyright (2007)). 
 
 
Diamond and graphite are the two allotropes of carbon with a 3D configuration. 
Diamond has carbon atoms in sp3 hybridization due to the mixing of one 2s and three 2p 
orbitals, producing a transparent, insulating, and rigid structure, and graphite is constituted 
by carbon atoms in sp2 hybridization, since one of the 2s electrons hybridizes with two of 
the 2p electrons. Graphite is organized in planar sheets of graphene, with strong σ bonds 
in graphene layers and weak van der Waals interactions between layers, and it is 
hexagonally configured having a black, conductive and fragile appearance. Graphene is 
planar with hexagonal arrangement of carbon atoms. Regarding fullerenes, such as C60, 
they are stable and approximately spherical structures consisting of tri-coordinated carbon 
atoms which are interconnected in icosahedral structure, that is, with twelve pentagonal 
and twenty hexagonal rings. Such spherical curvature produces angle strain which allows 
fullerenes to undergo characteristic reactions of electrophilic addition at double bonds, 
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reducing angle strain by changing sp2- into sp3-hybridized carbons. Recently, the scientific 
attention has turned to CNT which have the same hybridization of fullerenes (sp2 
character); three of the four valence electrons of carbon participate in the bond of 
neighbor carbon (in the σ-orbital), and they do not contribute to the conduction, while the 
fourth electron is in a π-orbital, corresponding to the valence band, and contributes to the 
conduction. In a graphene sheet, these π-orbital electrons are distributed in the 
conduction (high energy band, π*) and valence (low energy band, π) bands (Bandaru, 
2007). CNT could be considered as elongated fullerenes (up to 1.5 cm) and with an 
atomic structure similar to graphene. CNT are rolled in tubular forms, constituting SWCNT 
with diameters in the range of 1 to 10 nm, or up to fifty concentric CNT sharing a common 
axis, constituting MWCNT with inner diameters of up to 2 nm and outer diameters in the 
range of 10 to 50 nm. In MWCNT, adjacent graphene layers are separated approximately 
by 0.34 nm, which is the interlayer distance in graphite. 
The way as the graphene layer is rolled-up affects the properties of resulting SWCNT, 
as well as their diameter and chirality. Chirality is related to the way as the roll-up of 
graphene layer is made in relation to the direction of the translational vector (T) axis, 
which has the same direction than the major axis of resulting SWCNT (Popov, 2004). The 
schematic representation of a SWCNT is shown in Figure 2.3.  
 
Figure 2.3 Schematic representation of a graphene layer where chiralities of SWCNT are shown 
based on the relative orientation of the carbon hexagons in relation to CNT axis. 
 
 
The chirality of a CNT is represented by a pair of indices (n,m) called the chiral vector 
Ch, which forms a right angle with the T axis (vector OB), and it is expressed as:      
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Ch=na1 + ma2 , where a1 and a2 are the unit cell vectors of the graphene hexagonal 
structure, and (n,m) is an integer pair corresponding to the atomic structure of a CNT. T is 
the smallest graphene lattice vector perpendicular to Ch, and the rectangle defined by 
vectors T and Ch is called the unit cell for the nanotube. In other words, starting at the 
(0,0) on the graphene layer, the (n,m) point is obtained by moving n units in the a1 
direction and m units in the a2 direction. If (0,0) and (n,m) points are connected, the chiral 
vector Ch is defined.  
The chiral angle (θ) is the angle between Ch and a1, and it can vary between 0º and 
30º. In this way, there are three possible configurations of CNT, as shown in Figure 2.4, 
where an example of each configuration is shown: a) when the roll-up in the axis is made 
with m=0 or n=0, being θ about 0º, zig-zag nanotubes are produced; b) when m=n and θ 
is 30º, armchair nanotubes are produced; and finally, when m≠n being θ between 0º and 
30º, chiral nanotubes are synthesized. 
 
Figure 2.4 Schematic representation of three types of SWCNT produced by the specific orientation 
of roll-up of the graphene layer: atomic structures of two achiral tubes, that is, a) zigzag 
tubes (12,0) and b) armchair tubes (6,6), as well as one chiral tube (6,4) (Adapted and 
reprinted from Charlier et al., Copyright (2007) with permission by The American 
Physical Society). 
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The diameter of a CNT can be determined from its (n,m) indices according to the 
following equation (Saito et al., 1992):  
 
  
    
 
 
          
 
    [2.1] 
where ‘a’ is the atomic lattice constant of graphene (a = 0.246 nm). In the same way, the 
chiral angle can be calculated by the following equation (Saito et al., 1992):  
 
        
    
    
      [2.2] 
 
As stated above, the chirality is the simplest way to specify the structure of an 
individual CNT, which is determined by CNT diameter and the relative orientation of the 
carbon hexagons in relation with the tube axis, and thus, the chirality has important 
implications on the material properties, with a specific and strong impact on the electronic 
properties of CNT. The (n,m) integers determine whether the CNT is metallic (m-CNT) or 
semiconducting (s-CNT), and a wide range of possible CNT configurations can be 
mapped, as illustrated in Figure 2.5. All methods of synthesis produce a mixture of m-CNT 
and s-CNT, called CNT networks; from a statistical point of view, the distribution of Ch 
vector is uniform as one-third of the probable CNT configurations are metallic with            
n - m = 3j (j being an integer), and two-thirds are semiconducting (n - m ≠ 3j). Only 
armchair CNT (n = m) are strictly metallic. 
 
Figure 2.5 Index map with possible configurations for CNT (Reprinted with permission from Saito 
et al., Applied Physics Letters 60. Copyright (1992), American Institute of Physics). 
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2.1.2. Synthesis of CNT 
 
In general, all methods of synthesis of CNT require nanoparticles of transition metals, 
such as Fe, Co, and Ni or their alloys, to function as catalysts for CNT formation, as 
shown in Figure 2.6. Metal catalysts help to initiate the CNT precipitation at the nucleation 
stage, and when the CNT growth stops, the metal becomes non-functional. Such metals 
are commonly chosen due to the high solubility of carbon in these metals at high 
temperatures, and due to the high carbon diffusion rate into their surface. When the 
catalysts are in contact with hydrocarbons, for example, methane, ethylene, and 
acetylene, or even carbon monoxide, such carbon sources are decomposed and the 
resulting carbon atoms precipitate in a tubular form. As shown in Figure 2.6, the diffusion 
of carbon atoms occurs through the metal catalyst and when it is fully covered with excess 
carbon, its catalytic activity finishes and the CNT growth stops. 
 
Figure 2.6 General growth mechanisms for synthesis of CNT. 
 
 
In terms of their large scale production, CNT are currently synthesised by high-
temperature processes such as electric arc discharge and laser ablation, and by chemical 
vapour deposition. Table 2.1 compares the various operational parameters of such 
synthesis processes, and their schematics. 
The arc discharge method is based on the arc discharge between two graphite 
electrodes at high temperatures (3000 - 4000 ºC) and low pressures of helium or argon 
(600 mbar) for the formation of CNT on the cathode. Such synthesis can also occur 
without catalyst, as firstly proposed by Iijima (1991), and in this method, carbon atoms are 
ejected from the anode and they are deposited at the cathode forming CNT. Although the 
presence of high quantities of impurities, such as amorphous carbon, and metal clusters 
coated with carbon is the main disadvantage, the arc discharge method provides high 
yields of CNT. 
The laser ablation consists in the production of SWCNT using a high-power laser 
beam. The graphite is placed in the middle of an inert quartz tube (with argon) at 
temperatures up to 1200 ºC which, in turn, is in a furnace, that can reach temperatures 
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even higher than 1200 ºC. The laser allows the vaporization of graphite and the CNT are 
grown into a cooled collector, producing a small quantity of long CNT with high purity. It 
should be highlighted that the quality of synthesised CNT is defined in terms of purity 
(content of CNT vs. amorphous species), and defect density (presence of structural 
defects on the CNT walls), and thus, when CNT with high quality are synthesised, high 
purity and low defect density are present. The diameter of CNT produced by either arc 
discharge or laser ablation is controlled by varying reaction temperatures, and low defect 
density is attained by these methods. However, the high cost due to the expensive laser is 
the main limitation of the laser ablation method. 
 
 
Table 2.1 Operational parameters for the three main processes of production of CNT (Adapted 
from Trends in Analytical Chemistry, 45, Justino et al., Copyright (2013a), with 
permission from Elsevier). 
 Electric arc discharge Laser ablation 
Chemical vapour 
deposition 
Temperature 800 - 5000 ºC Up to 1200 ºC 300 - 1200 ºC 
Gas pressure 50 - 700 mbar Around 670 mbar Up to 10 atm 
Yield 80 % Up to 70 % 30 - 99 % (MWCNT) 
Length/Diameter Short tubes, 2 - 20 nm Ø Long tubes, 1 - 2 nm Ø Long tubes, 0.6 - 4 nm Ø 
Main advantage High production rates High CNT purity 
Control of growth 
direction 
Main limitation Non-continuous process Expensive lasers 
High defect density of 
CNT 
Schematics of 
process 
 
 
 
 
 
Regarding the chemical vapour deposition, it uses gas-phase molecules based on 
hydrocarbons which are thermally decomposed using a heated metal catalyst, leading to 
the CNT growth. When compared with arc discharge and laser ablation methods, the 
chemical vapour deposition is a simple and economic process of synthesis which has the 
disadvantage of producing CNT with high defect density, and it has the advantage of the 
selective growth of CNT. The selective growth is possible due to the control of the place of 
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growth after the deposition of the metal catalyst onto a substrate such as quartz, silicon, 
silica, alumina, and magnesium oxide, among others, and depending on the required 
application of synthesised CNT. Thus, the synthesised CNT on substrates by chemical 
vapour deposition could be immediately applied, which is not the case with arc discharge 
and laser ablation methods, where CNT should be collected after their synthesis. 
The production of CNT have been improved in order to respond to modern science and 
process engineering, and variants of the chemical vapour deposition process for the 
synthesis of CNT have been further developed, such as the processes of high-pressure 
carbon monoxide reaction (HiPCO) and cobalt-molybdenum catalysis (CoMoCAT). In 
HiPCO, CO is used as the carbon source to form SWCNT through the reaction with Fe 
nanoparticles (from iron pentacarbonyl, Fe(CO)5) at 800 - 1200 ºC and 10 atm. During the 
CNT growth, nanoparticles of Fe provide a nucleation surface for the transformation of CO 
into carbon. CoMoCAT is a registered method of synthesis forwarded and optimized by 
Resasco’s team, where high purity SWCNT are produced with a narrow distribution of 
tube diameters (Resasco et al., 2002). In the CoMoCAT process, Co and Mo are used as 
catalysts, and the SWCNT are grown by the decomposition of CO into C and CO2, at 
temperatures between 700 and 950 ºC and at pressures from 1 to 10 atm. The plasma-
enhanced chemical vapour deposition (PECVD) is also based on original chemical vapour 
deposition process, where large quantities of SWCNT or MWCNT are produced by 
decomposition of a hydrocarbon, as gaseous carbon source, in the presence of a metal 
catalyst (Ni, Fe or Co) (Melechko et al., 2005). The main difference with original chemical 
vapour deposition is the activation of the carbon source by electron impact in PECVD, due 
to the generation of a plasma during the growth process, rather than by thermal energy. 
In the synthesis of CNT, several variables such as carbon sources, metal catalyst 
concentration, gas-flow rate, gas pressure, carrier gas composition (for example, He, Ne, 
Ar, N2, and Xe), temperatures, and mixture of catalysts can affect the quantity and the 
quality of CNT, as well as the mean diameter and the diameter distribution of CNT, thus 
affecting their properties. For example, Fe is responsible for the production of long CNT 
with larger diameter (55 nm), while Co is responsible for the production of CNT with the 
smallest diameter of 20 nm, as studied by Sato (2003). 
Commonly, the process of synthesis of CNT is chosen taking into account the required 
application of CNT. For example, for microelectronics technologies, the chemical vapour 
deposition is the most used process, since it is based on the simplicity of operation, the 
possibility of growth control, the energy efficiency, the high yield and purity of CNT, as well 
as the potential for large scale production (Patel, 2011). Regarding the electronic 
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applications, such as field emitting devices and field effect arrays, and for the 
development of sensing devices, CNT can be either grown directly on substrates (in-situ 
growth) through chemical vapour deposition technique, or by depositing pre-grown CNT 
(Narasimhamurthy and Paily, 2011). For in-situ growth, the catalysts are patterned on the 
substrates where the CNT will grow, as shown in the work of Jiang and Zhang (2010) 
where MWCNT arrays were produced by chemical vapour deposition process on Ta foils 
as substrate. In turn, the depositing of pre-grown CNT from a solution can also be 
considered: the first step is the attachment of CNT to surfactant molecules in aqueous 
solution, followed by the elimination of residuals in order to obtain the most uniform CNT 
solution. Such approach was followed by Li et al. (2009) where a glucose sensor was 
based on MWCNT, which were prepared from a CNT suspension in phosphomolybdic 
acid solution as solvent, with subsequent sonication and centrifugation. 
In general, after their synthesis, CNT contain a large content of impurities such as 
graphite, amorphous carbon, residual meal catalyst, and small fullerenes, but in wide 
range of quantities depending on the synthesis method, as reviewed by Stetter and 
Maclay (2004). Thus, the resulting CNT need to be dispersed, purified, and functionalized 
by different techniques such as chemical oxidation, filtration, centrifugation, and annealing 
(Haddon et al., 2004) before further applications, as shown in Section 2.2. In addition, and 
also depending on their potential applications, CNT can be isolated by length, by 
diameter, or into m-CNT and s-CNT to emphasize their properties (Komatsu and Wang, 
2010), as discussed in Section 2.1.4. 
 
 
2.1.3. Properties and applications of CNT 
 
The peculiar chemical properties as well as the physical properties, that is, mechanical, 
optical, thermal, and electronic properties of CNT are responsible for the application of 
CNT in various areas such as in chemical and biological sensors, field emission displays, 
energy storage devices, drug-delivery devices, and reinforcement of composite materials, 
as shown in Table 2.2. The interest and importance of CNT could be evaluated by the 
increasing number of publications in latest years: between 2008 and 2012, the 
publications related to CNT and to the development of sensors and biosensors with CNT 
have increased 42 % and 83 %, respectively. The total publications with CNT from 2008 
to 2013 were identified in Chemistry (25 %) and Materials Science (23 %), which are the 
top two main leading subject areas. The other three subject areas are Physics, Science 
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Technology, and Engineering with 19 %, 14 %, and 7 % of the total publications, 
respectively. Table 2.2 grouped the areas of applications and the main CNT properties for 
each of the five main subject areas on CNT research. 
 
 
Table 2.2 Main subject areas on CNT research, principal areas of application of CNT, and 
corresponding properties of the applied CNT (Adapted from Trends in Analytical 
Chemistry, 45, Justino et al., Copyright (2013a), with permission from Elsevier). 
Subject areas Areas of application CNT properties 
Chemistry Drug-delivery devices 
High surface to volume ratio 
High loadings of therapeutic agents 
Materials 
Science 
Reinforcement of CNT in 
composite materials (for example, 
polymers, and ceramics, for 
photovoltaic devices and organic 
light-emitting diodes) 
High tensile strength (≈ 63 GPa, being 
50x higher than steel)
a
 
High Young’s elasticity modulus (which is 
the strength-to-weight ratio, 5x higher 
than steel)
b
 
High surface to volume ratio 
High conductivity 
Physics 
Field emission displays (for 
example, development of flat 
panel displays, and microwave 
generators) 
High surface to volume ratio 
High thermal conductivity (≈ 3 kW m
-1
 K
-1
, 
comparable with that of natural 
diamond, ≈ 2 kW m
-1
 K
-1
)
c
 
High electrical conductivity 
High current density (>1 GA cm
-2
)
c
 
Chemical stability 
Science 
Technology 
Electronic devices (for example, 
sensors) 
Nanoscale dimensions 
High current density  
High sensitivity 
Engineering 
Energy storage devices (for 
example, as CNT-based solar 
cells, and in lithium-ion batteries) 
Large surface area 
Low resistivity 
Good chemical stability 
High electrical conductivity 
a
Yu et al. (2000); 
b
Strano et al. (2003); 
c
Collins and Avouris (2000). 
 
 
Taking into account the properties of CNT reported in Table 2.2: a) the high electrical 
conductivity of CNT is due to their tubular configuration, allowing the confinement of 
electrons around the circumference of the CNT, b) the electronic properties of CNT are 
due to their small diameter and high length, providing a very large surface to volume ratio, 
c) the high mechanical, thermal, and chemical stability is due to the covalent and strong 
C-C bonds, and d) the high Young’s modulus promotes a large angle bending without 
breaking. 
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Regarding the areas of application of CNT, the development of field emission displays 
is a current application of CNT requiring large amounts of such nanomaterial, which 
function as source of field emission electrons and it is used for flat panel displays and 
microwave generators, since CNT provide stable emission, high surface to volume ratio, 
long lifetimes, high thermal conductivity, and high current densities. Recently, CNT have 
also been applied as electron guns for scanning and transmission electron microscopes, 
where they operate at the highest current density. In Materials Science, the particular 
mechanical and electronic properties of CNT, that is, their high tensile strength and high 
conductivity, respectively, are essential for their application as molecular reinforcement in 
nanocomposites, mainly in ceramic matrix composites, since CNT increase the toughness 
of composites to energy absorption due to their elastic character. Regarding the 
Engineering area, CNT have been applied as supercapacitors, lithium-ion batteries, solar 
and fuel cells due to their capacity for energy storage, considered as an important field in 
clean energy economy. Such applications are possible due to the good chemical stability 
and high electrical conductivity. The electronic devices have also been developed using 
CNT as sensing element due to their high sensitivity leading to lower power consumption, 
low cost and miniaturized devices. Although controversy continues to exist related to the 
identification of the long-term effects and the possible toxicity of CNT in vivo, the use of 
CNT for the delivery of therapeutic agents has been found in literature, and the clinical 
application of CNT for drug-delivery only can be made when such questions will be 
properly addressed. Thus, the ability of CNT to penetrate in the cells as effective carriers 
for delivering peptides, proteins, nucleic acids, and small molecular drugs, as well as their 
drug loading capacity are yet controversial issues. CNT have also been used as 
transducer elements for biosensing applications mainly due to the presence of all carbon 
atoms on the entire surface, leading to a potential increase in sensitivity with the 
neighbouring molecules. Thus, biosensors for the detection of neurotransmitters, 
biomolecule, tumour biomarkers, and pathogenic bacteria still are a hot research topic. 
For this thesis, the understanding of the electronic properties of CNT is important since 
CNT are a basic element on the transduction mechanism of developed biosensors. The 
electronic properties of materials are dependent on the separation of the various valence 
energy states (occupied by electrons) and the conduction states (empty, but that can be 
occupied by electrons). For example, in metals, the valence and conduction bands are 
overlapped and then, the conduction is easily performed (without energy gaps, and with 
conduction bands not fully occupied). In this way, free electrons exist together with 
partially filled valence bands. In semiconductors, there is an energy gap and additional 
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energy (from thermal or optical excitation) is need to the movement of electrons to the first 
available conduction state. In insulators, the filled valence bands and empty conduction 
bands exist with a large band gap, leading to high resistivity. Regarding the electronic 
properties of CNT, if a band gap exists between valence and conduction bands, SWCNT 
are semiconducting. Thus, if any energy gap is present between such bands, and 
electrons of one energy state can move from valence to conduction band without 
additional energy, CNT are metallic. CNT display either a metallic or a semiconducting 
character depending of the (n,m) indices: CNT with n = m are metallic, and quasi-metallic 
CNT (with a small band gap) have (n - m) divisible by 3; the other remaining type of CNT 
are semiconducting. A diagram of electronic density of states (DOS) shows the group of 
DOS at specific energy levels for a material, which are the states at each energy level that 
are available to be occupied by electrons. Figure 2.7 shows the diagram of DOS for 
semiconducting SWCNT (s-SWCNT) and metallic SWCNT (m-SWCNT) where the 
valence (vn) and conduction (cn) bands are represented. DOS are finite for m-SWCNT, 
since various states are available to be occupied, and they are zero for s-CNT, since no 
states can be occupied by electrons. The sharp energy peaks in the DOS are known as 
van Hove singularities, which are discontinuities in the DOS of a solid, usually as result of 
low dimensionality. The distance between such discontinuities is associated with the 
energy required to the transition of one electron, and they are dependent of the structure 
and diameter of CNT. 
 
Figure 2.7 Schematic diagram of electronic density of states for: a) s-SWCNT and b) m-SWCNT. 
The solid arrows depict the optical emission transitions for both m- and s-CNT 
(Reprinted from Carbon, 50, Battie et al., Copyright (2012), with permission from 
Elsevier). 
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The Snn (n=1,2,3,…) identifies the energy of electronic transition between the states vn and 
cn, and an expression was found to relate such electronic transition with the diameter of 
SWCNT (Dresselhaus and Eklund, 2000): 
 
    
      
 
     [2.3] 
 
where ɣ is the carbon-carbon (C-C) tight binding overlap energy (2.5-3.2 eV), ac-c is the 
distance between C-C bonds (0.144 nm), and d is the diameter of the CNT. In this way, 
the band gap energy depends only and inversely to the diameter of s-SWCNT, and such 
band gap in the DOS of m-SWCNT is inexistent, since there is no gap in the DOS 
between the valence band and the conduction band.  
The UV-Vis spectroscopy is the most widely used technique for characterization of the 
purity and structure of SWCNT, through the evaluation of the singular interband electronic 
transitions of SWCNT obtained in UV-Vs spectra (Figure 2.8). The absorption bands are 
due to transitions between spikes in the DOS in the electronic structure of CNT, as 
reported by Harris (2009). It is important to refer that underneath such absorbance 
features, a broad and featureless background of π-plasmon absorption exists as a linear 
sloping baseline due to SWCNT but also due to metal catalysts and carbonaceous 
impurities derived from the synthesis process, as reported by Haddon et al. (2004) and 
Ryabenko et al. (2004). According to Itkis et al. (2005), the sloping baseline on which the 
interband transitions ride can be used to evaluate the intensity of peaks associated with 
SWCNT, that is, the strength of the characteristic absorbance features compared with the 
baseline of π-plasmon background provides the measure of the purity of the SWCNT 
dispersion, as studied by Itkis et al. (2005). Figure 2.8 shows the electronic spectrum of 
SWCNT produced by the electric arc discharge in the work of Itkis et al. (2005). As 
highlighted in the inset of Figure 2.8, the region of S22 interband transition was used by 
Itkis et al. (2005) to SWCNT purity evaluation, the AA(S) is the area of the S22 spectrum 
band after linear baseline correction, and AA(T) is the total area of the S22 band including 
SWCNT and carbonaceous impurity contributions. The band of S22 was chosen because 
the absorption of carbonaceous impurities is not reflected, and S22 transition is less 
susceptible to incidental doping, and less sensitive to charge transfer, as explained by 
Kazaoui et al. (1999). In Figure 2.8 it is also shown that it is not yet possible to analytically 
separate these contributions, and the π-plasmon can be considered as the collective 
excitation of electrons of π-band in a sample (Pichler et al., 1998).  
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Figure 2.8 Schematic illustration of the electronic spectrum of a typical SWCNT sample with the 
background π-plasmon location relatively to the absorption features. Inset: region of 
the S22 interband transition used by Itkis et al. (2005) for NIR purity evaluation 
(Reprinted with permission from Itkis et al., Journal of the American Chemical Society 
127. Copyright (2005) American Chemical Society). 
 
 
Other methodologies for the evaluation of m-SWCNT and s-SWCNT have been 
considered, such as the one forwarded by Landi et al. (2005), who based their work in the 
method proposed by Itkis et al. (2005), and concluded that such method leads to an 
overestimation of SWCNT purity with an average error higher than 24 %, since the 
metallic portion of SWCNT (in the M11 region) is not considered. On the other hand, the 
uncertainty of the shape and position of background absorption constitutes a limitation 
together with the variation of the absorbance intensity with the dispersion state, as 
reported by Ryabenko et al. (2004). Then, Landi et al. (2005) proposed a nonlinear model, 
based on the Lorentzian function for the π-plasmon absorption, as a physically based 
background subtraction, where both the overlap of electronic transitions and the peak 
broadening are considered. The overlap of electronic transitions is due to the variation of 
DOS of various SWCNT chiralities and diameters, and the peak broadening is influenced 
by the structural distortions and defects or bundling effects originated from the van der 
Waals interactions between the SWCNT. With the model proposed by Landi et al. (2005), 
the accuracy of SWCNT purity assessment was improved with an average error lower 
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than 7 %, and a physically background subtraction over the entire range of SWCNT 
electronic transitions is identified. 
The interaction of electromagnetic radiation with SWCNT can take place as absorption 
and as scattering. The light scattering depends on the dimension of scattering particles 
and the wavelength of radiation. Rayleigh scattering occurs when the diameter of the 
particle (d) is much smaller than one tenth of the wavelength (λ) of the incident beam      
(d << λ/10). The amount of Rayleigh scattering (Is) is inversely proportional to the fourth 
power of the wavelength of the incident beam (Is   1/λ
4) (Haddon et al., 2004), and thus 
the shorter the wavelength of light, the stronger the scattering. On the other hand, Mie 
scattering can also occur when the particle size is equal to or greater than the incident 
wavelength. 
Raman spectroscopy can also be used for the characterization of the dispersed 
SWCNT, in order to identify their electronic and vibrational structures producing typical 
spectroscopic signatures. Moreover, Raman spectroscopy is effective to obtain qualitative 
and quantitative information of SWCNT in terms of diameter, electronic structure, and 
purity, discriminating metallic and semiconducting components (Dresselhaus et al., 2005). 
This technique is based on the interaction between the incident light in a material and the 
vibrations of lattice. Since such interaction is done through polarizability variations due to 
atomic vibrations, it is strongly related to the electronic structure of material. Moreover, 
this technique is quick, sensitive, non-destructive, and requires little sample preparation.  
With the exposition of materials to monochromatic radiation, the incoming light interacts 
with an electron which is excited from the valence energy band to the conduction energy 
band, that is, it is transferred to higher energy level by absorbing a photon. In those higher 
energy levels, the interaction with phonons occurs (through electron-phonon coupling) and 
then the excited electron is scattered by emitting (or absorbing) a phonon, relaxing back to 
the electronic ground state by emitting a photon leading to the inelastic scattering of 
photon, as reported by Dresselhaus et al. (2005) and by Freiman et al. (2008). When the 
intensity of the scattered light is measured as a function of frequency downshift (losing 
energy) of the scattered light, Raman spectra are plotted and an accurate measure of the 
phonon frequencies of the material is obtained (Dresselhaus et al., 2005). Specifically, 
Raman spectroscopy is based on the light scattering effect: Rayleigh scattering and 
Raman scattering. The Rayleigh scattering has the same energy (frequency and 
wavelength) as the incident photons, and the Raman scattering is the inelastic scattering 
of photons by molecules due to changes in frequency. Figure 2.9 shows the energy level 
diagram of the states involved in the Raman scattering process, where the energy 
                                                      Introduction 
_________________________________________________________________________ 
25 
difference between the incident photon and the Raman scattered photon is the energy of 
a vibration of the scattered molecule. Thus, Stokes process occurs with the production of 
a phonon (phonon emission) and anti-Stokes process occur with annihilating a phonon 
(phonon absorption) in a material. It should be highlighted that the virtual energy states 
result from the virtual absorption, which is the absorption that occurs without energy 
consumption (Long, 2002).  
 
Figure 2.9 Energy level diagrams of the states involved in the Raman signal. 
 
 
Regarding SWCNT, when the energy of the incident laser is close enough to the 
energy between the van Hove singularities in the valence and the conduction bands, a 
strong resonantly enhanced Raman signal of a single SWCNT can be obtained, as stated 
by Thomsen and Reich (2007). When a bundle or a collection of isolated SWCNT is 
exposed to the laser line, only those tubes with inter-band transition energies resonant 
with the excitation energy will contribute strongly to the spectrum. 
 
 
2.1.4. Methodologies for separation of metallic and semiconducting CNT from CNT 
networks 
 
The separation of metallic (m-CNT) and semiconducting CNT (s-CNT) from CNT 
networks is advantageous for many electronic and sensing applications such as the 
fabrication of conductive films, field effect transistors (FET), and optical devices, as 
applied by Javey et al. (2003), Green and Hersam (2008), and Weisman (2010). The 
complete separation of CNT into s-CNT is not accomplished, since the synthesis 
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processes of CNT are not able to synthesise only s-CNT or totally remove m-CNT without 
damaging s-CNT for functional microfabricated devices. Thus, physical methods such as 
alternating current dielectrophoresis (Krupke et al., 2003), selective electrical breakdown 
(Collins et al., 2001), density gradient ultracentrifugation (Arnold et al., 2006; Yanagi et al., 
2008), and microwave irradiation, as well as chemical methods such as gel 
chromatography and selective functionalization are some methodologies employed to 
isolate m-CNT and s-CNT from a CNT network. For the development of FET with CNT 
(NTFET), such isolation is needed since the presence of an excessive number of m-CNT 
can degrade the electrical signal of NTFET on current-voltage curves, decreasing the 
ON/OFF ratio, which is the extent of current obtained between the lowest and highest 
voltage applied. It is known that the higher such ratio, the higher the performance of 
NTFET. However, the application of the CNT network in the NTFET biosensing devices 
has been reported, for example, by Gui et al. (2007), Cid et al. (2008a; 2008b), and 
Villamizar et al. (2011) but with resulting low ON/OFF ratios, although in a CNT network, a 
higher content of s-CNT are present relatively to m-CNT. 
Various methodologies have been attempted in order to obtain isolate s-CNT or to 
enrich them in CNT dispersions, for further application in electronic and biosensing 
devices. In alternating current dielectrophoresis, the dispersed SWCNT are exposed 
under an electrical field, and since m- and s-CNT have different dielectric constants under 
an alternating current (1000 vs. 5, respectively), the electronic separation is possible 
(Krupke et al., 2003; Krupke and Hennrich, 2005). The m-CNT are collected toward the 
high applied electric field in a microelectrode array, while the s-CNT are left in solvent, 
which has an dielectric constant of approximately 80, but this process can only be 
operated at a small-scale. Tanaka et al. (2008) also employed electrophoresis but with 
agarose as the matrix gel (stationary phase) for separation of m-CNT and s-CNT from a 
CNT dispersion with an aqueous solution of sodium dodecyl sulphate (SDS) as dispersant 
(mobile phase). In gel electrophoresis, the migration of charged molecules was observed 
in a gel across an electrical field, sorting analytes by differences in molecular weight 
(MW). Using this technique, Tanaka et al. (2008) verified that, when a constant direct 
current is applied to the agarose gel, m-CNT coated with negatively charged SDS migrate 
toward the anode, as shown in Figure 2.10, leaving the enriched s-CNT in the gel. 
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Figure 2.10 Sequential photographs of the separation of SWCNT dispersed by agarose gel 
electrophoresis (Reproduced from Tanaka et al., Copyright (2008) with permission by 
The Japan Society of Applied Physics). 
 
 
As depicted in Figure 2.11, other separation methodologies based on agarose gel were 
also developed by Tanaka et al. (2009), namely: the manual squeezing of the frozen and 
thawed gel, centrifugation, diffusion, and permeation. 
 
Figure 2.11 Schematic diagrams of separation methodologies based on agarose gel: a) freeze and 
squeeze, b) centrifugation, c) diffusion, and d) permeation (Adapted and reprinted with 
permission from Tanaka et al., Nano Letters 9. Copyright (2009), American Chemical 
Society). 
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In the squeezing method, the agarose gel is mixed with a SWCNT dispersion and SDS, 
then, the mixture is frozen, and thawed. The s-SWCNT are selectively adsorbed to the 
agarose gel matrix, and the m-SWCNT remain in solution with the SDS micelles, as 
shown in Figure 2.11. In the centrifugation method, the SWCNT mixture is centrifuged and 
the supernatant becomes enriched with m-SWCNT, while s-SWCNT is precipitated 
together with the gel. In the diffusion method, the SWCNT in gel are added to an elution 
buffer, and in the permeation method, the agarose gel is added to a dispersion of 
SWCNT; then, for both methods, s-CNT and m-CNT are separated with centrifugation. 
Thin-film transistors (TFT) with separated portions were tested by Fujii et al. (2009) and 
high ON/OFF ratios were observed, although with large hysteresis, which constitutes an 
experimental problem for NTFET applications, as explained in Section 2.3. In all methods 
based on agarose gel shown in Figure 2.11, the s-SWCNT are selectively adsorbed in 
agarose gel. Thus, the separated s-SWCNT/gel should be refluxed in an aqueous solution 
of 1 % of citric acid at 95 ºC to decompose the agarose gel, and with a brief centrifugation, 
the s-SWCNT are removed from gel. After that, the separated portion is redispersed in 
surfactant or solvents such as N-methylpyrrolidone, but this redispersion could introduce 
structural defects on CNT. Such structural defects are imperfections that change the 
curvature of CNT, or they occur due to the presence of carbon atoms arranged in 
pentagons and heptagons embedded in the hexagonal structure of CNT. Finally, the 
separation process can be significantly improved if an optimization procedure is followed 
in order to find the optimum values for the gel concentration and the composition of 
agarose (Li and Li, 2011). 
The selective electrical breakdown method is based on the current induced oxidation to 
selectively eliminate m-SWCNT from SWCNT networks. High currents are applied to the 
SWCNT networks and the m-SWCNT are selectively removed because they are burned in 
contact with air. Collins et al. (2001) have performed this separation process and used the 
remaining s-SWCNT for producing FET devices. However, the electrical breakdown is 
difficult to control, affecting the reproducibility of the process of fabrication, since losses in 
s-SWCNT could occur limiting the CNT density. 
In the density-gradient ultracentrifugation method, CNT are moved in a density gradient 
solution by the centrifugal force. For example, Arnold et al. (2006) have used a non-ionic 
density gradient agent (iodixanol) to produce density gradients where SWCNT are 
separated in layers. The s-SWCNT were retained in the upper layer (low density) and the 
m-SWCNT were located in the lower layer (high density). The iodixanol can constitute a 
problem due to the presence of iodine atoms, which function as electron acceptor by 
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SWCNT, degrading the electronic characteristics of s-SWCNT since its conductivity 
increases. Yanagi et al. (2008) also used the density-gradient ultracentrifugation 
technique, with sucrose as a gradient medium, which does not work as an electron 
donor/acceptor, and it has a small MW, thus leading to fast removal by centrifugation, and 
obtaining highly enriched solutions of m-SWCNT and s-SWCNT. According to Izard et al. 
(2008), the density-gradient ultracentrifugation still leaves traces of surfactant and density 
gradient materials in CNT, which interfere with the performance of FET.  
The microwave irradiation method has been used by Shim et al. (2009) as a method to 
obtain separated s-SWCNT. In this technique, the energy is directly applied to the 
SWCNT by an electromagnetic field, and as the m-SWCNT have higher dielectric 
constant than the s-SWCNT, they are broken down since the energy absorbed by the m-
SWCNT is much higher than that by the s-SWCNT, which makes possible the destruction 
of m-SWCNT. The limitation of this method is the possible damage of s-SWCNT after the 
microwave treatment. 
The selective reaction is also used for removal of m-SWCNT in order to obtain 
enriched s-CNT from a SWCNT network. For example, Yang et al. (2006) have used 
fluorine gas to induce stronger electrostatic binding with m-SWCNT due to the presence 
of more abundant π-electrons near the Fermi level when compared to s-SWCNT. Ghosh 
and Rao (2009) have employed the selective reaction of a diazonium salt of                     
4-heptadecafluororooctylaniline with the m-SWCNT to produce covalent aryl bonds, thus 
extracting electrons from nanotubes and providing high selectivity towards the m-SWCNT. 
However, the presence of covalent chemical groups degrades the electrical properties 
and devices performance, and vacuum annealing treatment at 600 ºC is needed for the 
elimination of such functional groups from the remaining s-SWCNT, which could introduce 
defects in the CNT walls. 
The size exclusion chromatography has been another technique applied for the 
separation of CNT by electronic type. Liu et al. (2011) used Sephacryl S-200 of            
GE-Healthcare as the size exclusion gel and SDS surfactant solution with a high 
dispersibility to elute the bound s-SWCNT. In this technique, several chromatography 
columns are connected in series, and when an excess amount of SWCNT dispersion is 
applied onto the top of the column, the selective adsorption of s-SWCNT in the various 
columns occurs due to the different strengths of interaction with the gel. As the m-SWCNT 
have the lowest interaction with the gel, they are eluted firstly, while the s-SWCNT are 
adsorbed in gel. However, Liu et al. (2011) have found structural defects in the separated 
s-SWCNT when Raman analysis was used to confirm the electronic structure of the 
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SWCNT and in order to obtain a scalable separation, a suitable combination between 
stationary and mobile phases should be found taking into account the different affinities 
towards the different type of SWCNT. 
 
 
2.2. Molecular recognition and applications of CNT in sensing devices 
 
The molecular recognition is defined as the energy and the information involved in the 
selection and binding of an analyte of interest into a recognition molecule due to their 
complementarity, that is, affinity interaction. In general, the immobilization of biomolecules 
such as proteins, enzymes, antibodies, and peptides on CNT surface can be made by 
non-covalent adsorption or covalent bonding of functional groups through reaction with the 
π-conjugated network of the SWCNT, increasing the specificity and the sensitivity of 
biosensors, as reported by Zhao and Stoddart (2009), Lei and Ju (2010), and Liu et al. 
(2010). The typical reactions can be based on the formation of covalent bonds, for 
example with porphyrin-based compounds (Guo et al., 2006), or non-covalent bonds, for 
example with phospholipid-poly(ethyleneglycol) (Liu et al., 2009). The covalent 
functionalization of CNT can cause drastic changes on electronic band structures of CNT, 
since functional groups, such as carboxylic acids at the ends and sidewalls of CNT, 
contribute with defects on CNT structure, breaking the π-conjugated network on CNT and 
affecting their properties (Harris, 2009). The incorporation of polymers for CNT 
functionalization is also used, since polymers protect the CNT surface from unspecific 
molecules and they are suitable for covalent adsorption of receptor molecules on CNT, 
obtaining more selective sensors for specific analytes (Katz and Willner, 2004). For 
example, Star et al. (2003) used polyethyleneimine (PEI) and poly(ethyleneglicol) (PEG) 
as polymers for providing the covalent attachment of amine groups to the receptor 
molecule in CNT surface (through PEI), and to prevent unspecific adsorption of 
biomolecules (through PEG). 
As CNT display a poor solubility due to their hydrophobicity and strong van der Waals 
attractions between the nanotubes, the chemical functionalization of CNT surface can also 
be employed for their dispersion by attaching hydrophilic species, in order to widen their 
applications, as demonstrated by Star et al. (2004), and Zhao and Stoddart (2009). 
SWCNT can be dispersed in organic and aqueous solutions of surfactants in order to 
assess the optimal conditions for their surface functionalization, either covalently or non-
covalently, as demonstrated by Bandyopadhyaya et al. (2002), Nakashima et al. (2002), 
                                                      Introduction 
_________________________________________________________________________ 
31 
and Islam et al. (2003). The non-covalent functionalization of CNT, which preserves the 
sp2 structure of SWCNT without disrupting the CNT structure, can be made through the 
use of surfactants such as sodium cholate, sodium dodecyl sulphate, and Triton X-100 
(Moore et al., 2003), as well as by wrapping CNT in polymers such as polyvinylpyrrolidone 
and polystyrenesulfonate (Banerjee et al., 2005). Such functionalization employs 
functional aromatic compounds that have π-π stacking behaviour on the surface of 
SWCNT, which is a non-covalent interaction between molecules with aromatic structures. 
Regarding the application of CNT for the development of sensing devices, biosensors 
such as immunosensors and genosensors have been reported for the detection and 
quantification of biomolecules (for example, enzymes and proteins), antibodies/antigens, 
and DNA sequences, respectively, as studied by Daniel et al. (2007), Veetil and Ye 
(2007), and reviewed by Roman (2010). In immunosensors, the functionalization of CNT 
surface should occur in order to obtain the immobilization of antibodies (Chen et al., 
2003). The incorporation of CNT in point-of-care (POC) biosensors is also a promising 
research area, due to their sensitivity, their adequate response time, and their fitness for 
purpose, since POC biosensors can be hand-held and used by patients. As reviewed by 
Justino et al. (2013a), the application of CNT on POC systems has been under 
consideration for the analysis of biological analytes such as DNA, glucose, proteins, and 
viruses, and this research area has been expanding due to the increasing demand for 
rapid diagnostic devices. However, analytical improvements on POC biosensors are 
greatly needed for the detection of cancer biomarkers for the diagnosis of cancers, and 
detection of glucose to diabetes diagnosis and prognosis. As reviewed by Justino et al. 
(2010), many of the available POC devices are based on electrochemical sensing, and 
the research in clinical field is likely to progress in this very same direction due to reasons 
of portability, cost effectiveness, fast response of such biosensors, and high analytical 
performance provided, mainly in terms of sensitivity and selectivity. 
 
 
2.2.1. Antibody-antigen interaction and label-free biosensors 
 
Antibodies are glycoproteins with molecular weight (MW) between 140 and 970 kDa, 
also known as immonuglobulins, and they are secreted by lymphocytes, that is, by the 
immune system of an organism. Antibodies can be collected from a living organism, 
separated, and concentrated for use in biosensing applications. In this thesis, the 
antibodies used are the anti-human C-reactive protein (CRP) and they were obtained from 
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goat using CRP purified from pooled inflammatory human serum as the immunogen 
(Sigma-Aldrich Química, Portugal). Biochemically, the structure of an antibody consists of 
a Y shaped unit, which has polypeptide chains, as shown in Figure 2.12. The polypeptide 
chains are based on two heavy (H) chains (with 450 amino acid residues and MW of 50 
kDa) and two light (L) chains (with 212 amino acid residues and MW of 25 kDa), which are 
linked by disulphide bonds (-S-S-). Both chains are divided in structural domains based on 
amino acid sequences. The H chain has four domains (VH, CH1, CH2, and CH3), and the L 
chain has two domains (VL and CL), which are responsible for the flexibility and globular 
nature of antibodies (Killard et al., 1995), where V and C are the initials of variable and 
constant domains, respectively. The variable domains of both chains are the most 
important in the antibody structure since they determine the variability of antigen 
interaction. 
 
Figure 2.12 Schematic basic structure of an antibody, with typical light chains (red), heavy chains 
(blue), and disulphide bonds (green). 
 
 
As also shown in Figure 2.12, the Y shaped structure of an antibody can also be 
characterized by regions, that is, two regions called Fab (fragment containing antigen 
binding site) and Fc (fragment that crystallizes) regions. In the Fab domain, a site named 
epitope is present to bind with the corresponding antigen, and Fab segments provide 
flexibility to the antibody through rotational and lateral movements of the two Fab 
segments. The Fc domain is responsible for the linking of the antibody to the receptor 
molecule. 
The antibody-antigen interaction is the detection mechanism used both in 
immunosensors (sensing devices) and in immunoassays (traditional analytical 
techniques). Antibodies function as recognition elements in immunoassays and 
immunosensors, due to their strong specificity and affinity for their equivalent antigens. 
The immunoassay is an analytical method capable of quantifying the amount of an 
antigen within a sample through its selective and affinity reaction with a specific antibody. 
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Normally, antigens are labelled with an enzyme to produce a coloured product which 
accumulates in the solution for signal detection, which is related to the initial concentration 
of antigen. The immunosensors are analytical devices where the interaction between 
antibody and antigen has a non-covalent nature (Moina and Ybarra, 2012), and the 
analytical signal generated from such interaction is converted through a transducer into a 
physico-chemical response, for example, based on the variation of optical properties, 
electric charge, mass or heat, as shown in Table 2.3, where the various categories of 
immunosensors are identified according to their transduction principle. 
 
 
Table 2.3 Categories of immunosensors according to their transduction principle. 
Immunosensor Transduction principle Response 
Electrochemical 
Amperometry / FET Current 
Potentiometry 
Electrode potential or voltage 
differences 
Conductimetry Conductance or resistance 
Optical 
Surface Plasmon Resonance 
Refractive index  
Grating couplers 
Differential interferometry 
Optical path or refractive index Reflectrometric interference spectroscopy 
Resonant mirror (mode coupling) 
Mass sensitive 
Surface acoustic wave Elasticity or density  
Quartz Crystal Microbalance Mass 
 
 
For example in electrochemical immunosensors, the response is based on an electrical 
signal and in optical immunosensors, an optical signal can be generated or a change in 
optical properties can be monitored. As reviewed by Justino et al. (2010), the 
immunosensors based on surface plasmon resonance, FET, and quartz crystal 
microbalance are label-free, ease of use, less expensive, with minimal requirements of 
sample preparation, and the output signal is obtained directly from the sensor software. 
The good mechanical and conductive properties of CNT, such as high energy densities 
and low driving voltages, respectively, can lead to expectable developments in the field of 
immunosensors. For example, NTFET immunosensors have been already reported as 
optimal transducers because they are label-free and the biological sensitive elements are 
immobilised onto the transducer surface also functioning as the electronic part of the 
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device, as reviewed by Hu et al. (2010). Thus, immunosensors have been pointed out as 
an alternative for immunoassays because they can provide fast screening results, they 
are small, semi-automated and increasingly portable (Lin and Ju, 2005). Such an increase 
in portability has been the consequence of improvements in sensor miniaturization. 
Usually, immunoassays are analytical techniques used for the validation of a new 
methodology developed for antigen detection. Various immunoassay formats exist, that is, 
various types of antibody-antigen interaction are known, such as the capture, sandwich, 
competition, and inhibition assays. Sandwich assays tend to be more sensitive and 
robust, and they are the most commonly used together with the competitive binding 
assay, which are schematically shown in Figure 2.13. 
 
Figure 2.13 Schematic diagrams of the two most commonly used immunoassays: a) sandwich 
immunoassay and b) competitive binding assay. 
 
 
In a sandwich immunoassay (Figure 2.13a), two antibodies are used, which bind to 
different sites in the antigen. The capture antibody is attached to a solid surface and it is 
specific for antigen. Typically, an enzyme (for example, the horseradish peroxidase) is 
attached, that is labelled, to the detection antibody in order to react with a substrate 
responsible for the detection signal. Usually, the colorimetric detection is used, and the 
signal is proportional to the amount of antigen present in the sample. In a competitive 
binding assay (Figure 2.13b), a competition between labelled and unlabelled ligand occurs 
for a limited number of antibody binding sites, and only an antibody is used. A fixed 
amount of labelled ligand is incubated with the antibody, and with variable amount of 
unlabeled ligand, being the amount of labelled ligand a function to the total concentration 
of labelled and unlabelled ligand. The signal is lower with the increase of unlabelled 
analyte, that is, the signal of immunoassay is inversely proportional to the concentration of 
analyte in the sample. In this thesis, the capture format was used for the developed 
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NTFET immunosensors, and the sandwich assay was used for ELISA methodologies for 
the determination of CRP in saliva and serum samples. 
Another classification of biosensors is based on the nature of the molecule detected, 
that is, they can be classified as label-based or label-free biosensors. In label-based 
biosensors, the label molecule is detected and it could be radioactive, enzymatic, 
fluorescent, or redox in nature. In label-free biosensors, any label is used, the analyte of 
interest is directly detected in its native form, and the intermediate step of tagging is 
unnecessary. Thus, the reduction of number of steps for the assay is an advantage to the 
application of such label-free biosensors, since the chemical modifications of 
biomolecules with labels are not necessary, leading to simplification, higher speed of 
analysis, increased reliability, and lower cost, as specified by Fan et al. (2008). 
Concerning the transduction technique used in immunosensors, FET devices become 
successful alternatives to the complex optical sensors due to their low cost, low power 
consumption, miniaturization, and multiplexing capabilities, as well as due to their simple 
detection principle based on electrical measurements. In this thesis, the mechanism of 
transduction of the electrochemical immunosensors is based on the FET principle. 
 
 
2.3. Operation principles and applications of field effect transistors with carbon 
nanotubes (NTFET) 
 
Field effect transistors with carbon nanotubes (NTFET) constitute a type of detection 
systems which use SWCNT as active elements. They were firstly reported by Martel et al. 
(1998), and Tans et al. (1998), and they can be made of either a unique SWCNT or a 
network of SWCNT as studied by Star et al. (2003), and Byon and Choi (2006), 
respectively. Figure 2.14 shows a typical configuration for a NTFET with the electrical 
associations between the source, drain, and gate contacts. NTFET use the semiconductor 
characteristic of SWCNT to the construction of sensor devices with an excellent 
performance in terms of analytical figures of merit, such as low limit of detection, and high 
sensitivity (Kauffman and Star, 2008). MWCNT can also be used, but the SWCNT are 
preferable due to their simpler structure, and easier study in terms of chemical and 
physical properties, as reported by Liang et al. (2007). 
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Figure 2.14 Schematic of a typical NTFET (ID, drain current; VD, drain voltage; VG, gate voltage). 
 
 
As shown in Figure 2.14, a typical NTFET is an electronic device constituted by a 
source and drain contacts, and a gate contact separated by a thin insulated layer of SiO2. 
The gate insulator could also be a double layer of SiO2-Si3N4, SiO2-Al2O3, or SiO2-Ta2O5. 
NTFET are currently called unipolar transistors due to the use of only one of the two 
carrier types, holes or electrons, depending on the nature of conduction. NTFET are 
considered as p-type devices, when the conduction is mostly made through holes, and as 
n-type when the conduction is made by electrons, as major carriers (McEuen, 2000). For 
an intrinsic semiconductor, the number of holes is similar to the number of electrons. In 
electronics, the concept of hole is related to a missing electron in the valence band, and 
the term electron refers to free electrons in the conduction band. Sometimes FET also 
show ambipolar behaviour, as studied by Martel et al. (2001), when the charge carriers 
are both holes and electrons in the same device. 
In a NTFET, the current flows between the source and the drain contacts, through the 
CNT channel and it depends of the voltage applied and the resistance of the CNT 
channel, being modulated by the gate contact (Derycke et al., 2002). When a negative 
bias voltage is applied to the gate (gate voltage, VG < 0), the hole conduction is induced, 
and the s-SWCNT are turned ON; then, when the bias is positive (VG > 0), SWCNT are 
turned OFF. This ON/OFF current ratio is a particular characteristic of each FET device 
constituting one of its figures of merit. With the decrease of VG, electrons are pushed 
away from the CNT and into the contacts, thus increasing the conduction. Increasing the 
VG, more electrons are pulled onto the CNT from the contact, polarizing the system and 
accumulating negative charges, thus stopping the conduction process. In a network of 
SWCNT, the m-SWCNT have a pronounced effect on the conductance of the “OFF” state 
(achieved by positive gate voltages), reducing the modulation (difference between the ON 
and OFF states of the device). Thus, the higher the semiconductor content of the CNT 
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network, the higher the modulation of current response obtained through the application of 
gate voltages on NTFET. When a network of SWCNT is used instead of only a single 
nanotube, the signal monitoring of sensing systems is the average of all signals produced 
by the CNT network. 
In the NTFET, the SWCNT allow the current conduction between contacts (source and 
drain), contrarily to typical metal-oxide semiconductor FET (MOSFET), a type of transistor 
where the conduction is controlled by the application of gate voltages at the surface of 
insulating layer of SiO2. In a NTFET, the region involving metal contacts and SWCNT 
interfaces with a region with high electronic density, which generates an electronic 
valence band, called depletion region, and a potential barrier, called Schottky barrier, 
which generates an electrical resistance due to the inhibition of holes transmission 
between SWCNT and the metal. Then, the NTFET behaviour as transistors is based on 
the transport through the Schottky barrier in the interface of the metal contact/SWCNT, 
which in turn, depends on the geometry of the interface, the SWCNT diameter, and the 
type of metal, as studied by Javey et al. (2003), and Chen et al. (2005). 
The hysteresis is an experimental problem which can occur in NTFET due to the 
interaction of water molecules with SiO2, when the electrical characterization of NTFET is 
performed under ambient conditions, or it can be associated with the oxygen-related 
charge traps in the SiO2 (Balasubramanian et al., 2004; Kim et al., 2003). Kim et al. (2003) 
suggest that hysteresis is due to the charge trapping by water molecules around the 
nanotube: when positive VG values are applied, electrons are slowly trapped near CNT, 
and CNT have a more negative potential than that simply due to the VG, and an additional 
current arises. Such parasitic effect of hysteresis is not present in the NTFET developed 
in this thesis, being an additional advantage of such devices, as shown in Chapter 5. 
Regarding the gate contact of the NTFET, it can have two configurations: the back-
gated and the electrolyte-gated, as shown in Figure 2.15. 
 
Figure 2.15 Schematic diagrams of different gate configurations for NTFET: a) back-gated 
configuration and b) electrolyte-gated configuration. 
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In back-gated configuration (Figure 2.15a), the gate electrode is placed at the back of 
the devices, and in contact with the SiO2 layer. In this way, the CNT are in contact with the 
sample, and the originated signal can be easily related to the presence of the analyte of 
interest, and measured. Thus, any additional reference and external electrodes are 
unnecessary. In the electrolyte-gated configuration (Figure 2.15b), an external electrode 
(usually a Pt electrode, due to its stability) is placed in contact with the aqueous sample 
solution and the SWCNT. The VG is applied to the external electrode, and this voltage 
affects the CNT via ions in the electrolyte. The target ion presents in the solution is 
determined due to the electrostatic potential difference monitored between the CNT and 
the electrolyte solution, which is due to the various redox reactions occurring at the metal-
liquid interface. In the electrolyte-gated configuration, the distance between the gate 
electrode and the SWCNT channel is short, but the challenge is on the development of 
reference electrodes at the micrometer scale. Minot et al. (2007) have concluded that the 
potential of the Pt electrode is unstable when proteins bind to its surface, and a reference 
electrode Ag/AgCl should be used to control the solution potential. In this thesis, the back-
gated configuration was applied to the NTFET fabricated, where the silicon wafer, which 
serves as the basis for the microfabrication, was used as the back-gate. 
Regarding the applications of NTFET, they are considered as relatively new devices for 
the detection and quantification of biomolecules, such as glucose (Besteman et al., 2003), 
xenobiotic compounds such as bisphenol A (Sánchez-Acevedo et al., 2009), DNA (Star et 
al., 2006), pathogenic microorganisms such as Salmonella Infantis (Villamizar et al., 
2008), proteins such as human chorionic gonadotropin and bovine serum albumin, as 
reported by Chen et al. (2004), as well as prostate-specific antigen (Kim et al., 2009). The 
interaction between such compounds and the SWCNT have various response 
mechanisms on the NTFET, but the most reported is the variation of electrical properties, 
that is, the transference of charges, or the modification of Schottky barrier, as proposed by 
Chen et al. (2005) and Wang (2005), as well as the scattering potential for mobile charges 
or charge scattering caused by local deformation, as stated by Heller et al. (2008). 
Although the performance of various NTFET, when applied to environmental quality 
and clinical diagnosis, have been highlighted as reported by Kauffman and Star (2008), 
and Burghard et al. (2009), the incorporation of CNT and other nanomaterials in sensors 
and biosensors still shows some limitations which hinder their wider potential applications. 
Some characteristics of nanomaterials such as CNT density, diameter, and chiralities may 
cause considerable variability on the devices properties affecting the analytical 
performance of the sensing systems, as shown in Figure 2.16. For example, Ishikawa et 
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al. (2010) studied the effect of the density of SWCNT network on the analytical 
performance of FET devices for streptavidin detection, and concluded that, when the 
density of CNT is lower, the sensitivity is higher in terms of both limit of detection (LOD) 
and the magnitude of analytical response (defined as normalized conductance), and the 
reproducibility of such biosensors is better. The enhanced sensitivity associated with a low 
density of SWCNT is partly explained by the elimination of direct metallic nanotube 
pathways, enhancing the semiconductor behaviour of nanotubes and providing strong 
gate dependence, lower capacitance, and high ON/OFF ratios, while the high density of 
SWCNT reflects their quasi-metallic behaviour. Fu and Li (2010) also reported a 
ultrasensitivity of FET biosensors with SWCNT networks for detection of DNA molecules 
(0.1 fM) when lower density of CNT were applied: ON/OFF ratio and LOD have been 
improved three and five orders of magnitude, respectively. 
 
 
Figure 2.16 Characteristics of the nanomaterials that can influence the analytical performance of 
chemical and biological sensors (Reprinted from Trends in Analytical Chemistry, 47, 
Justino et al., Copyright (2013b), with permission from Elsevier). 
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2.4. C-reactive protein (CRP): characterization, clinical importance, and 
methodologies for its quantification 
 
Cardiovascular diseases (CVD), for example, cerebral vascular accident and coronary 
heart disease are among the major causes of ill health, invalidity, and death in Portugal, 
according to the latest Portuguese National Health Plan for 2012-2016 (PNHP, 2012) and 
the National Programme for Prevention and Control of the Cardiovascular Diseases 
(NPPCCD, 2006). Such diseases are mainly associated with smoking, high blood 
pressure, high cholesterol levels, and sedentary habits, and then the prevention of such 
risk factors should be taken into consideration. In Europe, there is a similar pattern and 
CVD cause nearly half of all deaths (48%), according to the latest European 
Cardiovascular Diseases Statistics (Nichols et al., 2012), also being the main cause of 
death worldwide (Roger et al., 2012). 
In the biomedical area, the determination of specific blood compounds (biomarkers) 
has been suggested as a tool for the identification of high-risk patients in terms of the 
CVD risk (Vasan, 2006). According to Packard and Libby (2008) the diagnosis of such 
compounds, such as C-reactive protein (CRP), interleukin 18, matrix metalloproteinase 9, 
adiponectin, and soluble CD40 ligand, in real-time and with rapid analysis is required for 
the adequate evaluation and prediction of CVD risk. CRP is currently considered the best 
validated inflammatory biomarker (Packard and Libby, 2008), and functions as an acute-
phase protein, since it is found at trace levels in serum and increases dramatically during 
tissue damage, infection, and inflammatory processes. According to Mitaka (2005), the 
CRP has a plasma half-life of 19 hours, and even after a single stimulus, it may take 
several days to return to the baseline. Thus, as the CRP levels keep relatively stable 
without significant diurnal variation, this parameter is quite amenable to its correct 
quantification (Macy et al., 1997). The name of such protein, called fraction C when 
discovered by Tillet and Francis (1930), is due to its precipitation with the C-
polysaccharide of pneumococcus in the acute-phase pneumococcal pneumonia.  
Chemically, the CRP is composed by five identical non-glycosylated (without attached 
glycans) polypeptide subunits, and each of them has approximately 23 kDa. As displayed 
in Figure 2.17, the subunits are non-covalently associated in an annular configuration, 
each of them containing two calcium ions in the ligand-binding sites. Due to its cyclic 
pentameric configuration, the CRP belongs to the family of pentraxins (acute-phase 
reactants characterized by a cyclic structure) which are a group of proteins that are 
expressed with infection, systemic inflammation, and tissue damage. 
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Figure 2.17 Molecular structure of CRP (Reproduced from Black et al., Copyright (2004) with 
permission by The American Society for Biochemistry and Molecular Biology). In 
zoom: the ligand-binding site of CRP with the calcium ions (yellow) complexed with 
phosphocholine (green) of a damaged cell. 
 
 
The CRP is synthesized in the serum by the hepatocytes and its production can be 
regulated by inflammatory cytokines, mainly by interleukin-6 (Bucova et al., 2008). The 
CRP, through its calcium ligands, binds to phosphocholine, which is a component of 
phospholipids on cell membranes and plasma lipoproteins (Thompson et al., 1999). The 
complexed CRP activates the complement system, and a range of processes, such as 
phagocytosis and lysis of invading cells is initiated. Biochemically, the complement system 
is constituted by approximately 35 proteins, which become activated through sequential 
proteolytic cleavages in response to endogenous ligands, such as immunoglobulins or 
pentraxins, among others (Tulamo et al., 2010). 
The monitoring of CRP levels is important to predict the risk of atherosclerotic 
diseases, including CVD, and various epidemiologic studies have demonstrated the 
association of CRP with the increase of cardiovascular risk, as reviewed by Calabró et al. 
(2009), and Silva and Lacerda (2012). The risk of CVD has been considered low if the 
levels of CRP in serum are below 1.0 mg L-1 and, in turn, it becomes elevated when levels 
of CRP are higher than 3.0 mg L-1. When levels of CRP are higher than 3.0 mg L-1 and up 
to 10 mg L-1, it functions as an indicator for significant risk of chronic CVD including acute 
coronary syndromes. Very high levels between 10 and 50 mg L-1 can also be found in late 
pregnant women and viral infections, and even higher levels, between 50 and 200 mg L-1, 
are related to bacterial infections and active inflammation (Clyne and Olshaker, 1999). 
Thus, and according to FDA (2005), patients with CRP levels higher than 10 mg L-1 should 
be checked for infection and inflammation, other than CVD. Therefore, biosensing 
systems as well as other analytical techniques fit for purpose should cover the whole 
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concentration range of interest, that is, they may be capable of evaluating levels of CRP 
lower than 1.0 mg L-1 and higher than 50 mg L-1. 
The CRP has been considered as an immunogenic protein, since it has a MW greater 
than 5 kDa (Vo-Dinh and Cullum, 2000), suggesting high recognition and antibody binding 
with very high specificity. Then, in all methodologies used for the detection and 
quantification of CRP, the interaction between antibody and antigen is applied due to the 
high specificity and affinity of antibodies to the target molecules. Clinical immunochemical 
methods based on high sensitivity assays, that is, immunoturbidimetric, 
immunochemiluminometric, and immunonephelometric assays, as well as enzyme linked 
immunosorbent assays have been traditionally used to the detection of CRP in blood 
serum with LOD ranging from 0.03 to 0.2 mg L-1 and detection range between 5 and 10 
mg L-1 of CRP (Dominici et al., 2004; FDA, 2005). Immunoassays, which are biochemical 
tests for quantifying a substance based on its ability to bind to an antibody 
(immunoreaction), require expensive instrumentation, sample pre-treatment protocols, 
laborious work, and rigid operational procedures. Besides, they are time-consuming, and 
the detection is indirect, since they are based on optical transduction and one of the 
reagents is labelled. In the 1990s, the CRP concentration in patient serum was 
determined by nephelometric assays measuring the formation of antibody-antigen 
complexes (ICSH, 1988), and such test would take 30 minutes with an analytical 
sensitivity of 0.04 mg L-1. Nowadays, the CRP quantification method used in routine 
clinical laboratories is the high-sensitivity CRP test based on the enzyme-linked 
immunosorbent assay (ELISA assay) (Rifai and Ridker, 2001), an immunoanalytical 
method which became a traditional technique to quantify the amount of CRP in blood 
serum with a sensitivity in the order of ng L-1. 
In the field of the development of electrochemical immunosensors for CRP detection, 
Meyer et al. (2007) developed a magnetic immunosensor with acceptable values for LOD 
(2.5x10-2 mg L-1) on a large dynamic linear range (2.5x10-2 - 2.5 mg L-1). However, Meyer 
et al. (2007) pointed out some disadvantages in the magnetic immunosensor, such as the 
high sample size (0.5 mL) and large time required for measurement (30 minutes). Bini et 
al. (2008) proposed an optical RNA-based aptasensor based on the surface plasmon 
resonance method, with a lower LOD (5 μg L-1) than that obtained by Meyer et al. (2007); 
however, the method is labour intensive and required expensive equipment for 
measurement of CRP. Sohn and Kim (2008) have developed a BioFET where the CRP 
was linked to an antibody which in turn was bound to a cystein-tagged protein G. The 
signal produced by the binding of the protein G with the CRP was similar to the application 
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of a negative gate voltage to MOSFET with a decrease in the channel conductance. Sohn 
and Kim (2008) obtained a linear sensor response in a concentration range between 3 
and 20 mg L-1 of CRP. In turn, Yang et al. (2009), and Quershi et al. (2009) proposed 
biosensing systems based on magnetic principles, that is, a microfluidic system and a 
capacitive immunosensor, with LOD of 1.25x10-2 and 2.5x10-2 mg L-1, respectively. 
Therefore, disposable, rapid, simple, and low-cost biosensing instrumentation for CRP 
has not yet been reported.  
Regarding biosensing systems with nanomaterials for the determination of CRP, a few 
examples can be found in literature. For example, Buch and Rishpon (2008) developed an 
electrochemical immunosensor based on MWCNT-modified screen printed electrodes, 
and more recently, Ibupoto et al. (2012) proposed a potentiometric sensor with ZnO 
nanotubes, with LOD of 5x10-4, and 10-3 mg L-1, respectively. In Section 5.2, the analytical 
performance of NTFET developed in this thesis for the determination of CRP will be 
compared to other biosensors. 
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3.1. Introduction 
 
The dispersion of carbon nanotubes (CNT) results from the unbalancing between the 
van der Waals forces responsible for the aggregation and bundling of synthesised CNT, 
which is enhanced by the mechanical energy provided by the sonication. The sonication 
of CNT is affected by dispersant properties and concentration, characteristics of ultrasonic 
bath, such as the water volume, the ultrasonic frequency, time and temperature of 
sonication. The geometry and position of the vessel in ultrasonic baths are also other 
factors which interfere in the performance of sonication, as reviewed by Hilding et al. 
(2003). 
Concerning the dispersants, the surfactants are the most used through non-covalent 
functionalization, preserving the sp2 structure of SWCNT and minimizing defects along 
with their electronic properties. The surfactants are amphiphilic molecules, that is, they 
have both polar and apolar groups, which constitute the hydrophilic (polar head group) 
and the hydrophobic (tail with hydrocarbon chains) regions, respectively. Thus, 
hydrophobic groups face toward the CNT surface while the hydrophilic groups face toward 
the aqueous phase. The surfactants are classified according to the charge of their head 
groups, being non-ionic, anionic and cationic. For example, the Triton X-100 
(C14H22O(C2H4O)n)(n = 9-10) is non-ionic, the sodium cholate (C24H39NaO5), the sodium 
dodecyl sulphate (NaC12H25SO4), and the sodium benzoate (NaC6H5CO2) are anionic, and 
the cetyltrimethylammonium bromide (C19H42BrN) is cationic. It has been proposed that 
the surfactants with benzene rings and naphthenic groups are responsible for the high 
dispersing ability of CNT through the π-π stacking interactions of the benzene ring onto 
the CNT surface (Vaisman et al., 2006). In this thesis, two surfactants (sodium cholate 
and sodium dodecyl sulphate), a polymer (sodium alginate) and an organic solvent 
(dimethylformamide) were compared in respect to their efficiency in dispersing SWCNT. 
 
 
3.2. Experimental methods 
 
3.2.1. Dispersion of SWCNT on dimethylformamide (DMF) and sodium cholate 
(SC) and spectroscopic characterization 
 
The comparison of the effectiveness on dispersion of SWCNT by a polar aprotic 
solvent (dimethylformamide, DMF, C3H7NO, Sigma-Aldrich) and an anionic surfactant 
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(sodium cholate, SC, Sigma-Aldrich) is reported in this section. The SC is the dispersant 
recommended by Sigma-Aldrich for the dispersion of commercial SWCNT and, as shown 
in Figure 3.1a, it has a naphthenic structure constituted by three C6 rings and one C5 ring 
contributing to the dispersing efficiency. In the case of DMF, which molecular structure is 
shown in Figure 3.1b, it is characterized by a high value for electron pair donation (which 
describes the ability of the solvent to donate a pair of non-bonding electrons to another 
molecule in order to form a coordinate bond) and with a negligible value for hydrogen 
bond donation parameter of Taft and Kamlet (which describes the ability of a solvent to 
accept an electron pair), enabling the good dispersion of CNT, as reported by Ausman et 
al. (2000), and it does not have aromatic rings. 
 
Figure 3.1 Molecular structures of a) sodium cholate (SC) and b) dimethylformamide (DMF). 
 
 
The SWCNT (#704113, Sigma-Aldrich, Portugal) used in the experiments were 
synthesised through cobalt-molybdenum catalysis (CoMoCAT, Southwest 
Nanotechnologies). For their dispersion as a non-covalent functionalization, SWCNT 
samples were prepared through dispersion of 4 mg of SWCNT in 14 mL of aqueous 
solution of SC (0.2 % w/v) according to published protocol (AL-265 Technical Information 
Bulletin, Sigma-Aldrich), or through dispersion of 3 mg of SWCNT in 20 mL of DMF, 
according to the procedures followed by Xiao et al. (2010). The SWCNT samples were 
maintained in a water bath ultrasonicator (Ultrasonik 57H Ney, 400W, 50/60 Hz) for 
periods of 40, 60, and 100 minutes, in order to compare the influence of sonication time 
for obtaining stable and uniform SWCNT dispersions. All experiments in the water bath 
ultrasonicator were made in round-bottom flasks, and in each sonication step, only one 
flask was used at the centre of the ultrasonic bath, in order to provide the same sonication 
characteristics for each sample. Besides the sonication, the effects of different 
centrifugation programs were also assessed. The centrifugation of SWCNT samples was 
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performed at a relative centrifugal force (RCF) of 2000 × g, and 10000 × g during 5 
minutes at 20 ºC with a centrifuge Medifriger BL-S (JP Selecta, Spain) in order to remove 
graphite, residual catalyst, and amorphous carbon, and approximately 70 % fraction of 
supernatant was collected for subsequent analysis. It is important to note that the 
centrifugation speed can be expressed in RCF or rotations per minute (RPM). In this 
thesis, RCF was employed as the correct rotational unit, since RPM unit is dependent of 
the rotational radius of the centrifuge, and thus RPM conditions are not the same with 
different centrifuges, while RCF, referred as g-force, is acceleration constant, and it can 
be exchanged between centrifuges for obtaining equivalent results. RPM and RCF are 
convertible using the following equation (Frei, 2011): 
 
                                      
   
    
 
 
    [3.1] 
 
As SWCNT strongly absorb from the UV to the NIR regions, the SWCNT dispersions in 
DMF and SC were analyzed by UV-Vis spectroscopy in order to obtain adequate 
information about the SWCNT purity and structure through the evaluation of the singular 
interband electronic transitions of SWCNT, as studied by Itkis et al. (2005), and Jeong et 
al. (2008). In order to provide such typical spectroscopic signature of SWCNT, UV-Vis 
optical absorption spectra (200 - 800 nm) were recorded in a spectrophotometer 
(GBC/Cintra10e) using a quartz optical cell with a path length of 10 mm. The 
spectrophotometer comprised a light source with a wavelength range between 190 and 
1000 nm, providing an accuracy of 0.08 nm in the UV-Vis region, and 0.3 nm in the IR 
region, a monochromator for precise wavelength selection due to the diffraction grating 
incorporated, and a detector (silicon photodiode and photomultiplier tube). The UV-Vis 
instrument is a double beam UV-Vis spectrometer, and it is equipped with two optical 
sources: the tungsten iodine lamp (for wavelengths higher than 300 nm), and the 
deuterium lamp for wavelengths below 300 nm. 
In this thesis, Raman spectra (90 - 1900 cm-1) were also obtained for the SWCNT 
sample dispersed in SC, with a Bruker RFS/100S Raman-FT spectrophotometer. The 
spectrophotometer has a Nd:YAG (from neodymium-doped yttrium aluminium garnet, 
Nd:Y3Al5O12) laser of 1064 nm (in IR region), and the spectra were obtained at 100 mW 
power, with a spectral resolution of 4 cm-1, and 1500 scans. 
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3.2.2. Experimental design for screening the dispersion conditions of SWCNT in 
sodium cholate (SC) 
 
An experimental design based on a 23 factorial design with 2 replicates, and involving 
16 experimental runs, was applied to identify the factors which may affect the dispersion 
of SWCNT as well as to evaluate the effects of various factors, and to understand the 
interactions between the factors on the main steps of preparation of SWCNT dispersion, 
that is, sonication and centrifugation. The main effects and interactions of 3 quantitative 
variables (sonication time – factor A, centrifugation time – factor B, and RCF – factor C) 
on the dispersion of SWCNT were assessed by UV-Vis spectroscopy at 500 nm, which is 
the wavelength frequently selected to quantify different SWCNT dispersions, for example 
in the works of Bahr et al. (2001), Kim et al. (2003), and Sinani et al. (2005). The SWCNT 
samples were dispersed in aqueous solutions of surfactant by adding 4 mg of SWCNT to 
14 mL of a sodium cholate (SC) aqueous solution (0.2% w/v). Such samples were 
sonicated for 60 and 100 minutes, and centrifuged during 5 and 10 minutes at 2000 × g 
and 10000 × g, which correspond to the low and high levels for each factor, respectively.  
 
 
3.2.3. Comparison of the dispersion of SWCNT in sodium cholate (SC), sodium 
dodecyl sulphate (SDS), and sodium alginate (SA) 
 
Dispersion assays with another surfactant than SC, that is the sodium dodecyl sulphate 
(SDS), and a polymer, that is, the sodium alginate (SA) were also performed to compare 
the dispersing efficiency of SWCNT in SDS and SA with that obtained in SC. The SDS is 
an anionic surfactant since it has a sulphate ion in its head group, as shown in Figure 
3.2a, and the SA, which monomer is shown in Figure 3.2b, is a water-soluble polymer 
which becomes negatively charged in aqueous solution. Both the SDS and the SA were 
prepared in the same way as the SC, that is, at 0.2 % in distilled water. 
 
Figure 3.2 Molecular structures of a) sodium dodecyl sulphate (SDS) and b) sodium alginate (SA). 
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3.2.4. Effect of the concentration of the SWCNT in their optical properties 
 
According to O’Connell et al. (2002), the UV-Vis spectroscopy is sensitive to SWCNT 
bundles, to effects of charge transfer, and to the SWCNT concentration. Thus, the effect 
of the concentration on the optical properties of SWCNT was assessed by measuring the 
absorbance at 500 nm of six samples of different concentrations of SWCNT diluted in SC. 
Aliquots of a SWCNT solution at a concentration of 0.28 g L-1 were pippeted out, and 
diluted with fresh SC (0.2%, w/v) to reach concentrations of 0.25, 0.20, 0.15, 0.10, 0.05, 
and 0.01 g L-1 in SWCNT. Such dilutions were used to prepare a calibration curve by 
measuring the absorbance values at 500 nm against the different SWCNT concentrations, 
as well as to verify the influence of SWCNT concentration on the efficiency of dispersion 
process. The values of the absorbance at x = 0 g L-1 and x = 0.28 g L-1 in the calibration 
plot correspond to the absorbance values for the solution without SWCNT (only with SC), 
and for the SWCNT solution used to prepare dilutions, respectively.  
 
 
3.3 Results and discussion 
 
3.3.1. Dispersion of SWCNT on DMF and SC and spectroscopic characterization 
 
Figure 3.3 shows sets of SWCNT samples prepared in DMF and SC, after sonication 
and centrifugation. After sonication and centrifugation, the homogeneous gray 
suspensions of SWCNT in SC stayed under the form of stable colloidal solutions. It is 
known that when SWCNT are exfoliated, they are maintained dispersed and do not settle, 
and when they are bundled, they phase separate with the other impurities such as 
graphite, amorphous carbon, and catalysts, as verified by Bandyopadhyaya et al. (2002). 
In the experiments of this thesis, even after two months, the suspension was still stable 
without occurring coagulation and precipitation of particles at the bottom of the flasks. As 
also shown in Figure 3.3, when dispersed in DMF, the SWCNT settled down after 
centrifugation, with a resulting quasi-transparent supernatant with very few suspended 
particles and a precipitate. 
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Figure 3.3 Dispersions of SWCNT in DMF and SC, after sonication and centrifugation. 
 
 
Figure 3.4a and Figure 3.4c display the absorbance spectra of the prepared SWCNT 
samples in SC and in DMF, respectively, in order to characterize dispersed SWCNT in 
terms of their interband electronic transitions. As shown in Figure 3.4a, the absorbance 
spectrum of SC is transparent in the entire range of wavelength from 250 nm to 800 nm, 
thus allowing the observation of the characteristic electronic transitions of the SWCNT, 
and ensuring that all spectroscopic features observed in the spectra of dispersed SWCNT 
in SC are due only to the addition of SWCNT. At lower wavelength, in the UV region        
(λ < 400 nm), broad absorptions are due to plasmon resonances in the free electron cloud 
of the CNT π-electrons; the π-plasmon is associated with collective excitation of π-
electrons, at around 155 - 310 nm, and it has no practical significance in the interpretation 
of SWCNT absorption spectra, as firstly discussed by Kataura et al. (1999). Also shown in 
Figure 3.4a, the most pronounced peaks are observed at 455, 510, 570, and 655 nm. As 
shown in Figure 3.4c, DMF is not suitable for dispersing SWCNT, as also verified by 
Maeda et al. (2006) since there are no discriminative features between the spectra of 
SWCNT dispersed in DMF, and the DMF spectrum. The DMF as dispersing agent has 
lead to ambiguous conclusions: some works attribute to DMF a high potential for 
dispersing SWCNT, as reported by Ausman et al. (2000), and Krupke (2003), while others 
claim that is unsuitable since it can damage the SWCNT through the modification of the 
π*-states of carbons in SWCNT structure, as reported by Monthioux et al. (2001), and 
Costa et al. (2008). 
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The variation of the mean values of absorbance obtained from the most pronounced 
peaks in a SWCNT sample dispersed in SC as a function to the sonication time and for 
the two RCF values is shown in Figure 3.4b, where the absorbance values are higher 
when the SWCNT samples are subjected to lower RCF for the same sonication time. 
 
 
 
Figure 3.4 a) Absorbance spectra of dispersed SWCNT in SC, at different sonication times (40, 60, 
and 100 minutes) and RCF (2000 × g and 10000 × g), b) Variation of the mean 
absorbance values obtained from the most pronounced peaks in a SWCNT sample 
dispersed in SC in function of the sonication time, and for the two RCF values, and c) 
Absorbance spectra of dispersed SWCNT in DMF, at different sonication times (40, 60, 
and 100 minutes) and RCF (2000 × g and 10000 × g). 
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As shown in the Technical Bulletin of Sigma-Aldrich (AL-265), and also in the works of 
Maeda et al. (2006) and Strano et al. (2009), the UV-Vis absorbance spectra are usually 
normalized by the absorbance value at 780 nm in order to enhance the characteristic 
absorption bands of SWCNT. Effectively, as it can be seen in Figure 3.5a, the interband 
electronic transitions of SWCNT are highlighted using this procedure, and the effect of 
experimental conditions tested for the dispersion of SWCNT are more pronounced at   
550 - 600 nm and at 640 - 680 nm. The normalized absorbance spectra, shown in Figure 
3.5a, corresponds to the same samples of dispersed SWCNT in SC used in Figure 3.4a, 
and only in the range of 400 to 800 nm (visible and NIR regions), since those ranges 
include the optical interband transitions of m-SWCNT and s-SWCNT, such as M11 and S22. 
According to O’Connell et al. (2002), the electronic transitions between 400 and 600 nm 
are assigned to the m-SWCNT (M11 interband, corresponding to the absorbance feature 
v1→c1), and the absorbance features between 550 and 800 nm are assigned to the         
s-SWCNT (S22 interband, corresponding to the absorbance feature v2→c2). A slightly 
overlapping of bands is observed between 550 and 600 nm, which could difficult the 
correct assignment of bands to m-SWCNT or to s-SWCNT. However, in this work, it is 
considered that absorbance between 550 and 600 nm is associated with s-SWCNT, since 
Henrich et al. (2005), and Zheng and Semke (2007) have observed the S22 transition with 
higher absorbance at 576 nm and 574 nm for CoMoCAT SWCNT, respectively, which are 
SWCNT produced by the same synthesis method as used in this work, which means, that 
properties are expected to be identical. Thus, the S22 is considered to begin at 
approximately 550 nm. 
 
Figure 3.5 a) Normalized absorbance spectra of dispersed SWCNT in SC in the range from 400 to 
800 nm and b) Methodology used in this thesis for the quantitative determination of the 
s-SWCNT and m-SWCNT. 
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The networks of SWCNT synthesized by various methods are mixtures of nanotubes 
with typical ratios of 1/3 of m-SWCNT and 2/3 of s-SWCNT, as shown for example in the 
work of Dresselhaus et al. (2005). Thus, for the SWCNT samples obtained in this work, 
the ratio between m-SWCNT and s-SWCNT was calculated from the absorbance spectra 
by subtracting the value of each peak by the corresponding values of the background 
feature above the peak, as demonstrated in Figure 3.5b. A baseline was drawn at the 
points at either side of each peak and the height of the peak up to the baseline was 
measured. Specifically, the expression 
         
                        
     was considered 
(where A is absorbance value at a specific wavelength) in order to calculate the               
% m-SWCNT = 
   
       
    , and the % s-SWCNT = 100–(% m-SWCNT). In this way,       
m-SWCNT was about 27.9 %, and s-SWCNT was about 72.1 %, being the ratio between 
s-SWCNT and m-SWCNT of 2.6, which is accordance to the ratio of 3 expected for a 
random chirality distribution. 
Figure 3.6 shows the baseline corrected Raman spectrum obtained from the SWCNT 
dispersed in SC with the Bruker RFS/100S Raman-FT spectrophotometer. 
 
Figure 3.6 Baseline corrected Raman spectrum of SWCNT dispersed in SC (Reprinted from 
Talanta, 108, Justino et al., Copyright (2013), with permission from Elsevier). 
 
 
The two active Raman modes of SWCNT are present as first-order features, thus the 
low frequency radial breathing mode (RBM) is displayed between 100 and 300 cm-1, and 
the high frequency G-bands are shown between 1550 and 1605 cm-1.  
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The frequency of the RBM mode (ωRBM), which is the feature of primary interest for 
SWCNT, allowed the determination of the average diameter of the SWCNT (d) as 1.8 nm, 
by following the relation established by Dresselhaus et al. (2005): 
 
       
     
         
 
           [3.2] 
 
The G-band has two main components, the high (G+) and the low (G-) frequency 
components, which are due to the curvature of the sheet of graphene. In contrast to the 
graphite G-band, which is present only at approximately 1580 cm-1 due to the tangential 
mode vibrations of C atoms, the G-band of CNT is composed of several tangential modes 
due to the vibrations of stretching of the SWCNT sidewall C-C bonds (Itkis et al., 2005), 
and it is not affected by the defects on the SWCNT structure. The G+ feature is observed 
at 1590 cm-1 due to in-plane vibrations along the nanotube axis, while the G- feature at 
1570 cm-1 is attributed to in-plane vibrations along the circumferential direction. On the 
other hand, the line shape of the G-band can be used to differentiate the m-SWCNT from 
the s-SWCNT, as reported in Dresselhaus et al. (2002). The pattern shown in Figure 3.6 
can be compared to that present in the works of Dresselhaus and Eklund (2000), and 
Dresselhaus et al. (2005) where the peak at 1590 cm-1, narrow and symmetric, is 
associated with s-SWCNT. In turn, the weak frequency peak at ~1570 cm-1 (G- band), with 
its commonly called Breit-Wigner-Fano line shape, is originated from the electron-phonon 
interactions in the m-SWCNT. 
An additional feature at about 1300 cm-1 (D-band) is attributed to a second-order 
Raman scattering process, which characterizes the structural disorder of the                 
sp2-hybridized carbon. In Figure 3.6, such a band is very small which means that the 
impurities (for example, carbonaceous materials), defects, and disorder effects are 
minimal. On the other hand, the very low value of D/G+ intensity ratio (~ 0.02) is an 
indicator of the quality of the dispersed SWCNT, as reported in Dresselhaus et al. (2005). 
The Raman spectrum obtained in this thesis is in accordance with the typical spectra 
for the SWCNT. However, it is known that the spectral profiles depend on the laser 
excitation energy used in the spectrophotometer, with variations in the intensity of peaks 
but not influencing the peak position (same wavenumbers), as reported by Rao et al. 
(1997) and shown in Figure 3.7. Ouyang et al. (2008) have also observed that D/G+ 
intensity ratio hardly decreases with increasing laser excitation energy from 325 nm to 
514.5 nm and to 1064 nm. 
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Figure 3.7 Raman spectra at five different laser excitations (from Rao et al., Science, 275, 
Copyright (1997). Reprinted with permission from The American Association for the 
Advancement of Science). 
 
 
According to Harris (2009), the Raman spectroscopy has been of less value when 
applied to MWCNT, due to their large diameter (which is equivalent to weak RBM signals) 
and the non-observation of the splitting of the G-band observed in SWCNT. 
 
 
3.3.2. Experimental design for screening the dispersion conditions of the SWCNT 
in sodium cholate (SC) 
 
The details of the experimental design followed, as well as the results obtained are 
depicted in Table 3.1, and Table 3.2 displays the statistics associated with the main 
effects, the two-way and three-way interactions, and the coefficients for the response 
model obtained using Minitab software (Minitab Inc., 2010). 
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Table 3.1 Experimental plan and response of the 2
3
 factorial design with 2 replicates 
(Reprinted from Talanta, 89, Justino et al., Copyright (2012), with permission from 
Elsevier). 
Run 
order 
A 
(Sonication time, min.) 
B 
(Centrifugation time, min.) 
C 
(RCF, × g) 
Y 
(Abs500) 
1 100 10 10000 0.6380 
2 60 10 10000 0.9130 
3 100 10 2000 0.9940 
4 100 5 2000 1.1037 
5 60 10 2000 1.3039 
6 60 5 10000 1.0725 
7 100 5 10000 0.7756 
8 100 10 10000 0.6488 
9 60 10 2000 1.2871 
10 60 5 10000 0.9901 
11 100 5 2000 1.0946 
12 60 5 2000 1.4506 
13 100 5 10000 0.7789 
14 100 10 2000 0.9633 
15 60 10 10000 1.0570 
16 60 5 2000 1.4172 
 
 
Table 3.2 Main effects, interactions and regression coefficients (including 
respective standard error, SE) for the response model (Reprinted 
from Talanta, 89, Justino et al., Copyright (2012), with permission 
from Elsevier). 
Term Effect 
Regression 
coefficients 
SE t value p value 
Constant  1.0305 0.0108 95.07 0.000 
A -0.3118 -0.1559 0.0108 -14.38 0.000 
B -0.1098 -0.0549 0.0108 -5.06 0.001 
C -0.3426 -0.1713 0.0108 -15.80 0.000 
A*B -0.0174 -0.0087 0.0108 -0.80 0.445 
A*C 0.0140 0.0070 0.0108 0.65 0.537 
B*C 0.0197 0.0098 0.0108 0.91 0.390 
A*B*C -0.0264 -0.0132 0.0108 -1.22 0.259 
SE – Standard errors for regression coefficients. 
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According to Table 3.2, the main effects due to the individual factors A, B and C are 
statistically significant (p < 0.05), and the factorial design fitting is acceptable for the 
interpretation of future results with high determination coefficients (R2 = 0.9838, and 
adjusted R2 = 0.9696). On the other hand, the three two-way interactions (A*B, A*C, and 
B*C), and the three-way interaction (A*B*C) are not significant (p > 0.05), which means 
that the factors (that is, sonication time, centrifugation time, and RCF) affect the response 
only in an independent way, and not interactively. The normal probability plot and the 
Pareto chart of the standardized effects are displayed in Figure 3.8 in order to highlight 
the statistical significance of the main effects of the 3 factors and respective interactions 
on the response measured as the absorbance at 500 nm. 
 
Figure 3.8 a) Normal probability plot (■ Significant effect; ● Not significant effect), and b) Pareto 
chart of the standardized effects at 95% confidence interval (the absolute value of point 
2.31 is the minimum statistically significant effect) (Reprinted from Talanta, 89, Justino 
et al., Copyright (2012), with permission from Elsevier). 
 
 
The normal probability plot (Figure 3.8a) shows the statistical significance and the 
magnitude of both main and interaction effects at a significance level of 5 %, and through 
standardized values in x-axis (such values are the t statistics shown in Table 3.2, and they 
are calculated by dividing each coefficient by its standard error, also shown in Table 3.2). 
The points near the dashed line within -2.31 and 2.31 are the points expected to fall when 
the respective effect is not significant. The points which do not fall close to this dashed 
line, that is, those corresponding to the factors A, B, C are active effects, and they have a 
significant effect on the response. Moreover, factor C (RCF) has the largest main effect, 
higher than the other two factors (factor A – sonication time, and factor B – centrifugation 
time), while the factor A also has the second most important effect. 
The Pareto chart (Figure 3.8b) is another type of plot which provides the relative 
magnitude and significance of both individual and interaction effects, with the same 
standardized effects values that those of the normal probability plot. However, in the 
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Pareto chart, the x-axis contains the absolute values, and the factors studied as well as 
their interactions are in the y-axis, providing a quick and easy graphical method to identify 
the main effects on the response model. The vertical line of Pareto chart at a standardized 
effect of 2.31 has the same interpretation of the dashed line of the normality plot (Figure 
3.8a) and indicates the minimum statistically significant effect at a significance level of      
5 %. 
Also from the Table 3.2, the column “Effect” provides information about the relative 
strength of the effects through its absolute value, and such value to RCF factor (C) 
provides the highest effect on the response. Finally, the negative sign associated with 
each effect value means that when the factor level changes from low level to high level, 
the response decreases, which allows to conclude that the conditions of 60 minutes of 
sonication and centrifugation during 5 min at 2000 × g will allow to obtain a SWCNT 
solution most adequate for further studies. 
 
 
3.3.3. Comparison of the dispersion of SWCNT in sodium cholate (SC), sodium 
dodecyl sulphate (SDS), and sodium alginate (SA) 
 
The UV-Vis spectra of the SDS and SA are shown in Figure 3.9, in order to compare 
their effectiveness on the dispersion of SWCNT with that obtained with SC. 
 
 
Figure 3.9 UV-Vis spectra obtained from SWCNT dispersed on sodium dodecyl sulphate (SDS) 
and sodium alginate (SA), together with the UV-Vis spectrum of SWCNT dispersed on 
SC. 
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For samples of SWCNT dispersed in SDS and SA, less-resolved features were 
observed, that may be due to a loss of the typical interband electronic transitions. Li et al. 
(2005) have found that the SDS coated on the SWCNT appear to be relatively unstable, 
and as the SC is a bile salt molecularly more rigid than the SDS, the SC becomes more 
stable in aqueous solutions, as reported by Arnold et al. (2006). On the other hand, the 
SDS could not cover the surface of CNT uniformly, since the simple alkyl chains of the 
SDS could form non-specific hydrophobic interaction with CNT, as reported by O’Connell 
et al. (2002) and Tummala and Striolo (2009). Relatively to the polymer SA, it is known 
that interactions with mechanically rigid SWCNT may force them into energetically 
unfavourable conformations, thus providing some problems in efficient dispersion of 
SWCNT, as shown by Hu et al. (2009). 
 
 
3.3.4. Effect of the concentration of the SWCNT in their optical properties 
 
Figure 3.10 shows the absorbance spectra of the various SWCNT dispersions with 
different concentrations. At lower concentrations, there is a decrease of absorbance 
intensity, which means that lower SWCNT content is present, due to the loss of van Hove 
singularities. 
 
Figure 3.10 Absorbance spectra of dispersed SWCNT at different concentrations (Inset: 
photograph of SWCNT dilutions). 
 
 
The absorbance at the wavelength of 500 nm was plotted against the concentration of 
SWCNT, as shown in Figure 3.11. A high correlation is observed between the absorbance 
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(y) values recorded at 500 nm, and the concentration of different SWCNT concentrations 
(x), given by the high correlation coefficient (R = 0.9992), in a determination range from 0 
to 0.28 g L-1. The limit of detection (LOD), calculated as three times the standard error of 
the estimate (Miller and Miller, 2005) was 1.2x10-2 g L-1. 
 
 
Figure 3.11 Calibration plot of absorbance values at 500 nm for different SWCNT concentrations. 
 
 
As the length of quartz cell used for the spectra acquisition was of 1 cm, the 
absorbance and concentration are directly proportional to the absorption coefficient ε, as 
defined by the Beer-Lambert law (A = εLc), which corresponds to the slope of the fitted 
line. Thus, an absorption coefficient for the dispersed SWCNT was found as                
5.12 mL mg-1 cm-1. However, it should be considered that to follow the Beer-Lambert law, 
the plot should be passing through the origin. Thus, a little modification of the determined 
absorption coefficient was observed, which was of 5.04 mL mg-1 cm-1 (with R2 = 0.9996, 
and adj. R2 = 0.9736), corresponding to a difference of 2%. In the literature, only 
absorption coefficients for MWCNT are reported, where values between 17.9 and        
39.9 mL mg-1 cm-1 were obtained by Li et al. (2006). 
 
 
3.4 Conclusions 
 
In this Chapter 3, it was found that the sodium cholate (SC) is the dispersant more 
effective in the dispersion of SWCNT since UV-Vis spectroscopic features are well 
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defined, and in accordance to the literature. From an experimental design based on a     
23 factorial design, it was found that a dispersion of SCWNT obtained after 60 minutes of 
sonication and after 5 minutes of centrifugation at RCF of 2000 × g is the most adequate. 
The results obtained in this Chapter also showed that a typical SWCNT dispersion in SC 
applying such experimental conditions have a content of approximately 72 % of               
s-SWCNT, and with a ratio between s-SWCNT and m-SWCNT of 2.6, which is similar to 
the expected value of 3. Thus, the experimental conditions found for dispersion of 
SWCNT in SC were used in further work, in order to obtain uniform dispersions of 
SWCNT for application as a component of transduction mechanism in biosensors, as 
shown in Chapter 5. 
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In this Chapter 4, the microfabrication of field effect transistors (FET) is reported 
together with the description of each processing step and equipments used. The 
microfabrication consists in the process of manufacturing individual devices in micrometre 
sizes. The reported work of microfabrication of FET was developed at INESC-MN 
(Instituto de Engenharia de Sistemas e Computadores - Microsistemas e 
Nanotecnologias, Lisbon, www.inesc-mn.pt) in cleanroom facilities in order to avoid any 
contamination of the microfabricated devices. In a cleanroom, a controlled and dust-free 
environment is achieved through high-efficiency particulate air filters, maintaining low 
levels of environmental pollutants such as airborne particles, and chemical vapours, as 
well as acoustic noise, vibrations, and electromagnetic interferences. The controlled level 
of contamination is specified by the number of particles per volume of air at a specified 
particle size, thus defining various classes of cleanrooms. For example, the classes 10, 
100, and 10000 are those existing in the INESC-MN cleanroom, as depicted in Figure 
4.1a, where the limits of each class are associated with the maximum number of particles 
per cubic feet with size equal to and larger than 0.5 μm. Moreover, constant temperature 
and relative humidity are maintained, and the operators are required to use special 
garments such as hoods, gloves, boots, and coveralls, as shown in Figure 4.1b and 4.1c, 
to function as a barrier to particles and chemicals. 
 
Figure 4.1 a) Classification of cleanrooms (according to data of FED STD 209E, 1992), b) and c) 
Details of cleanroom garments used during microfabrication. 
 
 
The microfabrication of FET has aimed at the definition of an interdigitated architecture 
configuration, where each defined electrode has 1.5 µm of width and 1000 µm of length, 
as shown in Figure 4.2k. The architecture of interdigitated electrodes was chosen due to 
their large surface area which increases the probability of contacting multiple carbon 
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nanotubes in each device. FET with different geometry parameters, such as with different 
distances between electrodes, number of electrodes, and thickness of gold layer, were 
fabricated as explained in Section 4.1.3, in order to study the effect of such variation on 
device performance, that is, through the electrical device characteristics (current-voltage 
measurements), as reported in the Section 5.1 where the assemblage of FET with single-
walled carbon nanotubes is reported. 
 
 
4.1.  Experimental equipment and microfabrication process 
 
Two commercial p-type silicon wafers (diameter of 3 inch, and thickness of 0.5 mm, 
Sigma-Aldrich Química, Portugal) were used as substrate of FET, in order to study the 
influence of the thickness of the gold layer (40 and 100 nm, respectively, in wafers #1 and 
#2) in the sensor response. The schematics of the overall microfabrication process and 
the final FET architecture are shown in Figure 4.2. 
 
 
4.1.1. Oxide deposition 
 
After cleaning with a blow of nitrogen, the substrates were passivated with an insulating 
layer of 400 nm-thick SiO2 by plasma-enhanced chemical vapour deposition (PECVD, 
Electrotech Delta 201 CVD System), according to the conditions identified in Table 4.1. 
 
Table 4.1 Conditions used in oxide deposition for passivation. 
RF Power (W) Pressure (mTorr) SiH4 flow (sccm) N2O flow (sccm) Temperature 
430 700 125 2500 350ºC 
sccm - standard cubic centimetres per minute 
 
This technique consists on the deposition of thin films of SiO2 from vapour gases, that 
is, SiH4 and N2O to provide electrical insulation, through following reactions:                 
SiH4 + O2 → SiO2 + 2 H2, and SiCl2H2 + 2 N2O → SiO2 + 2 N2 + 2 HCl, respectively. Such 
chemical reactions occur after the production of a plasma of reactive gases, by a direct-
current (DC) discharge at 700 mTorr between two electrodes. 
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Figure 4.2 Schematic 1) cross views and 2) top views of microfabrication steps of FET: a) SiO2 and 
Ti/Au depositions, b) Coating with photoresist, c) Lithography (inverted mask, resist 
mask defining the contacts), d) Ion milling Ti/Au films to remove undesired zones, e) 
Resist strip, f) Coating with photoresist, g) Lithography for opening contact via (non-
inverted mask, resist all over, except in 150x150 µm
2
 holes), h) Reactive ion etching of 
SiO2, i) Metallic layer deposition (Cr/Au for wafer #1 and Ru for wafer #2), j) Lift-off, and 
k) final FET architecture. 
 
 
4.1.2. Ti/Au deposition 
 
The insulation by oxide deposition was followed by the deposition of a thin layer of Au 
(40 and 100 nm, respectively, in wafers #1 and #2), with a 10 nm-thick adhesion layer of 
Ti underneath, on SiO2 (step depicted in Figure 4.2a) through physical vapour deposition 
(PVD) by sputtering (Alcatel Magnetron Sputtering System), which is the most often used 
technique for depositing Ti and Au films on substrates. The conditions used for the PVD 
are identified in Table 4.2. The deposition of a Ti film is required prior to the Au deposition 
to assure film adhesion, as Au tends to delaminate from all surfaces (Cr is also often 
used). 
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Table 4.2 Conditions used in the Alcatel Magnetron sputtering system. 
Wafer 
designation 
Films 
thickness 
(nm) 
Deposition conditions 
Time 
(min.) 
DC Power 
(W) 
RF Power 
(W) 
Pressure 
(mTorr) 
Gas flow 
(sccm Ar) 
#1 Ti: 10; Au: 40 8 
20 20 3.1 20 
#2 Ti: 10; Au: 100 19 
DC – Direct-current; RF – Radio-frequency. 
 
In the sputtering technique, which occurs in a vacuum chamber, the metal atoms are 
ejected from a target material by high energy ion bombardment provided by direct-current 
(DC) and radio-frequency (RF) power supplies, and sputtered atoms can condense on a 
substrate as thin films. 
 
 
 
4.1.3. Coating with photoresist and lithography for contact definition 
 
The Ti/Au film was coated with a 1.5 µm-thick layer of a photosensitive polymer called 
positive photoresist (PFR 7790G-27cP, JSR Corporation), as depicted in Figure 4.2b, by a 
standard spin coating system (Silicon Valley Group, SVG), with a spin speed of 2800 
RPM for 40 s. The resist thickness was confirmed with a profilometer (Dektak 3030ST 
Surface Texture Analysis System), which has a piezo-resistive sensor able to detect any 
changes in the topography of samples, with minimum vertical resolution of 10 nm. Spin 
coating consists in the deposition of the photoresist onto the wafer that is spun to produce 
an uniform thin layer. The photoresist used in this work is a positive photoresist; the basis 
of its chemical composition is a resin and a photo-reactive component dissolved in a 
solvent which is a dissolution inhibitor. Such component becomes soluble when exposed 
to ultraviolet light (λ ~ 442 nm). Due to the breaking of polymer chemical bonds, the 
regions in the wafer with a resist mask are defined, while the remaining surface is 
cleaned. In this way, the optical lithography is performed by a Direct Write Laser 2.0 
Litography System (DWL, 120 mW, Heidelberg Instrument) to define the source (S) and 
drain (D) metal contacts, as depicted in Figure 4.2c. The lithography process, which uses 
a 442 nm HeCd laser, consists in the transfer of a geometric pattern (photomask) to the 
light-sensitive polymer (photoresist), with a resolution of 0.8 μm, which is the minimum 
feature resolved by DWL.  
The shape of the geometric pattern was produced by computer-assisted design 
software (AutoCAD). The DWL machine has the capability to convert the AutoCAD format 
file (.dxf) in adequate DWL machine language (.gdsii format) and each photomask layout 
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or layer correspond to a microfabrication process step. In this thesis, the resulting file 
(photomask) corresponds to an individual die, as shown in Figure 4.3b, which was 
automatically repeated in order to have a total of 30 dies in each wafer, as shown in 
Figure 4.3a.  
 
Figure 4.3 a) Silicon wafer (substrate) with 30 repeated dies, b) final pattern geometry (die with 12 
FET) designed by AutoCAD software, and c) example of three FET with different 
distance between electrodes. 
 
 
As shown in Figure 4.3b, the file image has two colours, which corresponds to different 
layouts, that is, the blue layer is associated with the FET pattern (selecting that, the 
lithography only develop such layer), and the red layout is associated with the               
150 x 150 μm2 hole (for third contact definition, which is reported in Section 4.1.6). In 
Figure 4.3b, it can be observed that in a die, two groups of FET were repeated depending 
on the number of electrodes. The first group (first two rows of FET) consists of six 
individual FET, each of them with 10 electrodes. The second group (last two rows of FET) 
consists of six FET, each of them with 30 electrodes. The distance between the 
electrodes will also be optimized for the sensor response, and thus, each die was divided 
into three columns of FET. Each column is constituted by FET with different distances 
between electrodes, that is, 0.8, 1.5 or 2.5 µm, respectively for each column. FET with  
0.8 μm as distance between electrodes, both with 10 and 30 electrodes were not used in 
this thesis, since they were not well defined by optical lithography. Figure 4.3c depicts the 
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photomask layer for the area of 3 FET with the interdigitated electrodes on the left hand 
zone of each picture, and the drain of each FET on the right hand zone of each picture. 
The wafers were observed at an optical microscope (BH3-MJL, Olympus Optical) to verify 
the correct spacing between the electrodes and the appropriate dimensions of the 
electrodes and contacts, and Figure 4.4 shows examples of the optical microscopy 
images of FET corresponding to the FET shown in Figure 4.3c. 
 
 
Figure 4.4 Magnified images of FET (wafer #2) after lithography process, corresponding to 
zoomed pictures of Figure 4.3c (500x images from optical microscope BH3-MJL, 
Olympus Optical). 
 
 
4.1.4. Ion beam etching 
 
The ion beam etching removes material from the target through the bombardment of 
high energy Ar ions. The plasma of Ar ions is not produced inside the vacuum chamber, 
as it happens in the sputtering system, but it is produced inside the gun through a RF 
antenna ion source. As the whole substrate surface was exposed to the UV laser (inverted 
mask), the uppermost layer of the substrate that is not protected by photoresist was 
removed by ion beam etching using an automated ion beam system (Nordiko 3000 
Series), as depicted in Figure 4.2d. In this microfabrication step, the etchings have 
removed 50 nm (10 nm of Ti, plus 40 nm of Au) or 110 nm (10 nm of Ti, plus 100 nm of 
Au) of material in wafers #1 and #2, respectively, and the specific experimental conditions 
are identified in Table 4.3. These conditions are also observed in the user interface of the 
program of Nordiko 3000 in the characteristics of the assist gun, as shown in Figure 4.5. 
The user interface of the program of Nordiko 3000 also displays the running time for the 
etching process, as well as the characteristics observed instantly for each component of 
the equipment. As shown in Figure 4.5, the characteristics of the deposition gun and the 
1.5 µm 
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assist gun are observed, since they are the two ion sources of this system, called ion 
beam guns: the deposition gun for deposition of thin films in substrates from targets, and 
the assist gun for ion milling directly to the substrate. However, the deposition gun is 
inactive since, for that microfabrication step, the Nordiko 3000 was only used for ion 
etching. 
 
Table 4.3 Conditions used in the Nordiko 3000 system for the Assist Gun. 
RF Power 
(W) 
(V
+
) Voltage 
(V) 
(I
+
) Current 
(mA) 
(V
-
) Voltage 
(V) 
(I
-
) Current 
(mA) 
Ar flow 
(sccm) 
Pressure 
(Torr) 
59 488.0 30.1 193.5 1.8 7.9 1.7x10
-4
 
V
+
 – acceleration voltage; V
-
 – deceleration voltage. 
 
 
 
Figure 4.5 User interface of Nordiko 3000 system of INESC-MN. 
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4.1.5. Photoresist strip 
 
The remaining photoresist on the surface of sensor structures was removed (step 
depicted in Figure 4.2e) through immersion of the wafer in a stripper solution (Microstrip® 
2001, Fujifilm) which functions as photoresist solvent at 65ºC. The stripper solution is an 
organic mixture of 2-(2-aminoethoxy)ethanol (40-55%) with N-methyl-2-pyrrolidone      
(45-55%) as the solvent. The wafers were then cleaned with isopropanol and distilled 
water, and finally dried with nitrogen in a wet bench, which is a station for cleaning the 
wafers and devices. 
 
 
4.1.6. Lithography for opening contact via (for third contact definition) and 
reactive ion etching of SiO2 
 
The final step of FET microfabrication was the definition of the third contact (gate) to 
reach to FET with back-gated configuration. The silicon substrate was used as the back 
gate electrode; for that, the wafers (substrate) were coated with a photoresist film (1.5 µm) 
as depicted in Figure 4.2f, and the second mask (red layout with 150 x 150 µm2, as shown 
in Figure 4.3b) was defined by optical lithography with a DWL system, as depicted in 
Figure 4.2g. Here, the mask is non-inverted, so that only an opening is defined in the 
resist by etching the oxide through the resist. In this way, 400 nm SiO2 were removed by 
reactive ion etching through a LAM Rainbow plasma etcher (LAM Rainbow 4400 System) 
as depicted in Figure 4.2h, and following the conditions shown in Table 4.4. 
 
Table 4.4 Deposition parameters used in the LAM Plasma Etcher. 
Time (sec.) RF Power (W) Pressure (mTorr) CF4 flow (sccm) Ar flow (sccm) 
3x150 100 140 100 200 
 
 
This technique uses chemically reactive plasma to remove material deposited on the 
wafer through high energy ions from plasma, which has been produced inside a grounded 
vacuum chamber, combining physical and chemical etchings. The sulphur hexafluoride is 
commonly used for silicon etching, exactly as it was used in this thesis. 
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4.1.7. Metal deposition and resist strip (lift-off) 
 
Keeping the same resist mask, Cr/Au 100 nm-thick (wafer #1) and Ru 50 nm-thick 
(wafer #2) films were deposited by ion beam deposition/milling (Nordiko 3000 Series) 
following the step depicted in Figure 4.2i, and immediately after ion beam etching. The 
same ion beam system Nordiko 300 used in step 4.1.4 was also used for milling, that is, 
for the deposition of material through the bombardment of high energy Xe ions in the 
deposition gun. 
Finally, the photoresist and the Cr/Au or Ru films were removed by lift-off (step 
depicted in Figure 4.2j), immersing the wafers in a microstrip solution (Microstrip® 2001, 
Fujifilm) at 65ºC. Ultrasounds were also used to accelerate the action, and as the 
Microstrip reacts with the photoresist also under the metallic layers, such material is also 
lifted-off. The wafers were then cleaned with isopropanol and distilled water, and finally 
dried with nitrogen in a wet bench. 
Figure 4.6 shows images obtained by optical microscopy of various FET at different 
microfabrication steps, that is, before and after the etching (reported in Section 4.1.4) and 
after Microstrip treatment (reported in this Section). It is possible to observe the effect of 
etching and the action of Microstrip by a visual inspection of FET and SiO2, which appears 
as green after etching and before Microstrip treatment. On the other hand, the metal 
electrodes after Microstrip treatment are well defined, due to the removal of photoresist 
layer. 
 
 
Figure 4.6 a) Wafer #1 before etching, b) wafer #2 after etching, and c) wafer #1 after Microstrip 
treatment (100x images from optical microscope BH3-MJL, Olympus Optical). 
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4.1.8. Wafer dicing 
 
In order to have individualized FET, the wafers were cut with an automatic dicing saw 
system (DISCO DAD 321) into their dies and then into individualized FET, as shown in 
Figure 4.7a. A previous layout was made according to the final dimensions required for 
the FET, as shown in Figure 4.7b. Each individualized FET (Figure 4.7c) has dimensions 
of approximately 3 x 2 mm2 and they have back-gated geometry and interdigitated 
architecture configuration which allows a large surface area for sensing. 
 
Figure 4.7 a) Diced wafer into individual dies and individualized FET, b) Layout of dimensions for 
the dicing, and c) Individualized FET (2975 x 2150 µm
2
). 
 
 
Visual inspection was enough to check whether some of FET were not defined 
because the DWL system for photolithography have a resolution of 0.8 μm, which is 
exactly the distance between electrodes. Thus, the FET existing closer to the edge of the 
wafer are not well defined, and consequently they were not used. Figure 4.8 shows two of 
these FET containing such defects and making them unfit for further use. 
 
Figure 4.8 Magnified images of FET (wafer #1) with non defined areas (500x images from optical 
microscope BH3-MJL, Olympus Optical). 
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4.1.9. FET mounting 
 
Individualized FET were washed with acetone and distilled water, and dried with 
nitrogen, as well as mounted to a printed circuit board (PCB). The PCB pattern was 
obtained by AutoCAD software, as shown in Figure 4.9a. The role of PCB strip is to allow 
the connection of the contacts (source, drain, and gate) of each FET to soldered pins. The 
FET were fixed on the PCB with acrylate-based glue (super-glue), and they were        
wire-bonded with aluminium wires (25 µm Ø). For each FET, three chromium strips were 
defined and a pin was soldered at the end of each of them, in order to make the 
connections which would allow the characterization of sensors by measuring the electrical 
output signals, in further experiments. Finally, the wirebondings were protected by a 
silicon gel (Elastosil E41, Wacker) which also allows to open a chamber (~1 mm ø) for 
further sensing experiments, as shown in the zoom image of Figure 4.9c, and the resulting 
PCB strips are shown in Figures 4.9b, and 4.9c, with three bounded FET in each of them. 
 
Figure 4.9 a) PCB pattern used to fabricate PCB strip, b) PCB with three individualized FET with a 
silicone cell, and the three chromium strips to the soldering of pins, for each FET, and 
c) lateral view of PCB with mounted FET, showing the soldered pins, and a zoom 
image of the silicone chamber where the sensing experiments were performed. 
 
 
In order to verify the correct structure of the microfabricated FET after their mounting in 
the PCB, images from scanning electron microscopy (SEM) were taken, as shown in 
Figure 4.10. In SEM imaging, a high beam of primary electrons with typical energies of 1 
to 40 keV is scanned over a sample, rather than photons as in optical microscopy, 
producing secondary electrons. Such electrons are generated and emitted in a series of 
signals producing a topographic image as final result. For the SEM visualization of the 
FET, no coating was deposited, since the microfabricated structures were already 
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conductive. In Figure 4.10, the contrast between Au electrodes and SiO2 surface is clearly 
highlighted. 
 
Figure 4.10 SEM images of different zones of the FET after their mounting in the PCB (obtained 
with RAITH 150 SEM). 
 
 
4.2  Conclusions 
 
In this Chapter 4, the microfabrication of FET was demonstrated, being an important 
step for the aim of this thesis, since FET are the basis for the transducer mechanism of 
the biosensors developed, as shown in Chapter 5. Thus, various microfabrication steps 
were followed to obtain disposable FET with simple electric circuit. 
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5.1. Assemblage of NTFET and effects of their geometry parameters on the I-V 
measurements 
 
This section reports the assemblage of NTFET with different geometry parameters by 
means of direct deposition for as-prepared network SWCNT dispersion, and their 
characterization by current-voltage (I-V) measurements. From I-V measurements, the 
resistance for each NTFET was also calculated in order to evaluate the NTFET 
performance. Based on the study of different geometry parameters, the NTFET type with 
lower resistance was selected for further sensing experiments due to its enhanced device 
performance. 
 
 
5.1.1. Introduction 
 
The NTFET approach is considered essentially for sensing applications due to the 
particular mechanical and electronic properties of SWCNT, since the nanometric 
dimensions of SWCNT together with the carbon atoms over their entire surface allows 
high electron transfer reactivity (Balasubramanian and Burghard, 2005). The need for a 
low sample volume, a quick response, the miniaturization, and the label-free process 
make the nano- and microfabrication of low-cost devices, such as NTFET, even more 
attractive and advantageous in the field of Analytical Chemistry. 
NTFET are usually fabricated on Si/SiO2 substrates based on several device 
architectures using dispersed SWCNT or SWCNT directly grown in substrates. In both 
cases, the main challenge is the control and enhancement of the SWCNT output, and 
consequently the improvement of the electronic characteristics of the devices. For such an 
accomplishment, the complete control of the process of synthesis of SWCNT is 
demanded for decreasing their defects and impurities and to allow a higher production 
yield of individual or networks of SWCNT. 
Simple circuits based on NTFET have already been demonstrated with networks of 
SWCNT (Snow et al., 2003; Hong and Myung, 2007). Although the device performance 
can be compromised due to the mixture of SWCNT, leading to the high resistance of 
electronic devices from intertube junctions (Hecht et al., 2006), Martel et al. (2001) have 
referred that the combined properties of both kinds of nanotubes can produce a particular 
type of “building block” for electronics. 
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5.1.2. Experimental methods 
 
Before every experiment, the FET surface was washed with acetone and 1-propanol to 
remove any traces of grease, rinsed twice with distilled water, and finally dried under a N2 
flow. A 1.2 µL droplet of the SWCNT dispersion (0.28 mg L-1), based on a random network 
of SWCNT, was placed over the microfabricated FET surface. After a delay of 5 minutes, 
the liquid of droplet was blown off using a N2 flow in order to produce a SWCNT network 
bridging the FET electrodes. As the solution was dried, the SWCNT diffused to the 
surface and adhered through strong van der Waals interactions (Lay et al., 2004). This 
same approach based on placing the SWCNT from liquid suspensions onto fabricated 
substrates has been already used after the definition of the metallic electrodes (Javey     
et al., 2002; Lim et al., 2010). However, the deposition of SWCNT before the definition of 
metal contacts through physical techniques, such as drop casting or annealing have been 
also used (Wind et al., 2002). The amount of the SWCNT was previously determined as 
the ideal to have the I-V characteristics typical for NTFET. Various volumes of SWCNT 
dispersion were placed on the NTFET surface with subsequent washing with distilled 
water, and the volume above mentioned was the minimum volume to have an ohmic 
behaviour on the NTFET. Volumes higher than that lead to degradation of signal, and 
therefore they were considered unsuitable. The SWCNT were observed at micrometer 
scale by Scanning Electron Microscopy (SEM, FE-SEM Hitachi SU-70) giving an idea 
about the density and uniformity of the individual SWCNT used for application on the 
NTFET. For that, the samples (NTFET) required a little pre-treatment with an ultrathin 
coating of graphite obtained from a Carbon Evaporator (Emitech K950x) to be electrically 
conductive samples, and Figure 5.1 shows the difference on the printing circuit board 
(PCB) surface, before and after such exposition. 
 
 
Figure 5.1 Printing circuit board (PCB) surface before and after the graphite exposition. 
 
 
The SWCNT dispersion was prepared through non-covalent functionalization of 
commercial SWCNT with an anionic surfactant (sodium cholate) after 60 minutes of 
sonication, and 5 minutes of centrifugation (2000 × g) at 20 ºC. The suitable experimental 
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conditions were found by application of an experimental design as published elsewhere 
(Justino et al., 2012) and reported in Chapter 3. 
The electrical characterization of the disposable NTFET was performed at room 
temperature, in air, and in real-time, using a semiconductor parameter analyzer 
(HP4155C, Japan). The normal laboratory conditions used for electrical characterization 
can cause an inherent variability in the experimental conditions but it also simulates real 
conditions in non-controlled environments. The parameter analyser was linked to a test 
fixture (Agilent 16442A, Japan) which is a closed box where the devices were positioned, 
and the drain, the gate, and the source of each FET were connected to respective 
terminals to provide the appropriate electrical circuit for sensing measurements. The 
software Desktop EasyExpert from Agilent was used for the acquisition of data and also 
for the control of the experiments through an USB/GPIB interface. The NTFET were 
characterized in terms of their drain current (ID) as a function of the applied drain voltage 
(VD), and the gate voltage (VG) to obtain the output and the transfer characteristics, 
respectively. In order to obtain an accurate estimate of the instrumental variability, all the 
measurements were carried out three times. 
As described in Chapter 4, the microfabrication process allowed fabricating FET with 
the same configuration, that is, with an interdigitated architecture, which allows a large 
surface area due to the interdigitated electrodes, leading to a simple and rapid analysis. 
Figure 5.2 shows the configuration of the FET devices (Figure 5.2b) with the main 
components (source, drain and gate), and the corresponding top view (Figure 5.2a). In the 
fabricated FET, the source and drain contact electrodes (constituted by Ti/Au layers) are 
positioned on the Si/SiO2 surface. The Si substrate is the back gate (third contact of the 
FET configuration) and the SiO2 is the insulating layer, with the role of isolating the 
SWCNT from the Si layer. It is important to refer that the leakage current, that is, the 
current recorded through the insulating region, was considered as negligible from I-V 
measurements performed without the SWCNT. In other words, the SiO2 was perfectly 
deposited, since insulator characteristics were experimentally observed. 
 
Figure 5.2 Schematic diagram of a) the top view of fabricated FET and b) the FET configuration. 
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As reported in Section 4.1.3, the dies of silicon wafers have FET with different 
geometry parameters. The influence of such geometry parameters on the electrical 
properties of devices was then assessed, by testing different values of thickness of gold 
(40 and 100 nm), distance between the electrodes (0.8, 1.5, and 2.5 µm), and number of 
electrodes (10 and 30). As the FET with 0.8 μm as distance between electrodes were not 
used, as also explained in Section 4.1.3, a total of eight types of FET were used to 
compare their electrical characteristics. Table 5.1 shows the employed designation of the 
tested FET according to their geometry characteristics. Thus, in the FET with general 
designation of “#Y-Zn”, Y is associated with the thickness of gold layer, that is, 1 
corresponds to 40 nm of gold and 2 corresponds to 100 nm of gold, Z is associated with 
the distance between electrodes, that is, A corresponds to 1.5 μm and B corresponds to 
2.5 μm, and n is associated with the number of electrodes, that is, 10 or 30 electrodes. In 
Figure 5.3, a layout of such types of FET is shown on a die of silicon wafer. 
 
 
Table 5.1 Geometry parameters tested on the various experiments with FET. 
 
Experiments 
Geometry parameters 
Thickness of gold 
layer (nm) 
Distance between 
electrodes (µm) 
Number of 
electrodes 
#1-A10 40 1.5 10 
#1-A30 40 1.5 30 
#1-B10 40 2.5 10 
#1-B30 40 2.5 30 
#2-A10 100 1.5 10 
#2-A30 100 1.5 30 
#2-B10 100 2.5 10 
#2-B30 100 2.5 30 
 
 
 
Figure 5.3 Layout of the various FET on a die of silicon wafer (lines 10 and 30 correspond to the 
number of electrodes and columns C, A, and B correspond to the distance between 
electrodes: C - 0.8 μm, B - 1.5 μm, and A - 2.5 μm). 
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5.1.3. Results and discussion 
 
Figure 5.4 shows a SEM image of the surface of a typical NTFET (Figure 5.4a) where a 
dense network of SWCNT was observed, as well as the output characteristics (ID-VD 
graph) obtained (Figure 5.4b) where various VG curves (between -5 to +5 V) were plotted 
as the means of three successive measurements.  
 
Figure 5.4 a) Schematic cross section of a typical NTFET with a zoom SEM image of the SWCNT 
network (image obtained with FE-SEM Hitachi SU-70), and b) Output characteristics 
(for VG curves between -5 and +5 V) for one typical NTFET (inset: corresponding 
transfer characteristics for VD curves between 0 and +1 V). 
 
 
As shown in Figure 5.4b, there is a strong linear dependence between the measured ID 
and the applied VD, suggesting the achievement of ohmic contacts and the potential of 
transistor behaviour for sensing devices, since the current decreases with increasing gate 
voltages, being modulated linearly by the gate voltage. Such decreasing pattern is clearly 
observed in the inset of Figure 5.4b, where for increasing values of VG from -5 to +5 V, the 
ID values decreased from 81.4 to 68.8 nA at VD = +1 V, also suggesting that the 
conduction process corresponds to hole transport as usually observed in the SWCNT 
(Teker et al., 2006). In other words, s-SWCNT present in the NTFET have a p-type 
electrical behaviour in air, being the conduction made through holes (positive carriers) 
instead of electrons (negative carriers). Commonly, two main theories have been 
proposed to explain such p-type behaviour as suggested by Collins and Avouris (2000) 
and Derycke et al. (2001), that is, the p-type behaviour of NTFET could be due to the 
absorption of oxygen on SWCNT with the withdrawn of electrons from SWCNT surface, or 
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due to the metal contacts nature, respectively, but a consistent theory has not yet been 
well established. In the Figure 5.4b, it has been also shown that the ON/OFF ratio of 1.2, 
calculated from ID values between the lower and higher VG values at VD = +1 V, was as 
low as reported in other studies with biosensors based on SWCNT networks, for example, 
in the works of Cid et al. (2008a; 2008b), and Villamizar et al. (2011). These low values of 
ON/OFF ratios are due to the presence of m-SWCNT in the SWCNT network, as also 
reported in the works of Hone et al. (2004), and Villamizar et al. (2009). Therefore, the 
random network of the SWCNT used as the conducting channel in the FET configuration 
displays the tolerance of individual SWCNT breakdown, since the average over a large 
number of SWCNT is considered (Peng et al., 2008; Lim et al., 2010), and they exhibit the 
averaged properties of a large number of random individual SWCNT (Cao and Rogers, 
2008). According to Kreupl (2008), low ON/OFF ratios could be due to the parallel 
connection of m-SWCNT and small band gap SWCNT together with the s-SWCNT. For 
the different types of NTFET, the range of the ON/OFF ratio values is between 1.1 and 
2.4, also confirmed by the transfer characteristics (ID-VG graph) observed in the inset of 
Figure 5.4b, where a weak dependence of ID on the VG was observed. It should be 
highlighted that in Figure 5.4, the VD value is about +1 V, since it provides a better 
modulation of the NTFET electrical signal, that is, at such value the ON/OFF ratio is 
higher than with other VD values. Thus, along this thesis, such value will also be used in 
the different sensing experiments. 
Also from Figure 5.4b, the resistance values of the conducting channel made of a 
SWCNT network can be extracted as the inverse slope of the ID-VD curve in the linear 
range between 0 and +2 V at a fixed VG value of 0 V for each type of NTFET, as 
suggested by Cid et al. (2010), in order to evaluate the NTFET performance. Table 5.2 
reports the calculated resistance values obtained from the different types of NTFET; for 
each type of FET, five individual devices were used to assess the variability which was 
determined as coefficient of variation (CV). It was found that the experiments exhibited an 
adequate repeatability, since a variation between 0.6 and 4.9 % of the resistance values 
was observed when performing three successive measurements on the same NTFET. 
Curutchet et al. (2008) and Villamizar et al. (2008) obtained variations on the electrical 
current of 5 %, and up to 10 %, respectively, when successive measurements were 
carried out, which means that the low variability obtained in this work is quite acceptable. 
Curutchet et al. (2008) suggest that this behaviour is related to the influence of the 
environment since the devices are not passivated, which also happened with our tested 
devices. 
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Table 5.2 Resistance values obtained by the NTFET as function of various geometry parameters. 
 
FET 
type 
Geometry parameters Device performance 
Thickness of 
gold layer (nm) 
Distance between 
electrodes (µm) 
Number of 
electrodes 
Resistance 
(MΩ) 
CV (%) 
#1-A10 40 1.5 10 893 6.2 
#1-A30 40 1.5 30 483 8.9 
#1-B10 40 2.5 10 15.3 18.1 
#1-B30 40 2.5 30 179 16.5 
#2-A10 100 1.5 10 3.84 13.8 
#2-A30 100 1.5 30 53.9 11.2 
#2-B10 100 2.5 10 2.53 9.5 
#2-B30 100 2.5 30 28.3 10.3 
 
 
From Table 5.2, the resistance values are in accordance with the typical resistance 
values range, that is, in the order of MΩ, as reported by Cid et al. (2010), and the 
variability of the resistance values for the five devices of each type of NTFET varied 
between 6.2 % and 18.1 %. Karp et al. (2009) referred that the variability on different 
devices can be associated with the structural properties of the deposited CNT, affecting 
considerably the conductance of devices with same characteristics. Justino et al. (2013c) 
have recently reviewed the main strategies for the enhancement of analytical performance 
of sensors using nanomaterials, particularly nanowires and carbon-based materials, 
emphasizing the way to overcome the problem of device-to-device variation, and 
discussing the influence of nanomaterial characteristics, sensor dimensions and 
operational conditions on sensing performance, 
A three-way analysis of variance (ANOVA) was performed with the results reported in 
Table 5.2 in order to test whether differences exist between the levels of each parameter, 
that is, the thickness of gold layer, the distance between electrodes, and the number of 
electrodes on the response (resistance). As the normality test have failed (p < 0.05), the 
Holm-Sidak method has been performed for pairwise comparison, and an estimated 
statistically significant difference was found between the various types of NTFET             
(p < 0.001), that is, between NTFET with different thickness of gold layer, distance 
between electrodes, and number of electrodes. Specifically, the variation in geometry 
parameters affects the obtained resistance values of the various NTFET, and some 
considerations could be stated, as follows: 
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a) there is a statistically significant difference between the two levels (40 and 100 
nm) of the factor thickness of gold layer (p < 0.001). Thus, by changing the 
thickness from 40 to 100 nm, the resistance values decrease between 0.84X 
and 1X, since the lower resistances are provided with 100 nm of gold layer; 
b) there is a statistically significant difference between the two levels (1.5 to     
2.5 µm) of the factor distance between electrodes (p < 0.001). Thus, when 
increasing the distance from 1.5 to 2.5 µm, the electrical resistance decreases 
for all NTFET devices between 0.34X and 0.98X, and this could be due to the 
higher conduction channels which provide lower resistances. On the other 
hand, the higher the surface area between the electrodes of devices, the 
higher will be the sensitivity of devices to the receptor molecules when such 
devices will be applied for sensing; and, 
c) there is a statistically significant difference between the two levels (10 and 30) 
of the factor number of electrodes (p < 0.001). Thus, when increasing the 
number of electrodes from 10 to 30, the largest impact was recorded in the 
obtained resistance values, that is, the resistance values increased from 
10.2X to 13.0X, which is also related to the large increase of NTFET 
dimensions with the increase of the number of electrodes. However, an 
exception was observed for NTFET with 40 nm-thick gold, and 1.5 µm where a 
small decrease of resistance values of 0.46X was recorded. 
 
Taking into account the considerations above mentioned, the type of NTFET with     
100 nm gold-thick, 2.5 µm of distance between electrodes, and with 10 electrodes (that is, 
5 source and 5 drain electrodes), leads to lower resistance values and it was selected for 
further sensing experiments. 
 
 
5.2. Calibration of the NTFET with CRP standard solutions 
 
After their assemblage, the NTFET with 100 nm-thick of gold, a distance between the 
electrodes of 2.5 µm, and 10 electrodes were found to be the most suitable for further 
sensing experiments, and the calibration of the NTFET was performed with standards 
solutions of CRP, as reported in this Section. 
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5.2.1. Experimental methods 
 
5.2.1.1. Immobilization of the specific antibody for the CRP (the anti-CRP) 
 
Due to the affinity of the SWCNT with amino groups of antibodies, as reported by 
Wang et al. (2003) and Bradley et al. (2004), the immobilization of antibodies specific to 
the CRP (the anti-CRP produced in goat, Sigma-Aldrich Química, Portugal) on the 
SWCNT surface was directly processed through a non-covalent adsorption, since this 
method preserves the structure of the SWCNT and consequently their mechanical and 
electronic properties (Allen et al., 2007). Thus, a 1 µL droplet of the anti-CRP was 
pippeted onto the surface of the NTFET, which were stored overnight at 4 ºC. The anti-
CRP solution of 1 g L-1 has been previously prepared by adding 62.1 μL of the purchased 
anti-CRP in a volumetric flask of 5 mL, using Dulbecco’s phosphate buffered (pH 7.4) 
saline solution (PBS). In order to prevent evaporation of the anti-CRP solution, each one 
of the NTFET were placed in a small Petri dish (10 cm Ø) hermetically sealed with 
parafilm. Any unbound molecules were then washed from the NTFET with the PBS and 
distilled water, and finally dried with nitrogen for further electrical characterization. 
It is known that the concentration of the antibody on the CNT is associated with the 
number of antibodies available for interaction with the target analyte. Thus, the most 
suitable value of concentration of anti-CRP immobilized on the NTFET surface (1 g L-1) 
was previously found by comparing the electrical signal (current) of four anti-CRP 
solutions with concentrations of 0.01, 0.1, 1, and 10 g L-1. The solutions of 0.01 and       
0.1 g L-1 were obtained through dilution of the anti-CRP stock solution (1 g L-1), and the 
solution of 10 g L-1 was prepared by adding 621.1 μL of purchased anti-CRP in a 
volumetric flask of 5 mL using PBS as solvent. 
 
 
5.2.1.2. Control experiments for determining the nonspecific binding and 
specificity of the NTFET 
 
Two control assays were performed in parallel experiments in order to ascertain the 
nonspecific binding of other compounds and possible interferences on the SWCNT, as 
well as to study the specificity of the fabricated NTFET to the CRP analyte. Nonspecific 
binding of biomolecules is not desirable in an immunoassay, since false positive signals 
can be produced, and such unwanted interactions and consequent analytical artefacts 
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should be avoid in the process of the development of biosensors. Therefore, in order to 
prevent the nonspecific binding of other compounds (such as bovine serum albumin, BSA) 
and avoiding possible interferences on the SWCNT, a Tween 20 solution was used as 
blocking agent, by dropping 1 µL of 0.5 % Tween 20 in PBS on the surface of the NTFET 
without anti-CRP for one hour, since it is commonly used to block the CNT surface of 
nonspecific molecules (Chen et al., 2004; Star et al., 2003; Shim et al., 2009). The 
devices were washed with PBS and distilled water, and dried with a stream of nitrogen. 
Then, a high concentration of CRP (100 mg L-1) was deposited on the NTFET surface to 
evaluate the analytical response. This control experiment confirmed that the change of 
drain current (ID) values when the CRP was dropped onto the NTFET surface is only due 
to the detection of the CRP by immunoreaction. The 100 mg L-1 CRP solution was the 
CRP stock solution considered along this thesis, and it was prepared by adding 217.5 μL 
of purchased CRP (human CRP, Sigma-Aldrich, Portugal) in a volumetric flask of 5 mL 
using PBS as solvent. For the specificity test, NTFET were exposed to BSA (1 µL of       
10 mg L-1) during one hour at room temperature, after the immobilization of the anti-CRP 
(1 μL of 1 g L-1) on the blocked CNT. This assay allowed to assess the specificity of the 
fabricated NTFET to the CRP analyte. Since the serum albumin is the most common 
protein in blood serum, many studies tested the specificity of biosensing devices to the 
BSA, which has an amino acid sequence very similar to the human serum albumin. Then, 
the obtained results help to confirm the specific interaction of the CRP with its respective 
antibody. 
 
 
5.2.1.3. Detection of CRP standard solutions 
 
For the detection of CRP, 1 µL of each CRP solution at concentrations from 10-4 to   
102 mg L-1 were introduced into the silicone chamber of three individual NTFET, and 
incubated 15 minutes at room temperature. The NTFET were washed with distilled water, 
dried with nitrogen, and their electrical characterization was immediately processed. Since 
the FET devices are easily affected by ionic strength, as reported by Cid et al. (2008a), 
and Villamizar et al. (2011), the electrical measurements were carried out under dry 
conditions, after rinsing and evaporating the remaining antigen solution, in order to 
eliminate the influence of ions present in aqueous solutions which could promote noise in 
the electrical signal of FET, and which are no longer of concern in a dry environment. On 
the other hand, Ah et al. (2012) have obtained an enhancement of the electrical signal of 
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FET in dry conditions applied for the biosensing of small molecules (< 400 kDa), through 
an increase of two orders of magnitude of the electrical current in comparison to 
measurements in solution systems. Moreover, the Debye screening length, which is a 
screening distance where charge carriers of a molecule in buffer solution are unaffected 
by other charges, is absent in the dry state, being measurements more sensitive, as 
concluded by Kim et al. (2012) when they have studied label-free FET biosensors for 
avian influenza in both aqueous and dry environments. In this thesis, the electrical signal 
for both anti-CRP and CRP expositions were determined under dry conditions, following 
closely the works of Star et al. (2003; 2004). 
The drain current (ID) was measured as a function of the drain voltage (VD), between 0 
and +2 V, to find the output characteristics of the NTFET, after SWCNT deposition, 
antibody immobilization, and introduction of each CRP solution at various concentrations. 
The experiments in each condition were repeated three times. The reproducibility was 
evaluated performing all measurements in three individual FET devices. The transfer 
characteristics of such NTFET were also assessed by measurement of the ID values 
against the back-gate voltage (VG), between -5 and +5 V, at a fixed drain voltage           
(VD = +1 V). The changes in ID values in each NTFET after the exposure of any solution 
on the CNT surface are due to the variation of the flow of electrons through the nanotubes 
between the source and the drain of each NTFET, as reported by Kamahori et al. (2007). 
As the detection of the CRP antigen (ICRP) depends on the interaction with its specific 
antibodies (anti-CRP) and in turn, with the extent of binding of the anti-CRP onto the 
SWCNT (Ianti-CRP), the analytical response (current change, ∆ICRP) for the sensing 
experiments with the fabricated NTFET was considered as the change in ID values for 
each CRP concentration after their interaction with antibody (ICRP – Ianti-CRP). The analytical 
response from various NTFET was then plotted against the values of the CRP 
concentration between 10-4 and 102 mg L-1 to obtain the calibration curve. Due to the high 
stability of the interaction between the antibody and the antigen, the majority of 
immunosensors are of single-use, that is, they are disposable, and such configuration was 
also considered for the NTFET developed in this thesis. In addition to such strong 
interaction, there is also a very difficult regeneration of the devices, which is based in the 
obtaining of free antibody capturing sites by dissociation of antibody and antigen, and in 
the removal of antibodies from the CNT, which in turn are immobilized on the FET 
surface. Moreover, such regeneration should be done on each individual device, leading 
to expensive and time-consuming tasks. 
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5.2.2. Results and discussion 
 
5.2.2.1. Immobilization of the anti-CRP 
 
Figure 5.5 shows the variation of the drain current (electrical signal) as a function of the 
drain voltage (VD) in the NTFET only with the SWCNT and in the NTFET with solutions of 
anti-CRP at concentrations of 0.01, 0.1, 1, and 10 g L-1. 
 
Figure 5.5 Variation of the drain current (ID) as a function of the drain voltage (VD) obtained for the 
four anti-CRP concentrations in comparison with that of SWCNT (at VG = +1 V) (Inset: 
ID difference values between SWCNT and each anti-CRP concentration at VD = +1 V). 
The error bars show the standard deviation of three successive measurements. 
 
 
Figure 5.5 shows that after the immobilization of the anti-CRP, the current decreases 
when compared to the drain current observed for NTFET only with SWCNT. As reported 
in the work of Teker et al. (2006), where a decrease in the current of the NTFET has 
occurred after the exposure of the antibody molecules on the CNT channel, the amine 
groups of antibodies provide electrons for the nanotubes, reducing the number of holes as 
major charge carriers, and consequently also reducing the drain current. On the other 
hand, it is also observed that when the antibody concentration increases, the current 
decreases for all VD values, since more molecules are adsorbed onto the SWCNT 
surface. However, an exception is observed for the electrical response obtained when the 
anti-CRP concentration of 10 g L-1 was applied on the NTFET surface, that is, the current 
is higher than that obtained with a concentration of 1 g L-1, which could mean that an 
               Development of NTFET for CRP Detection 
_________________________________________________________________________ 
105 
excess of antibodies is certainly present retarding the electron transfer on the NTFET 
surface and thus NTFET are not sensitive to antibody concentration above 1 g L-1. With an 
antibody concentration of 1 g L-1, the difference between the SWCNT and the anti-CRP 
response is higher than the differences with other antibody concentrations, as shown in 
the inset of Figure 5.5, where the differences between the drain current obtained for 
NTFET only with SWCNT and the drain current obtained for NTFET with the various 
solutions of anti-CRP are plotted. In this way, the antibody concentration of 1 g L-1 was 
chosen to be used in the biosensing experiments, due to the enhanced change of current 
signal provided relatively to the current observed for NTFET only with SWCNT, and also 
providing the more effective number of anti-CRP immobilized on SWCNT surface. 
Figure 5.6 shows the output characteristics of a typical NTFET device (at VG = +1 V) 
before (that is, only for the SWCNT) and after the modification of the NTFET surface with 
specific antibodies for the CRP, that is, the anti-CRP of 1 g L-1. The VG value of +1 V was 
chosen, since it allows a higher correlation between ID and VD, as studied in the 
preliminary work, with a set of NTFET. 
 
Figure 5.6 Change in output characteristics (at VG = +1 V) of a typical NTFET before () and after 
() the incubation of anti-CRP (1 g L-1) for one hour. The error bars show the standard 
deviation of three successive measurements. 
 
 
 The direct charge transfer is one of the proposed mechanisms about how the 
immobilization of the charged analytes can affect the conductance of the SWCNT, as 
studied by Gruner (2006). Thus, and according to the experimental data shown in Figure 
5.6, the adsorption of a charged biomolecule (the anti-CRP) at the nanotubes surface 
leads to a decrease of ID values of 88 % (calculated from the difference between output 
Chapter 5                                                         
_________________________________________________________________________ 
106 
curves before and after the incubation of the anti-CRP at VD = +1 V), which means that 
the immobilization of the anti-CRP onto the SWCNT has occurred. As above mentioned, 
the decrease of the drain current is associated with the reducing of the number of holes as 
major charge carriers in NTFET after the immobilization of the antibody molecules onto 
SWCNT. 
 
5.2.2.2. Control experiments for determining the specificity and the nonspecific 
binding of the NTFET 
 
One of the two control experiments was performed to determine the specificity of 
NTFET and Figure 5.7a shows the results obtained, that is, the change of NTFET 
response after the introduction of BSA. The nonspecific binding of NTFET was also tested 
and Figure 5.7b shows the obtained results from the control assay with Tween 20. As 
shown in Figure 5.7a, no decrease of the BSA signal is shown in comparison to the signal 
of the anti-CRP signal being only slightly higher. It means that no specifically binding of 
BSA occurred in the NTFET after one hour of incubation, that is, BSA did not bind to 
antibodies specific to CRP, as also verified by Quershi et al. (2009). The PBS signal on 
the NTFET was also determined, being lower than that of BSA, which demonstrates that 
the buffer used for the preparation of solutions do not influences the final response (ID 
values). 
 
Figure 5.7 a) Control assay showing the effect of the BSA on the NTFET response, and b) 
response change before and after the exposure of Tween 20 to a typical NTFET (at VG 
= +1 V and VD = +1 V). The errors bars show the standard deviation of three assays. 
 
 
In order to confirm that the change in drain current (ID) is due to the interaction between 
the anti-CRP (the receptor) and the CRP (the analyte), an additional control assay was 
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performed by blocking the CNT free sites with Tween 20, without the previous exposure to 
the anti-CRP. The NTFET was then exposed to the high concentration of the CRP       
(100 mg L-1), and a weak decrease in ID values has occurred after the exposure of CRP 
on NTFET with Tween 20, as shown in Figure 5.7b. Based on such results, it is 
considered that Tween 20 blocks the CNT sites, and without the anti-CRP, the devices do 
not respond to the CRP, being the interaction between the anti-CRP and the CRP unique 
for the NTFET response. 
 
 
5.2.2.3. Analytical response for the CRP standard solutions 
 
After the characterization of the electrical behaviour of the NTFET through I-V 
measurements (Figures 5.4b and 5.6) and performing the control experiments, the NTFET 
were tested for their sensing features towards the CRP. The detection of CRP standard 
solutions of concentrations ranging from 10-3 to 102 mg L-1 was carried out through the 
measurement of the drain current at VG = +1 V and VD = +1 V on three individual NTFET 
for each of the CRP concentrations. The plot of the analytical response (current change, 
that is, ∆ICRP) is shown in Figure 5.8, where each vertical bar represents an average value 
based on three successive measurements, and the respective standard deviation is 
reflected in each error bar. The analytical response ∆ICRP was considered as the change in 
drain current of NTFET by the interaction of CRP with their specific antibody              
(∆ICRP = ICRP – Ianti-CRP). 
As shown in Figure 5.8, the current change decreases from 6.4 to 0.9 nA as the CRP 
concentrations increase from 10-3 to 102 mg L-1, since as the concentration of CRP 
increases, more binding sites are occupied which limits the interaction between the anti-
CRP and the CRP molecules, thus leading to a larger decrease in the analytical response 
(∆ICRP). As a result of the binding events, that is, the antibody-antigen interactions, a 
geometrical deformation of nanotubes could occur, thus increasing the scattering centres 
among them, and decreasing the current, as studied by Star et al. (2003). Moreover, 
Gruner et al. (2006) suggest that the decrease of current after binding events could be 
due to a potential scattering which leads also to a decrease on the mobility of holes, which 
are the major charge carriers of the NTFET. 
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Figure 5.8 Variation of the analytical response obtained from three individual NTFET for each of 
the CRP concentrations between 10
-3 
and 10
-2
 mg L
-1
 (error bars show the standard 
deviation of three individual NTFET). 
 
 
The variability of the current change for the three individual NTFET was assessed as 
coefficient of variation (CV), and the following results were obtained for the successive 
decimal concentrations of CRP between 10-3 and 102 mg L-1, respectively, 8.2, 1.4, 14.5, 
12.9, 5.6, and 8.8 % with an average CV of 8.6 %. Such variability may be due to: a) the 
random nature of the nanotubes networks in terms of their chirality and their diameter, b) 
the variations in the SWCNT networks, c) the density of the SWCNT bundles, and d) 
different ratio of m-CNT and s-CNT, as stated by Tey et al. (2009), who obtained a 
variability between 10 and 15 % in current measurements when poly-L-lisine was detected 
with CNT-based biosensors. Such physical features can affect the electronic structure of 
the SWCNT and consequently their mobility and the current on each device. However, the 
ANOVA applied to the experimental data showed that there is no statistically significant 
difference (p = 0.958) between the various NTFET for the same concentration of CRP. 
Based on the response of the NTFET to the different concentrations of CRP, as shown 
in Figure 5.8, the best calibration model was sought for fitting the experimental data. In a 
first attempt, a logistic regression model based on a four-parameter logistic (4PL) curve 
was applied to the experimental data, since such calibration curve has been 
recommended for limited reagent immunoassay (Little, 2004), and this is the most used 
calibration model for immunoassays (Robison-Cox, 1995). Figure 5.9 shows the 4PL 
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curve applied to calibrate the NTFET, and Table 5.3 contains the parameters of the model 
obtained by SigmaPlot software (SigmaPlot, 2008). 
 
Figure 5.9 Logistic regression based on the 4PL model obtained from three individual NTFET 
(error bars show the standard deviations of three individual NTFET). The inset graph 
shows the log-log regression plot for the mean current change of the NTFET to the 
CRP through immunoreaction; a schematic of the principle of detection in the NTFET is 
also included in the inset graph. 
 
 
The 4PL curve is given by the following equation: 
 
  
   
                 
      [5.1] 
 
where y is the response, that is, the current change, A is the asymptotic maximum of the 
equation (maximum signal in the absence of analyte), B is the slope coefficient at the 
inflection point given by the parameter C which is the CRP concentration (x) to produce  
50 % of the maximum y range, and D is the asymptotic minimum of the equation 
(background signal). 
This 4PL calibration model can be applied to experimental results when the 
recommendations proposed by Findlay and Dillard (2007) are met, that is, a minimum of 
five concentrations and not more than eight are used, the measurements should be 
analyzed in duplicate or triplicate, and the concentration progression should be 
logarithmic. Such recommendations have been considered as important to ensure the 
adequate estimate of the four parameters of the calibration model, to reduce the standard 
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error of the response, and to use a fixed dilution ratio for the preparation of analyte 
concentrations through serial dilutions. 
An appropriate adjustment to the experimental data was obtained since acceptable 
value for the determination coefficient was found as estimate of the goodness of fit (R2 of 
0.9809; p < 0.001). An adequate standard error of the estimate (sy/x) of 0.3161 was also 
found as estimate of the variability of the regression model based on the measure of the 
accuracy of predictions, corresponding to 0.32 % of the R2. However, such 4PL model 
shows as the main limitation that only the linear region of the function (with three 
calibration points from 10-2 to 101 mg L-1) can be used for further determination of 
unknown concentrations, thus restricting the working range. Therefore, if the estimated 
concentrations are outside such linear range, then the experiments should be repeated by 
diluting the sample, becoming a major drawback for the application of the method on a 
routine basis. 
In order to attempt using the entire range of concentrations, the analytical response 
from Figure 5.8 was plotted in a logarithmic scale as a function of the logarithmic 
concentration of CRP, as shown in the inset of Figure 5.9, and the corresponding 
analytical parameters are shown in Table 5.3 in order to compare them with those 
obtained with the 4PL model. Then, a six-point log-log curve fitting was obtained with a 
better goodness of fitting (R2 = 0.988, p < 0.001, and adjusted R2 of 0.985) than that 
obtained by the 4PL model, with the possibility of using it in a much broader range of CRP 
concentrations (six orders of magnitude). 
 
Table 5.3 Analytical parameters for the two regression plots of Figure 5.9. 
Regression equation 
4PL model Log-log regression 
y = D + [(A - D) / (1 + (x/C)^-B] logy = a + b.logx 
Equation parameters 
A = 7.1380 ± 0.5382 
B = - 0.5764 ± 0.1112 
C = 0.0333 ± 0.0132 
D = 1.0694 ± 0.1834 
a = 0.319 ± 0.0167 
b = - 0.171 ± 0.00937 
R
2
 0.9809 0.9882 
Adjusted R
2
 0.9750 0.9850 
sy/x 0.3161 0.0390 
sy/x - Standard error of estimate 
 
In order to improve the dynamic linear range, an additional CRP solution was used with 
a concentration of 10-4 mg L-1, and the log-log curve fitting was improved in comparison 
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with that of six points. Thus, the regression plot obtained, as shown in Figure 5.10, has a 
standard error of the estimate (sy/x) of 0.036, a value of 0.9924 for the R
2, and a value of 
0.9910 for the adjusted R2, which are better than those observed in Table 5.3 for the     
six-point log-log curve. 
 
Figure 5.10 Log-log regression plot for the analytical response obtained from three individual 
NTFET for CRP concentration between 10
-4 
and 10
-2
 mg L
-1
 (error bars show the 
standard deviation of three individual NTFET).  
 
 
The practical value of such disposable biosensing devices is here highlighted since it 
includes the normal concentration range of CRP levels in human blood serum                  
(1 - 3 mg L-1), as well as it includes values well below 1 mg L-1, and well above 3 mg L-1 of 
the CRP. In other words, the residual CRP levels between 10-4 and 1 mg L-1 can be 
detected corresponding to the typical values for a healthy subject without any sign of 
inflammations, as well as it becomes possible to identify pathological cases, that is, levels 
higher than 10 mg L-1. In addition, the dynamic linear range obtained with the NTFET   
(10-4 - 102 mg L-1) is much broader than in the case of traditional high-sensitivity 
immunoassays for CRP in serum, which is between 5 to 10 mg L-1 (Dominici et al., 2004; 
FDA, 2005). 
Concerning the sensitivity of the NTFET, estimated as the experimental slope of the 
calibration curve (Figure 5.10), it is shown that a decrease of response (current change) 
by about 0.2 % is observed for every 1 % increase of the CRP concentration. In turn, the 
limit of detection (LOD) obtained was about 10-4 mg L-1, considering the LOD as the 
lowest concentration of the CRP, which is far better by 2 to 3 orders of magnitude than the 
traditional immunochemical assays (LOD from 0.03 to 0.2 mg L-1). Furthermore, the LOD 
of these NTFET is much lower than the clinical relevant range of concentrations in serum, 
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and it is better than other measurement systems used for the detection of the CRP, such 
as optical RNA-based aptasensor (Bini et al., 2008), chemiluminescence-based 
microfluidic system (Yang et al. 2009), and magnetic sensor (Meyer et al., 2007), with 
LOD values of 5x10-3, 1.25x10-2, and 2.5x10-2 mg L-1, respectively. It is important to 
highlight that the calculation of the LOD accordingly to the traditional method, that is, 
considering yLOD=yB+3sB (Miller and Miller, 2005) is not possible in a log-log graph, since 
in a graph with logarithmic axis, it is not possible to calculate the value when                     
x approaches zero, because the corresponding y value tends to infinite. In the context of 
this work, the CRP solution without analyte has an electrical signal equal to the anti-CRP, 
since the relative electrical response of the NTFET is considered as ICRP-Ianti-CRP, and thus 
the value for the NTFET only with the anti-CRP (x = 0) is zero, and that is insignificant in 
the context of the curve fitting shown in Figure 5.10. Then, the LOD is considered as the 
lowest concentration of CRP, that is, about 10-4 mg L-1. Finally, only 1 µL of the CRP 
solution are required for performing the analytical determinations in the range of 10-4 and 
102 mg L-1 which is an additional advantage and a factor of competitiveness in comparison 
with the above mentioned biosensing systems. Table 5.4 shows such a favourable 
comparison of the analytical figures of merit (linear range and LOD) of this work against 
some recent biosensors forwarded for the CRP detection. 
 
Table 5.4 Comparison of figures of merit from biosensors for the CRP detection. 
Biosensor Linear range (μg/mL) LOD (μg/mL) References 
NTFET immunosensor 10
-4 
- 10
2 
(R
2
 = 0.992) 10
-4 a
 This work 
SPR-based immunosensor 2.0 - 5.0 (R
2
 = 0.987) 1.0 
b 
Meyer et al., 2006 
Magnetic immunosensor 
2.5x10
-2 
- 2.5 
(R
2
 = 0.989) 
2.5x10
-2 c 
Meyer et al., 2007 
Electrochemical 
immunosensor with MWCNT 
5x10
-4 
- 0.5 
 
5x10
-4 d
 
Buch and Rishpon, 
2008 
Optical RNA-based aptasensor up to 0.1 (R
2 
= 0.982) 5x10
-3 e
 Bini et al., 2008 
QCM immunosensor 
1.3x10
-4 
- 2.5x10
-2 
(R
2
 = 0.979) 
1.3x10
-4 f
 Kim et al., 2009 
MEMS-based microfluidic chip NA 1.25x10
-2 g
 Yang et al., 2009 
Capacitive immunosensor 
2.5x10
-2 
- 8.0x10
-1 
(R
2
 = 0.9255) 
NA 
Quershi et al., 
2009 
Potentiometric immunosensor 
with ZnO nanotubes 
10
-5 
- 1 (R
2
 = 0.990) 10
-3 e
 Ibupoto et al., 2012 
SPR - Plasmon surface resonance; MWCNT - Multi-walled carbon nanotubes; QCM - Quartz crystal 
microbalance; MEMS - Micro-electro-mechanical-systems; NA - Not Available. 
a
minimum detectable 
concentration; 
b
LOD is higher than four times the background (0.5 AU, Arbitrary Units); 
c
LOD is 10 times the 
background noise; 
d
3 times the standard deviation from the blank; 
e
NA; 
f
3 times the standard deviation from 
the baseline drift; 
g
signal-to-noise ratio of 3. 
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The absence of systematic errors was tested by means of recovery functions, as stated 
by Danzer et al. (2004). Thus, the comparison of the CRP concentration estimated by the 
regression model (Figure 5.10) with respective known concentration was performed, and 
recoveries of 102, 93, 115, 93, 88, and 98 % were obtained from CRP concentrations of 
10-4, 10-3, 10-2, 10-1, 101, and 102 mg L-1. 
 
 
5.3. Separation of SWCNT by electronic type 
 
According to the methodologies described in the Section 2.1.4, and taking into 
consideration the facilities of the available laboratories, some techniques were tested for 
the separation of the SWCNT by electronic character, that is, the selective reaction of a 
diazonium salt with the m-SWCNT, and methodologies based on agarose gel, that 
involves manual squeezing of the frozen and thawed gel, centrifugation, diffusion and 
permeation, were tested. 
The methodology developed by Ghosh and Rao (2009), which employed the selective 
reaction of a diazonium salt of 4-heptadecafluororooctylaniline with the m-SWCNT of a 
dispersion, was tested and ended-up in failure by several reasons. Firstly, the 
experimental details are not entirely described in their work in terms of proportions of 
reagents, and experimental conditions. Secondly, the need of synthesis of an unstable 
gas (HNO2) is very difficult, since its formation is in situ after the addition of a cooled 
aqueous solution of NaNO2 to fluorous aniline in HCl, which should be cooled at 4 ºC, 
requiring specific laboratory conditions and safety precautions, and not clearly identified in 
the article of Ghosh and Rao (2009). Thirdly, in any step, a complete degree of dryness 
must not exist since diazonium salts are unstable at temperatures above 5-10 ºC, and 
some could explode if allowed to dry, being a dangerous methodology. 
Methodologies based on agarose gel, that involves manual squeezing of the frozen 
and thawed gel, centrifugation, diffusion, and permeation (Tanaka et al., 2009a) were also 
tested, but with no success at all. The main problem with those methods is the need for 
heating in order to remove the gel impurities from s-SWCNT: the gel is melted and a brief 
centrifugation removes the gel from s-SWCNT (Tanaka et al., 2011), but such separation 
is not easy to perform. The control of temperature when preparing the CNT-containing gel 
is slightly difficult, since too high temperature of melting agarose gel may diminish the 
dispersability of the surfactant. 
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Finally, the separation process to obtain s-SWCNT and m-SWCNT from a SWCNT 
network was carried out in this thesis, using a column separation method with agarose 
beads, as reported by Tanaka et al. (2009b), since it was found easier and adequate to 
use besides allowing to obtain reproducible results.  
 
 
5.3.1. Experimental methods 
 
The column chromatography is used in this work as a method for the separation of the 
CNT by their electronic nature: agarose beads are used as stationary phase, sodium 
dodecyl sulphate (SDS) is used to eluting the m-SWCNT, and the sodium deoxycholate 
(DOC) solution is used to eluting the s-SWCNT. Thus, the methodology developed by 
Tanaka et al. (2009b) is a continuous separation method where the s-SWCNT show more 
affinity with the stationary phase than the m-SWCNT, being selectively adsorbed on the 
agarose beads, and then eluted with a DOC solution. The mechanism of retention of the 
s-SWCNT in agarose is not well understood, and various works aimed at studying this 
phenomenon: a) Silvera-Batista (2011) stated that the selective interaction of s-SWCNT 
with agarose is caused by the van der Waals forces between s-SWCNT coated with SDS 
molecules and agarose beads, or by their electrostatic interactions, and b) Duque et al. 
(2010) explained such interaction on the basis of the differences in surfactant coverage 
between the m-SWCNT and the s-SWCNT, since the m-SWCNT could be likely 
surrounded by a larger number of surfactant molecules. Thus, the s-SWCNT in the initial 
suspension could have a surfactant structure with the molecules lying flat on the sidewall 
of the SWCNT while the m-SWCNT could have the surfactant orientated away from the 
nanotube surface. As a consequence, the m-SWCNT and the s-SWCNT have weaker and 
stronger interaction with the agarose matrix, respectively, as explained by Silver-Batista 
(2011), and, when the eluent is changed from SDS to DOC, the SDS configuration is 
disrupted and the DOC molecules might also adsorb strongly to agarose and displace the 
adsorbed s-SWCNT. 
A schematic diagram of the process of the SWCNT separation is shown in Figure 5.11. 
A 5 mL disposable syringe is filled with 2.5 mL of agarose beads (bead size range:         
60 - 200 μm; Sepharose 2B, GE Healthcare). In order to make the agarose gel ready for 
the experiments, the purchased agarose gel, which was supplied in 20 % ethanol, was 
previously washed with distilled water using a vacuum pump for the complete removal of 
the ethanol. After the addition of the agarose gel to the syringe, the gel was washed with 
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water, and equilibrated with 1 % SDS solution in order to obtain a compactable bed 
volume. Then, 3.5 mL of SWCNT dispersion, referred as initial SWCNT network, was 
loaded onto the column, with the successive application of 4 mL of SDS 1 % solution to 
remove the shorter m-SWCNT. In this way, s-SWCNT are adsorbed in the upper region of 
agarose beads, while the m-SWCNT are eluted and collected at the bottom of the column 
into a fraction enriched in m-SWCNT, thus called m-fraction. Then, the s-SWCNT were 
eluted with the addition of 3 mL of 1 % DOC solution, and collected into a fraction 
enriched in s-SWCNT, thus called s-portion. This methodology is quick since small 
agarose gel beads are used, providing a large surface area of contact of the SWCNT with 
the stationary phase of agarose. 
  
 
Figure 5.11 Schematic diagram of the chromatographic separation of the m- and the s-SWCNT 
from an initial SWCNT network. 
 
 
The assessment of the relative content of the m-SWCNT and the s-SWCNT both in the 
m-portion and in the s-portion can be obtained by absorption spectroscopy, as suggested 
by Haddon et al. (2004). In this thesis, the UV-Vis spectroscopy and the Raman 
spectroscopy were used to evaluate the effectiveness of separation of the SWCNT 
dispersion in the m-portion and s-portion through the calculation of the content of            
m-SWCNT and s-SWCNT in both portions. According to Haddon et al. (2004), the Raman 
spectroscopy can be more useful when a large distribution of SWCNT diameters is 
present in the dispersion of the SWCNT network, since in this case the S22 and the M11 
can be overlapped in absorbance spectra. Regarding UV-Vis spectroscopy, the contents 
of m-SWCNT and s-SWCNT in separated fractions were evaluated through the 
methodology discussed in Section 3.3.1, where the quantitative determination of m-
SWCNT and s-SWCNT in a typical SWCNT dispersion was exemplified (Figure 3.5b), and 
compared with the initial network SWCNT sample before separation in order to assess 
whether any change in the s-SWCNT and the m-SWCNT percentages has occurred with 
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separation. According to An and Lee (2006), the absorbance intensity is proportional to 
the amount of SWCNT dispersed in the solution and furthermore, it provides information 
from the peaks produced by the van Hove singularities. 
 
5.3.2. Results and discussion 
 
After the collection of the two portions, the percentages of m-SWCNT and s-SWCNT 
were determined and they were compared with those of the initial SWCNT network 
sample by UV-Vis spectroscopy. Figure 5.12 shows the absorbance spectra obtained 
from the initial SWCNT network together with those obtained from the m- and s-portions 
after the chromatographic separation. 
 
 
Figure 5.12 a) UV-Vis spectra of the initial SWCNT network and the separated s- and m- portions, 
b) zoom of the absorbance spectra in the M11 region corresponding to the absorbance 
bands of the m-SWCNT, and c) zoom of the absorbance spectra in the S22 region 
corresponding to the absorbance bands of the s-SWCNT. 
 
 
According to Figure 5.12a, the absorbance features obtained from the two SWCNT 
portions are different from that obtained from the initial SWCNT network. Based on the 
methodology reported in Section 3.3.1 used to determine the content of m- and s-SWCNT 
from a SWCNT network, the percentages of the m- and s-SWCNT calculated from the 
initial SWCNT network and the separated m- and s-portions obtained by the 
chromatographic separation are identified in Table 5.5. 
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Table 5.5 Percentages and ratio of m- and s-SWCNT in the initial SWCNT network and in the 
separated m- and s-portions. 
Sample % m-SWCNT 
(M11/M11+S22)x100 
% s-SWCNT 
(S22/M11+S22)x100 
m- to s-SWCNT 
ratio 
Initial SWCNT network 23.2 76.8 1/3.3 
m-portion 33.0 67.0 1/2.0 
s-portion 19.4 80.6 1/4.2 
 
In the M11 region (Figure 5.12b), the absorbance is higher for the m-portion, which 
means that higher content of metallic SWCNT (33 %) was collected on the m-portion than 
in the s-portion (19 %), as expected. On the other hand, the s-portion has fewer              
m-SWCNT (19 %) than initial SWCNT dispersion (23 %), indicating a higher concentration 
of s-SWCNT, which was also expected and in agreement with the observations of Fujii et 
al. (2009). In the S22 region (Figure 5.12c), where the absorbance bands correspond to 
the s-SWCNT, an increase of s-SWCNT in the s-portion (81 %) was observed in 
comparison to the initial SWCNT network (77 %). According to Figure 5.12, in the M11 
region, the higher absorbance was observed for the collected m-portion and in the S22 
region, the higher absorbance was observed for s-portion, suggesting an enrichment of   
s-SWCNT in the last collected portion. 
As discussed in section 2.1.3, the exact method for purity assessment of the SWCNT 
sample is not yet defined, and uncertainties still exist. For that, Raman spectroscopy has 
also been used to assess the purity of SWCNT, and Figure 5.13 shows the Raman 
spectra recorded for the initial SWCNT network and the separated m- and s-portions. 
 
 
Figure 5.13 Raman spectra of the initial SWCNT network and the separated s- and m-portions. 
Chapter 5                                                         
_________________________________________________________________________ 
118 
The increasing of peaks associated with the s-SWCNT and the m-SWCNT in s- and  
m-portions, respectively, was also observed in Raman spectra and they could be 
considered as important qualitative results. From Figure 5.13, the radial breathing modes 
(RBM) at 149 cm-1 is observed for the three portions, with different intensities: the highest 
intensity was observed for the s-portion, being higher than that obtained for the initial 
SWCNT network and also higher than that obtained for m-portion. Such order of RBM 
intensities is in agreement with that obtained by Feng et al. (2011), where density gradient 
ultracentrifugation was used to separate the m- from the s-portions in samples of SWCNT. 
Regarding the intensity height of D-bands at approximately 1250 cm-1 which characterizes 
the structural disorder of the sp2-hybridized carbons on the SWCNT, they are similar for 
the s- and the m-portion, as well as for the raw SWCNT, which suggests that defects were 
not added with the separation. 
Raman spectra in the range of 1400 to 1700 cm-1 is associated with changes in the 
metallic content. A large peak was observed at 1590 cm-1 corresponding to the G-band, 
and it is well known that the G-band for the m-SWCNT has an asymmetric and broad 
band around 1530 - 1560 cm-1, called Breit-Wigner-Fano (BWF) line shape (Brown et al., 
2001). In the inset of the Figure 5.13, there is an enlargement of the G-band where such 
BWF shape is observed for the m-portion, suggesting the metallic contribution. Such BWF 
shape only appears in the m-portion being absent in the Raman spectra of the initial 
SWCNT network and in s-portion, which means that a lower content of m-SWCNT is 
present in the initial SWCNT network and in the s-portion, in comparison to the content of 
m-SWCNT in the m-portion, which is confirmed with the percentages from the absorbance 
spectra observed in Table 5.5. 
The separated s-portion was tested as conducting channel in the NTFET to evaluate 
the potential of separated SWCNT for the enhancement of biosensing activity, that is, for 
the detection of the CRP. The procedures for biosensing assays were the same as those 
described in Section 5.2, but using the separated s-portion rather than the SWCNT 
dispersion. The regression plot obtained for the analytical response of the NTFET to the 
CRP using separated SWCNT is shown in Figure 5.14, together with the same type of plot 
obtained with the SWCNT network. The corresponding analytical parameters are reported 
in Table 5.6. 
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Figure 5.14 Comparison of the responses of NTFET fabricated with the SWCNT dispersion and 
with the separated s-portion. 
 
 
 
Table 5.6 Analytical parameters for the regression plots of Figure 5.14. 
 SWCNT dispersion Separated SWCNT 
Regression equation logy = a + b.logx 
 
a = 0.320 ± 0.0152 
b = - 0.174 ± 6.80x10
-3
 
a = 0.969 ± 0.0309 
b = - 0.242 ± 1.38x10
-2
 
R
2
 0.992 0.942 
Adjusted R
2
 0.991 0.939 
sy/x 0.036 0.127 
 
 
It is shown in Figure 5.14 and demonstrated in Table 5.6, that a higher sensitivity is 
obtained with NTFET with the separated s-SWCNT than with the SWCNT dispersion. 
However, the coefficients R2 and adjusted R2 are higher for the calibration curve obtained 
with the SWCNT dispersion, which means that the calibration curve obtained from the 
SWCNT dispersion displays a better goodness of fit than that obtained with the s-SWCNT. 
Similarly, a higher standard error of the estimate (sy/x) was obtained for the separated      
s-SWCNT. Although there is a statistically significant difference (p = 0.012) between the 
data of the two calibration curves, which was estimated from a Holm-Sidak comparison 
method at p = 0.05, the SWCNT dispersion was considered to be used for all biosensing 
experiments, due to its better cost-effectiveness, since only one surfactant is needed to 
disperse the SWCNT, contrarily to the mechanism and the labour-intensive process to 
obtain the separated s-SWCNT, which needs of a chromatographic assemblage with 
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expensive agarose beads. On the other hand, it is considered that the increase of s-
SWCNT content from the initial SWCNT network (77 %) to the separated s-portion (81 %) 
does not justify the expensive and time-consuming tasks involved in the separation. 
 
 
5.4. Application of the NTFET to the determination of the CRP in blood serum 
and saliva 
 
In this Section, the application of NTFET as immunosensors is reported for the 
determination of CRP concentrations in samples of undiluted blood serum and saliva 
collected from volunteer patients. The concentrations of CRP determined by the NTFET 
were compared with those obtained from a traditional methodology (ELISA technique) for 
the validation of the sensor. Furthermore, the CRP levels in blood serum and saliva were 
compared in order to identify a possible correlation between them. The correlation 
between serum CRP and other risk factors associated with the development of 
cardiovascular diseases (CVD) has also been evaluated. 
 
 
5.4.1. Introduction 
 
The CRP is a diagnostic biomarker of systemic inflammation, which is a mechanism in 
the atherogenesis, that is, in the accumulation of lipids on the innermost layer of arterial 
walls as well as the presence and accumulation of monocyte-derived macrophages and T 
lymphocytes in fatty streaks, resulting in cardiovascular events (Ablij and Meinders, 2002; 
Ridker et al., 2004). The CRP is considered as a positive acute-phase protein since its 
level increases in response to a wide variety of disease states including CVD and 
systemic inflammatory conditions. The CVD are classified mainly as coronary heart 
disease (CHD), and lead to angina, heart attack, and congestive heart failure, thus 
becoming the world leading cause of morbidity and mortality, even bigger than cancer. 
According to the latest data by the American Heart Association, 40 % of all worldwide 
deaths are caused by CVD (Roger et al., 2012). Furthermore, the CRP is a strong 
indicator of myocardial infarction, stroke, sudden cardiac death, and peripheral vascular 
disease (Ledue and Rifai, 2003). 
The levels of CRP have no significant diurnal variation, and can thus be accurately 
measured (Macy, 1997). According to Smith et al. (2004), the CRP levels could be stable 
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at very high values even three months after an ischemic stroke. It is well established that 
the following levels of the CRP in blood serum are considered as low (< 1 mg L-1), 
moderate (1 - 3 mg L-1), and high (> 3 mg L-1) risks of development of CVD (Pearson et 
al., 2003; Danesh et al., 2004). According to Adams et al. (2008), CVD are associated 
with smoking, hypertension (blood pressure ≥ 140/90 mmHg), elevated low-density 
lipoprotein (LDL cholesterol ≥ 160 mg dL-1), low high-density lipoprotein (HDL cholesterol 
< 35 mg dL-1), diabetes mellitus (plasma glucose ≥ 126 mg dL-1), and predisposing 
factors, such as obesity and physical inactivity. Therefore, it is also of crucial importance, 
the interpretation of the CRP levels together with other CVD risk factors, in order to 
provide better prognostic information. 
In comparison to the invasiveness of blood sampling, the collection of saliva is 
advantageous for being cost-effective, non-invasive, pain-free, stress-free, and it can be 
performed without special laboratory equipment (Pfaffe et al., 2011). Thus, saliva may be 
a potential biological fluid for the diagnosis and monitoring of systemic conditions 
including CVD, due to the presence of many analytes derived from serum, for example, 
CVD biomarkers (Foley et al., 2012). 
 
 
5.4.2. Experimental 
 
5.4.2.1. Collection of blood and saliva samples from volunteer patients 
 
All serum and saliva samples were collected from volunteers at the S. João Hospital 
(Oporto, Portugal). All participants in this study were provided with signed and approved 
consent forms before sample collection, and the procedures were in accordance with 
Ethics Boards of the S. João Hospital through Institutional Human Ethics Committee. A 
copy of the consent form and the information provided to the volunteer patients before 
sample collection are provided in Appendix I. 
Serum and saliva samples from 30 volunteer patients were used in this study: 15 
samples were from healthy individuals undergoing a physical health examination, and 
other 15 samples were from patients with various recent inflammation conditions or 
diseased individuals suffering from coronary heart diseases and ischemic heart disease 
from the CVD unit at the Hospital. The first group of 15 healthy individuals were taken as 
the control patients, while the second group of diseased individuals were taken as the 
CVD risk patients group. The participants completed a questionnaire about their medical 
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history and daily habits, and a sample copy is provided in Appendix II. In the 
questionnaire, demographic data (gender and age) and complete lipoprotein profile (total 
cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides) were reported together 
with the data on the vascular risk factors, including hypertension, diabetes mellitus, 
dyslipidemia, previous transient ischemic attack, CHD, and lifestyle factors, such as 
cigarette smoking, and consumption of coffee and alcohol. The complete database of 
results of medical history and lifestyle factors collected from questionnaires of volunteer 
patients is provided in Appendix III, together with the classification of risk parameters as 
low, normal, and high levels. The collection of biological fluids was made to more than 50 
volunteer participants, but some serum and saliva samples had to be discarded for 
several reasons. In some cases, saliva samples were contaminated with blood, the 
volume of collected saliva was insufficient for further analysis, and some patients, mainly 
from the CVD unit, were not able to provide saliva, and thus, both the blood and saliva 
samples of such patients were not used in this study. 
A standardized protocol was used for collection and storage of venous blood samples, 
that is, a volume of 8 mL of peripheral blood was drawn using Venosafe tubes with gel 
and clot activator, and all serum samples were isolated after centrifugation at 5000 RPM 
for 15 minutes at 4 ºC. The serum was divided into three aliquots and stored at -20 ºC. 
Regarding the collection of saliva samples, oral swabs were used, as recommended by 
Salimetrics Europe Ltd, collecting saliva between cheek and gum. The samples were 
centrifuged at 5000 RPM for 15 minutes at 4 ºC in order to pellet the mucins, and all 
supernatant samples were stored immediately after centrifugation at -20 ºC.  
 
 
5.4.2.2. Determination of the CRP concentration in serum and saliva samples by 
NTFET and enzyme-linked immunosorbent assay (ELISA) 
 
After their collection, the serum samples were assayed for the CRP, as well as for the 
parameters characteristic of the lipoprotein profile (that is, total cholesterol, HDL 
cholesterol, and triglycerides) in a reference laboratory and through diagnostic kits of 
Beckman Coulter. The methods used for such assays and corresponding figures of merit 
are grouped in Table 5.7. Only the LDL cholesterol content was not directly determined 
from samples, but it was estimated through the Friedewald equation, that is, LDL 
cholesterol is estimated from quantitative measurements of total and HDL cholesterol and 
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triglycerides using the relationship established by Friedewald et al. (1972) as follows (all 
concentrations are expressed in mg dL-1): 
 
                                                         
               
 
  [5.2] 
 
 
The results of these assays listed in Table 5.7 were used to select the serum samples 
of control and CVD risk patients: control patients have CRP levels lower than 3 mg L -1 
(corresponding to low and normal CVD risk) as well as parameters characteristics of the 
lipoprotein profile at normal levels, and CVD risk patients have CRP levels higher than 3 
mg L-1 (corresponding to high CVD risk) as well as parameters characteristic of the 
lipoprotein profile at levels which are borderline high, high, and very high. 
 
 
Table 5.7 Methods and corresponding figures of merit obtained from the determination of various 
parameters on blood serum of volunteer patients. 
Parameter Method and assay principle 
Limit of 
detection 
Precision 
(% CV) 
Linearity 
CRP 
Immunoturbidimetric assay 
(immunoreaction) 
0.14 
mg L
-1
 
< 3.8 
0.2 - 480 mg L
-1
 
(R = 0.998) 
Total 
cholesterol 
Colorimetric enzymatic assay 
(reaction with cholesterol 
esterase, cholesterol oxidase, and 
peroxidise) 
2.71 
mg dL
-1
 
< 1.45 
20 - 700 mg dL
-1
 
(R = 0.996) 
HDL 
cholesterol 
Colorimetric enzymatic assay 
(reaction with cholesterol 
esterase, cholesterol oxidase, and 
peroxidase, after immunoreaction) 
0.077 
mg d
-1
 
< 1.92 
2 - 180 mg dL
-1
 
(R = 0.993) 
Triglycerides 
Colorimetric enzymatic assay 
(reaction with lipase, glycerol 
kinase, glycerol phosphate 
oxidase, and peroxidase) 
0.885 
mg dL
-1
 
< 1.76 
10 - 1000 mg dL
-1
 
(R = 1) 
 
 
As above mentioned, the serum and saliva samples of selected 30 patients were 
used to determine the CRP concentration through the NTFET and by the ELISA traditional 
technique for comparison and validation of the NTFET, and also to assess whether the 
NTFET could be used to accurately sense the CRP level. The traditional methodology 
was performed using the CRP ELISA kits from Sigma-Aldrich (Portugal) for the 
determination of the CRP in serum and from Salimetrics Europe Ltd for the determination 
of salivary CRP. The design, fabrication, and assemblage of the NTFET have been 
described in Chapter 4, in Section 5.1, and also in a published work by Justino et al. 
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(2013a). The results regarding the concentrations of the CRP in standard solutions by 
NTFET were obtained from a standard calibration curve through the methodology 
reported in Section 5.2 of this thesis as well as in the published paper found elsewhere 
(Justino et al., 2013b). 
Prior to all assays, the frozen samples were brought to laboratory temperature 
(approximately 23 ºC), and they were slowly and gently mixed. The ELISA technique was 
performed using a human CRP ELISA kit for the determination of CRP levels in duplicate, 
according to the protocol provided by Salimetrics Europe Ltd. based on an enzyme-linked 
immunoassay with standard 96-well microplates. As the relationship between the 
response (optical density) and the CRP concentration in each sample may change from 
one assay to another, two ELISA microplates were used to estimate the inter-assay 
precision of the ELISA technique. Briefly, the ELISA protocol includes the following basic 
steps, as depicted in Figure 5.15: 
a) transfer of 50 μL of 1:10 diluted saliva samples in phosphate buffered solution, 
standard solutions, control solutions corresponding to high and low levels of 
the CRP in a saliva-like matrix, and blanks (phosphate buffered solution) to 
the microplate wells pre-coated with mouse antibodies to human CRP; 
b) addition of 150 μL of 1:250 diluted enzyme conjugate solution (that is, goat 
anti-human CRP antibodies linked to horseradish peroxidase, in phosphate 
buffered solution) to each well, and incubation at 25 ºC for 2h with mixing at 
250 RPM; 
c) washing of wells 4 times by adding 300 μL of phosphate buffered solution and 
decanting the liquid to remove unbound components; 
d) addition of 200 μL of tetramethylbenzidine (TMB) to each well for color 
development (reaction of peroxidase enzyme with TMB for formation of the 
CRP peroxidase), and incubation in the dark, at 25 ºC for 30 minutes with 
mixing at 250 RPM; and, 
e) addition of 50 μL of stop solution (2 M aqueous solution of sulphuric acid), and 
mixing for one minute at 250 RPM. 
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Figure 5.15 Schematic of the basic steps of the ELISA technique and corresponding photographs 
of microplate. 
 
 
After addition of the stop solution, the readings of optical density (OD) at 450 nm with 
correction at 630 nm were performed on a microplate reader (SpectraMax PLUS 384). 
The mechanism of detection of ELISA technique is based on the proportionality between 
the amount of the CRP peroxidase and the concentration of the CRP. The OD values 
obtained from standard solutions were plotted against the CRP standard concentrations in 
order to obtain the calibration curve, and the OD values of saliva samples were used to 
determine the corresponding CRP concentrations from the calibration curve. The OD 
values of high and low salivary controls were used to certify that the obtained CRP 
concentrations with ELISA technique are similar to those claimed by the manufacturer. 
The intra-assay precision was determined by averaging the concentrations of CRP in 
duplicates high and low control samples for each of the two individual ELISA microplates, 
and the inter-assay precision was determined by averaging the CRP concentration of 
such samples obtained from the two individual plates. 
Regarding the ELISA technique used for the estimation of the CRP concentration in 
serum samples, the procedures employed were in accordance to the supplier (Sigma-
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Aldrich Química, Portugal), and they are a little different than the ELISA technique 
discussed above for saliva samples. The ELISA assay for serum samples was based on 
the quantitative sandwich enzyme immunoassay technique on a 96-well microplate pre-
coated with an antibody specific for the human CRP. Serum samples were diluted   
50000-fold by diluting the original serum sample with the diluent buffer provided in the 
ELISA kit by adding 2 μL of serum sample in 398 μL of diluent buffer to prepare a 200-fold 
dilution, and then, adding 2 μL of such diluted sample in 498 μL of diluent buffer. Standard 
solutions were obtained by diluting 12 μL of a 25 μg L-1 stock standard solution on 488 μL 
of diluent buffer to prepare a 600 ng L-1 standard solution (Standard 1). Then, a dilution 
series was produced by the consecutive addition of 400 μL of diluent buffer to 200 μL of 
each standard solution to prepare 200, 66.67, 22.22, 7.41, and 2.47 ng L-1 standard 
solutions (Standards 2 to 6, respectively). Control samples were obtained by dilution of 
standards, that is, the high control with the CRP concentration of 100 ng L-1 was obtained 
by diluting 2-fold the Standard 2, and the low control with the CRP concentration of 11.11 
ng L-1 was obtained by diluting 2-fold the Standard 4. A volume of 100 μL of each of the 
CRP standard solutions, serum and control samples, were added to duplicate wells, and 
the microplate was covered and incubated for 2.5 hours at approximately 25 ºC at 250 
RPM. In this way, the CRP present in a sample was bound to the wells through the 
immobilized antibody. The protocol then includes washing of wells 4 times by adding 
followed by discarding 300 μL of wash buffer, and addition of 100 μL of 80-fold diluted 
biotinylated CRP detection antibody (in buffer solution). The microplate was incubated 
during one hour at 25 ºC and 250 RPM. The unbound biotinylated antibodies were 
removed by washing the wells 4 times, and by adding followed by discarding 300 μL of 
wash buffer. Then, 100 μL of 300-fold diluted HRP-conjugated streptavidin solution (in 
buffer solution) was added to the wells, and the microplate was incubated 45 minutes at 
25 ºC and 250 RPM. An additional washing step was performed 4 times by adding 
followed by discarding 300 μL of wash buffer. A volume of 100 μL of TMB substrate 
solution (3,3’,5,5’-tetra-methylbenzidine in buffered solution) was then added to the wells 
for colour development. The microplate was incubated 30 minutes at 25 ºC in the dark 
and 250 RPM. The resulting colour intensity was proportional to the amount of bound 
CRP in the initial step. The final step included the addition of 50 μL of stop solution (0.2 M 
sulphuric acid) to each well, which changed the colour from blue to yellow, and the 
intensity of the yellow colour was measured immediately, at 450 nm in a microplate reader 
(SpectraMax PLUS 384). The obtained OD values for the standard solutions were plotted 
against the concentrations of standard solutions, and an equation was fitted in order to 
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obtain a calibration model, which could be used for estimation of the concentration of the 
CRP in the serum samples and controls. 
According to Pearson et al. (2003), the patients with persistently CRP levels higher 
than 10 mg L-1, should be evaluated for noncardiovascular etiologies, which means that 
they should be examined for sources of infection or inflammation other than CVD. In this 
work, 5 of the 30 serum samples from volunteer patients have values of the CRP higher 
than 10 mg L-1. For validation of the NTFET, all data of the serum CRP were used, but for 
the study of the correlation of the CRP with other risk factors, the samples with levels of 
the CRP higher than 10 mg L-1 were discarded.  
 
 
5.4.3. Results and discussion 
 
5.4.3.1. Overview of clinical characteristics of the sample of population under 
study 
 
The clinical characteristics of the sample of population under study are grouped in 
Table 5.8, according to the database of Appendix III, where the medical history and 
lifestyle factors are reported for each of the 30 volunteer patients. A visual inspection of 
Table 5.8 can lead to some conclusions regarding differences between the two groups of 
patients, mainly on the parameters of lipoprotein profile and consumption of tobacco, 
alcohol, and coffee. 
In quantitative terms, the application of the t-test with a significance level of 5 % to the 
independent samples of the control (N=15) and the CVD risk (N=15) group, obtained from 
the SPSS software (SPSS, 2012), shows that there is a statistically significant difference 
for total cholesterol (p < 0.001), LDL cholesterol (p < 0.001), ratio of total/HDL cholesterol 
(p < 0.001), triglycerides (p = 0.006), CRP (p < 0.001), and age (p = 0.011). In other 
words, the two groups have patients with different patterns regarding the mentioned 
parameters. However, no statistically significant difference between the two groups were 
found for HDL cholesterol (p = 0.132) and body mass index (BMI) (p = 0.131). In this way, 
the t-test was used to compare the means of each quantitative parameter between the 
independent patients. 
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Table 5.8 Clinical characteristics of the sample of population under study. 
Clinical characteristics Control group CVD risk group 
Total, N 15 15 
Men, N (%) 10 (67%) 13 (87%) 
Age (years) 49 ± 13 61 ± 12 
BMI (kg m
-2
) 26 ± 4 28 ± 4 
CRP (reference laboratory) (mg L
-1
) 0.9 ± 0.7 8.3 ± 6.4 
Lipoprotein 
profile 
Triglycerides (mg dL
-1
) 104 ± 33 166 ± 73 
Total cholesterol (mg dL
-1
) 166 ± 19 208 ± 35 
HDL cholesterol (mg dL
-1
) 52 ± 14 45 ± 8 
LDL cholesterol (mg dL
-1
) 94 ± 17 130 ± 32 
Total / HDL cholesterol ratio 3.4 ± 0.7 4.8 ± 1.5 
Tobacco 
consumer 
Ex-smoker, N (%) 
Never, N (%) 
Occasionally, N (%) 
5 (33%) 
10 (67%) 
0 
3 (20%) 
6 (40%) 
6 (40%) 
Alcohol 
consumer 
No, N (%) 
Occasionally, N (%) 
>2x / week, N (%) 
5 (33%) 
4 (27%) 
6 (40%) 
7 (47%) 
2 (13%) 
6 (40%) 
Coffee 
consumer 
No, N (%) 
Occasionally, N (%) 
Daily, N (%) 
3 (20%) 
3 (20%) 
9 (60%) 
5 (33%) 
9 (60%) 
1 (7%) 
Regular physical activity 8 (54%) 0 
Family history of CVD 7 (47%) 6 (40%) 
Stress 10 (67%) 10 (67%) 
Comorbidities 
Diabetes mellitus, N (%) 3 (20%) 5 (33%) 
Hypertension (%) 4 (27%) 12 (80%) 
Coronary Heart Disease (CHD), N (%) 3 (20%) 8 (54%) 
Dyslipidemia, N (%) 2 (14%) 9 (60%) 
Cerebral Haemorrhage (CH), N (%) 1 (7%) 3 (20%) 
Transient Ischemic Attack (TIA), N (%) 0 2 (14%) 
 
 
In order to obtain a comparison between the means of the qualitative parameters, the 
data for all patients was coded (for example, for gender, 1 = Male and 2 = Female), as 
displayed in Appendix IV, and from the application of a t-test, a statistically significant 
difference was obtained between the two groups for physical activity (p < 0.001), 
hypertension (p = 0.002), dyslipidemia (p = 0.001), and Framingham score (p < 0.001), 
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which are parameters associated with the development of CVD, and there is no 
statistically significant difference between the two groups of patients for diabetes mellitus 
(p = 0.130), gender (p = 0.208), stress (p = 1.000), family history of CVD (p = 0.724), 
tobacco consumption (p = 0.682), alcohol consumption (p = 0.664), and coffee 
consumption (p = 0.382). Curiously, in the sample of population under study, both the 
control and the CVD patients are associated with conditions of stress, also observing that 
there is not a statistically significant difference for the family history of CVD, being two of 
the CVD risk factors. 
 
 
5.4.3.2. Determination of the concentration of the CRP in serum and saliva 
samples by the NTFET and the ELISA: data comparison 
 
As an initial step of data analysis, box plots were produced as statistics to compare the 
data of the CRP concentration obtained with NTFET and ELISA from the serum and saliva 
samples of each patient of the control and the CVD risk groups, and displayed in 
Appendix Va (total of 30 patients). Figure 5.16 shows the box plots obtained with 
SigmaPlot software (2008) and it allows comparing the maximum and the minimum 
values, the percentiles, and medians of such data. The medians have the advantage of 
being unaffected by the outliers values, and their identification is important for further 
statistical analysis, as also shown in Figure 5.16: the maximum and minimum observed 
values correspond to the upper and lower whiskers of the box, respectively; the 75th and 
25th percentiles correspond to the upper and lower edge of the box, respectively, and the 
median, which marks the 50th percentile, correspond to the solid line within box. 
Concerning the outliers, they are data points which are lower than the lower quartile or 
higher than the upper quartile, by more than 1.5 times the interquartile range. 
Figure 5.16 shows that the levels of the CRP are higher in the CVD risk patients than in 
the control patients, both for serum and saliva samples, and there is a statistically 
significant difference between the medians of the two groups of patients for serum CRP 
obtained by NTFET (p (T = 120.00) < 0.001), and by ELISA (p (T = 120.00) < 0.001), as 
well as for salivary CRP determined by NTFET (p (T = 127.00) < 0.001), and by ELISA   
(p (T = 123.00) < 0.001), using a Mann-Whitney rank sum test. 
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Figure 5.16 Distribution of the CRP concentrations obtained in the serum and the saliva samples 
of patients from CVD risk and control groups.  
 
 
Based on the distribution of the CRP concentration observed in the box plots (Figure 
5.16), a little overlap can be observed between the groups of patients for CRP of saliva 
samples determined by both the NTFET and the ELISA, since the minimum value for the 
box plot of CVD risk patients is slightly lower than the maximum value for the box plot of 
control patients. That is not observed in the box plots obtained for the CRP levels of 
serum samples, and the significance tests should be considered in order to compare 
groups for significant differences. A visual inspection of the box plots of Figure 5.16 allows 
to conclude that for serum samples: a) the median of the CRP levels of control patients is 
0.71 and 0.77 mg L-1, when determined by NTFET and ELISA, respectively, and b) the 
median of the CRP levels of the CVD risk patients is 5.30 and 5.10 mg L-1, when 
determined by the NTFET and the ELISA, respectively. From the box plots, it is also 
observed that for saliva samples: a) the median of the CRP levels of the control patients is 
641.72 and 645.71 ng L-1, when determined by the NTFET and the ELISA, respectively, 
and b) the median of the CRP levels of the CVD risk patients is 3241.01 and 3271.07     
ng L-1, when determined by the NTFET and the ELISA, respectively. From the significance 
tests, it is concluded that there is no statistically significant difference between the median 
values of the CRP determined by the NTFET and the ELISA for serum samples of the 
control patients (p (T = 209.50) = 0.350), for serum samples of the CVD risk patients       
(p (T = 236.00) = 0.901), for saliva samples of the control patients (p (T = 231.00) =0.967), 
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and for saliva samples of the CVD risk patients (p (T = 229.00) = 0.901), using a Mann-
Whitney rank sum test. Thus, the determination of the CRP in saliva and serum samples 
of the volunteer patients is not affected by the methodology employed, when medians of 
the CRP obtained from the two methodologies are compared. It can also be highlighted 
that the LOD obtained for the ELISA technique, calculated as three times the standard 
error of the estimate (Miller and Miller, 2005) was about 170.9 ± 49.6 ng L-1 when applied 
to the salivary CRP (mean and standard deviation for two ELISA microplates), and when 
the ELISA technique was applied to the serum CRP, the LOD of 44.3 ± 12.9 ng L-1 was 
obtained (mean and standard deviation for two ELISA microplates). The calibration details 
for each ELISA microplate are shown in Appendix VI. The LOD obtained for the NTFET 
developed in this work (Section 5.2.2.3) for serum and salivary CRP (100 ng L-1) is 
comparable to that obtained with the ELISA technique, being better for the salivary CRP 
and slightly higher for the serum CRP. 
From the box plots of Figure 5.16, some outliers were identified for four patients, and a 
statistical test for outliers was performed to evaluate whether each outlier could be 
discarded at a given significance level from the population under study. The Grubbs’ test, 
which is recommended for outliers testing by ISO, was performed for each outlier by 
calculating the G value through the equation [5.3], thus comparing the deviation of the 
suspect value from the sample mean (  ) with the standard deviation of the sample 
population (s): 
 
  
                 
 
     [5.3] 
 
The calculated value of G should be compared to the critical value of G for p = 0.05, 
which in this case, for 15 patients in each box plot, is about 2.41. As the G values were 
lower than the critical G value, the suspect values identified in the box plots should not be 
discarded, since they cannot be considered as outliers. 
In order to summarize the descriptive statistics of the sample population (shown in 
Appendix Va), the mean and standard deviation (SD) were also calculated, as shown in 
Table 5.9, and variations in the CRP levels of serum and saliva samples collected from 
the control and the CVD risk patients determined by the NTFET and the ELISA technique 
could be compared. 
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Table 5.9 Mean and SD calculated of serum and salivary CRP for the 30 patients, as determined 
by the NTFET and the ELISA technique. 
Serum CRP (mg L
-1
) Control patients (N = 15) CVD risk patients (N = 15) 
NTFET devices 0.88 ± 0.67 8.57 ± 6.68 
ELISA technique 0.93 ± 0.70 8.17 ± 5.99 
Salivary CRP (ng L
-1
)   
NTFET devices 813.20 ± 520.35 4304.89 ± 3149.38 
ELISA technique 814.21 ± 512.10 4350.90 ± 3218.47 
 
 
Table 5.9 shows that the means of the CRP levels are similar between the NTFET and 
the ELISA, but they are very different between the control and the CVD risk patients, both 
for serum and saliva samples. In order to estimate the strength of the contribution of each 
source of variation, that is, type of patients (control vs. CVD risk), methodology (NTFET 
vs. ELISA), and clinical sample (serum vs. saliva), for the total variance of the results, a 
statistical test based on three-way ANOVA was performed with the data present in 
Appendix Va, and the results obtained are shown in Table 5.10. In other words, the three-
way ANOVA could allow concluding whether the variation caused by the changing of a 
factor leads to a significant difference in the CRP levels. As the normality and the equal 
variance tests have failed (p < 0.05), that is, the data do not follow a normally distributed 
population, and there is variability between the group means, respectively, the Holm-Sidak 
test was used for all pairwise comparisons, confirming the p values obtained. 
Table 5.10 shows that there is no statistically significant difference between the NTFET 
and the ELISA when they are used to determine the CRP levels (p = 0.912), which means 
that the difference in the mean values among the two levels of the factor “methodology” is 
not great enough to exclude the possibility that the difference is just due to random 
sampling variability. On the other hand, there is a statistically significant difference 
between the means of the CRP levels in the serum and the saliva samples (p < 0.001), 
and between the CRP levels of the control and the CVD risk patients (p < 0.001). Such 
results are explained on the basis of the comparison between the mean square of each 
source of variation (type of patients, methodology, and clinical sample) and the residual 
mean square. Thus, concerning the interactions, only the interaction between the type of 
patients and the clinical sample is significant since the respective mean square is higher 
than the residual mean square, which is understandable because the CRP levels in serum 
and saliva sample are very different as occurred with the CRP levels between the two 
groups of patients. 
               Development of NTFET for CRP Detection 
_________________________________________________________________________ 
133 
Table 5.10 ANOVA for the results obtained with the determination of the serum and the salivary 
CRP with the NTFET and the ELISA for the control and the CVD risk patients. 
Source of variation DF SS MS F p 
Type of patients 
(control vs. CVD risk) 
1 418.92 418.92 41.12 < 0.001 
Methodology 
(NTFET vs. ELISA) 
1 0.13 0.13 0.012 0.912 
Clinical sample 
(Serum vs. Saliva) 
1 650.70 650.70 63.87 < 0.001 
Type of patients vs. Methodology 1 0.38 0.38 0.037 0.848 
Type of patients vs. Clinical sample 1 418.13 418.13 41.04 < 0.001 
Methodology vs. Clinical sample 1 0.13 0.13 0.012 0.912 
Type of patients vs. Methodology vs. 
Clinical sample 
1 0.38 0.38 0.037 0.848 
Residual 112 1140.99 10.19   
Total 119 2629.75 22.10   
DF – degrees of freedom; SS – Sum of squares; MS – Mean square 
 
 
The results shown in Figure 5.16 and in Tables 5.9 and 5.10 allowed a statistical 
analysis of the sample of the population under study by comparison of the medians and 
means obtained for serum and salivary CRP levels from the control and the CVD risk 
patients determined by NTFET and ELISA. However, the variability of the data which 
leads to the estimative of the reproducibility of the methodologies should also be 
addressed, since the CRP levels were obtained by three individual NTFET and two ELISA 
microplates. The results for all determinations are displayed in Appendix Va, and they 
show that the variability on the CRP levels assessed as coefficient of variation is between 
1.0 % and 18.9 % (median of 3.6 %) when determined in serum samples of the control 
and the CVD patients with the NTFET, between 0.3 % and 29.9 % (median of 6.5 %) 
when determined in serum samples of the control and the CVD patients with the ELISA 
technique, between 0.2 % and 4.4 % (median of 1.4 %) when determined in saliva 
samples of the control and the CVD patients with the NTFET, and between 4.4 % and 
39.7 % (median of 19.5 %) when determined in saliva samples of the control and the CVD 
patients with ELISA technique. Thus, NTFET have the capability to determine the CRP 
levels with lower variability than ELISA independently of the clinical sample is serum or 
saliva. For each of the three NTFET, three successive measurements have been 
performed, and taking into account the data shown in Appendix Vb, the repeatability of the 
NTFET, assessed as coefficient of variation, was approximately about 8.5 % for the serum 
CRP determinations, and about 2.5 % for the salivary CRP determinations, which 
Chapter 5                                                         
_________________________________________________________________________ 
134 
suggests a good repeatability, being lower than the reproducibility of the NTFET, as 
expected. 
Among the many sources of variations which can be commonly found in 
immunoassays there are the timing, the relative humidity, as well as the washing steps of 
microplate, the dispensing of different volumes of samples due to the manual pipetting, 
and the differences in the adsorptive properties of different microplates or at different 
locations on the same microplate. For that, the inter-assay and the intra-assay precisions 
have been determined in the immunoassays performed in this work through control 
samples with high and low CRP levels. The inter-assay precision expresses the plate-to-
plate consistency, and the intra-assay precision is a measure of variability between 
duplicates on the same plate. The results of the precision study for the determination of 
the salivary CRP and the serum CRP by ELISA methodology are depicted in Table 5.11 
and Table 5.12, respectively. The intra-assay precision was evaluated from the mean of 
duplicates control samples in each ELISA microplate. The inter-assay precision was 
evaluated from the mean of duplicates of control samples for two ELISA microplates. 
 
Table 5.11 Precision data for the determination of the salivary CRP by the ELISA technique. 
 Sample Plate Mean (ng L
-1
) N SD (ng L
-1
) CV (%) 
Intra-assays
1
 
High Control
3
 
#1 2154 2 114.2 5 % 
#2 2119 2 206.3 10 % 
Low Control
4
 
#1 138.7 2 1.083 1 % 
#2 163.2 2 11.38 7 % 
Inter-assays
2
 
High Control
3
  2136 4 160.3 8 % 
Low Control
4
  150.9 4 6.232 4 % 
1
CV in the ELISA kits is 1.9 % for high control sample, and 5.9 % for low control sample; 
2
CV in the ELISA kits 
is 3.7 % for high control sample, and 11.2 % for low control sample;
 3
Expected value for the high control 
sample as defined in ELISA kit: 2085 ± 320.2 ng L
-1
; 
4
Expected value for the low control sample as defined in 
ELISA kit: 166.1 ± 87.40 ng L
-1
. 
 
 
The experiments for assessing the precision allowed concluding that the CV are less 
than 15 %, which is quite acceptable for immunoassays. Furthermore, the expected 
values for the high and low control samples provided by the manufacturer of the ELISA 
microplates for salivary CRP, are in accordance with the mean CRP obtained in this work, 
as shown in Table 5.11. Only the CV for the high control samples is higher in this work 
than the value provided by the manufacturer of ELISA microplates for salivary CRP. This 
was not observed for the determinations of serum CRP, since the CV provided by the 
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manufacturer (Table 5.12) is higher than the values obtained in this work, and the values 
obtained for the high control samples were smaller than expected. Thus, it could be 
concluded that the ELISA technique could be used to compare the CRP levels of the 
patients both in saliva and in serum with those obtained with the NTFET since the results 
obtained were precise and accurate. On the other hand, a lower variability was observed 
for the determination of salivary and serum CRP levels with NTFET, allowing their use for 
the non-invasive monitoring of CRP. 
 
Table 5.12 Precision data for the determination of the serum CRP by the ELISA technique. 
 Samples Plate Mean (ng L
-1
) N SD (ng L
-1
) CV (%) 
Intra-assays
1
 
High Control
3
 
#1 72.28 2 1.125 2 % 
#2 78.89 2 1.864 2 % 
Low Control
4
 
#1 15.54 2 2.090 13 % 
#2 9.42 2 0.363 4 % 
Inter-assays
2
 
High Control
3
  75.58 4 1.495 2 % 
Low Control
4
  13.39 4 1.226 10 % 
1
CV in the ELISA kits is less than 10 %; 
 2
CV in the ELISA kits is less than 12 %;
 3
Expected value for the high 
control sample: 100 ng L
-1
; 
4
Expected value for the low control sample: 11.11 ng L
-1
. 
 
 
5.4.3.3. Determination of the concentration of the CRP in serum and saliva 
samples by the NTFET and the ELISA: possible correlation of CRP 
between the two clinical samples 
 
As shown in the previous Section, the values of the concentrations of CRP can vary 
greatly from sample to sample and the values of CRP in saliva are about six orders of 
magnitude lower than in serum samples. A ratio between saliva and serum CRP of 
approximately 1/1138 for control group, and 1/1940 for CVD risk group were recorded in 
this study, and these ratios are in agreement with those observed by Ouellet-Morin et al. 
(2011), where a CRP ratio of 1/1634 was found. The low content of the CRP in saliva due 
to the limited transfer of the CRP from blood to saliva is due to the non-lipophilic nature 
and the high molecular weight of the CRP, thus the usually known mechanisms of transfer 
of lipophilic serum constituents to saliva (that is, passive diffusion or ultrafiltration) are not 
likely to occur, as studied by Kaufman and Lamster (2002) and Pfaffe et al. (2011). At 
stated by Ouellet-Morin et al. (2011), the transfer mechanism of the CRP molecules from 
serum to saliva remains unclear, although some studies have provided interesting 
conclusions. For example, Giannobile et al. (2009) concluded that CRP may reach saliva 
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through the gingival crevicular fluid or the salivary glands, during inflammation promoted 
by periodontal diseases. The gingival crevicular fluid is a serum exudate produced as a 
result of inflammation, thus the CRP and other biomarkers of serum can easily be 
transferred to saliva (Megson et al., 2010). 
In order to estimate the extent of the correlation between the serum and the salivary 
CRP determined by the NTFET and the ELISA technique, regression analysis was 
performed on the data reported in Appendix Va, and the results are shown in Figure 5.17. 
As mentioned in section 5.4.2.2, the levels of the CRP higher than 10 mg L-1 should be 
checked for sources of infections and inflammations other than CVD, and then they 
cannot be considered to the study of CRP concentrations as a inflammatory biomarker for 
assessing the CVD risk. Thus, the five patients from the CVD risk group with the CRP 
levels higher than 10 mg L-1 were discarded. Polynomial functions with different degrees 
were attempted as fitting equations for the results of the salivary and the serum CRP 
determined by the NTFET and the ELISA methodologies, in order to determine the best 
curve fitting, taken into account the values of the determination coefficient (R2) and 
adjusted determination coefficient (adj. R2) as shown in Table 5.13. It should be 
highlighted that the adj. R2 takes into account the number of degrees of freedom 
becoming crucial to conclude about the best curve fitting. 
 
Table 5.13 Results obtained from the study of fitting polynomial functions with increasing degrees. 
Degree of polynomial function 
NTFET ELISA technique 
R
2
 Adj. R
2
 R
2
 Adj. R
2
 
y = bx 0.775 0.765 0.770 0.760 
y = bx + cx
2
 0.882 0.872 0.863 0.853 
y = bx + cx
2
 + dx
3
 0.887 0.871 0.871 0.851 
 
 
As shown in Table 5.13, the evolution of the adj. R2 allows concluding that the 
quadratic model is the best to estimate the correlation between the serum and the salivary 
CRP with the NTFET and the ELISA technique. Thus, the quadratic functions obtained 
from the serum and salivary CRP determined by the NTFET and the ELISA. As shown in 
Figure 5.17, the saliva results were plotted as dependent variable (in y-axis, with 25 
values obtained by the NTFET and 25 values obtained by the ELISA technique) and 
serum samples were plotted as independent variable (in x-axis, also with 50 values) for 
possible prediction of CRP levels in serum through salivary CRP. The quadratic functions 
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were plotted with a zero intercept, since it is expected that the CRP is absent in saliva if 
the CRP in serum is zero, and the analytical parameters obtained are shown in Table 
5.14. 
 
 
Figure 5.17 Regression plots obtained for the serum and the salivary CRP obtained by a) NTFET 
and b) ELISA technique.  
 
 
 
Table 5.14 Analytical parameters associated with the regression plots of Figure 5.17. 
y = bx + cx
2
 NTFET 
Parameter Coefficient SD t value 95% Confidence limits p value 
b 794.95 60.96 13.04 668.84 921.06 < 0.001 
c - 46.54 10.2 - 4.58 - 67.54 - 25.53 < 0.001 
R
2
 = 0.882 (p < 0.001) 
Adj. R
2
 = 0.872 
y = bx + cx
2
 ELISA 
Parameter Coefficient SD t value 95% Confidence limits p value 
b 771.14 66.19 11.65 634.22 908.07 < 0.001 
c - 43.42 10.98 - 3.96 - 66.13 - 20.71 < 0.001 
R
2
 = 0.863 (p < 0.001) 
Adj. R
2
 = 0.853 
 
 
According to Figure 5.17, the two methodologies have similar responses patterns with 
similar regression parameters (b and c) and similar determination coefficient (R2), thus 
suggesting that the CRP concentrations determined by the NTFET are similar to those 
determined by the ELISA technique. The NTFET can then be advocated as an alternative 
to the traditional and expensive immunoassays. Moreover, there is no statistically 
significant difference between the serum CRP determined by the two methodologies       
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(p (T = 614.0) = 0.655), and between the salivary CRP determined by the two 
methodologies (p (T = 629.0) = 0.877). Therefore, a quadratic regression with all values 
could be used to estimate the correlation between the serum and the salivary CRP, then 
increasing the degrees of freedom, as shown in Figure 5.18. Table 5.15 shows the 
corresponding results obtained through the application of an ANOVA to the regression 
curve. 
 
 
Figure 5.18 Regression plot obtained for the serum and salivary CRP data obtained by the NTFET 
and the ELISA technique. 
 
 
 
Table 5.15 Analytical parameters obtained from the results of the CRP determinations (Figure 
5.18), and corresponding ANOVA analysis. 
Regression equation 
(y = bx + cx
2
) 
y = 783.02x – 44.98x
2
 
 Coefficient Standard error t p 
b 783.02 44.09 17.76 < 0.001 
c - 44.98 7.33 - 6.14 < 0.001 
R
2
 0.872 
Adj. R
2
 0.867 
Sy/x 372.896 
Analysis of Variance DF SS MS F p 
Regression 2 4.5x10
7
 2.2x10
7
 160.56 < 0.001 
Residual 47 6.5x10
6
 1.4x10
5
  
Total 49 5.1x10
7
 1.0x10
6
  
 
 
According to Figure 5.18 where the quadratic model is used to fit the data 
corresponding to the CRP concentrations obtained by the NTFET and the ELISA 
technique, correlating the serum CRP and the salivary CRP, it is shown that the central 
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part of the curve contains the set of data most dispersed in comparison to the sets of data 
at both extremes of the curve. That is, around the concentration value considered as the 
separation limit between patients with normal levels of serum CRP (< 3 mg L -1) and 
patients with high risk of development of CVD (CRP > 3 mg L-1), a large dispersion occurs 
approximately between 2.5 mg L-1 and 4.5 mg L-1 for serum CRP which corresponds to the 
salivary CRP levels approximately between 1700 ng L-1 and 2600 ng L-1. On the other 
hand, in the lower part of the curve, there is a linear relationship between the serum CRP 
and the salivary CRP, while at the final part of the curve, when the high values of the CRP 
occur, the levels of salivary CRP tend to reach a plateau. Thus, the CRP concentration of 
approximately 8 mg L-1 was determined as the inflexion point of the curve through the first 
derivative of the function, which could be mean that above 8 mg L -1, saliva could not 
contribute to the detection of the risk of a patient to develop a CVD, since the salivary 
CRP values do not significantly change above that value. However, even taking into 
consideration the above mentioned argument, the saliva samples do not lose their 
advantage as a non-invasive sampling method, since the CRP concentrations below and 
above 3 mg L-1 are well-determined, corresponding to patients with normal levels of CRP 
(with low risk of developing CVD) and patients with high risk to develop a CVD, 
respectively. Thus, this work is an additional contribution to clarify the correlation between 
the salivary and the serum CRP, which is not yet well defined in the literature. Some 
controversies have been found in recent works of Punyadeera et al. (2011), Ouellet-Morin 
et al. (2011), and Dillon et al. (2010). A significant association was observed by 
Punyadeera et al. (2011) with R2 = 0.84 (p < 0.001) in cardiac patients, a moderate-to-
strong association was reported by Ouellet-Morin et al. (2011) with R2 = 0.52 (p < 0.001) in 
healthy patients, and a non significant association was found by Dillon et al. (2010) with 
R2 = 0.001 in healthy patients. However, no information about the clinical characteristics of 
the participants is provided by Dillon et al. (2010), and then, the correlation of the serum 
and the salivary CRP with other risk factors associated with the CVD risk could not be 
tested. In this work and according to Table 5.15, a good determination coefficient (R2 of 
0.872) was obtained, which is higher than that obtained on the three works above 
mentioned, meaning that salivary CRP and serum CRP could be better correlated through 
the identified quadratic function. This correlation suggests that the saliva samples could 
constitute a potential advancement for the monitoring of the CRP through a non-invasive 
sampling, providing valuable information for assessing the risk of CVD, without involving 
an invasive and sometimes painful sampling procedure. Furthermore, a prediction of 
serum CRP levels from saliva can also be made from the regression plot of Figure 5.18, 
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that is, an analytical correspondence can be estimated. As the normal range of the serum 
CRP levels is currently well-established (Ridker et al., 2003a), it should be estimated that 
for CRP levels at the reference value or cut-off of 3 mg L-1 (maximum limit below high risk 
levels), a correspondence for the salivary CRP levels of approximately 1900 ng L-1 can be 
established. In the same way, patients with the CRP levels in saliva approximately below 
700 ng L-1 have low risk to develop a CVD, which corresponds to the serum level of 1    
mg L-1 in serum. Only Ouellet-Morin et al. (2011) have determined a salivary CRP cut-off 
of approximately 1600 ng L-1, which is quite similar to that suggested in this work. In order 
to confirm the cut-off value of 1900 ng L-1 suggested in this work for the salivary CRP, 
Receiver Operator Characteristic (ROC) curves, that is, plots of sensitivity (y-axis) vs.    
(1-specificity) (x-axis), were obtained to provide a statistical comparison of diagnostic 
accuracy of methodologies (in this case, NTFET and ELISA) in the determination of a 
specific analyte (in this case, the salivary CRP) through the comparison of the area under 
the curves, also known as the c statistic values (Cook, 2007), as shown in Figure 5.19a. 
The diagnostic capability for each methodology was determined by calculating the 
sensitivity (the fraction of patients with CVD risk that the test correctly identifies as 
positive, and determined by [true positives / (true positives + false negatives)]) and the 
specificity (the fraction of patients without CVD risk, that is, control patients that the test 
correctly identifies as negative, and determined by [true negatives / (true negatives + false 
positives)]), at all possible values for cut-off used to determine whether the results of the 
methodology are positive, as shown in Figure 5.19b, discriminating diseased vs. 
nondiseased patients, and determining the cut-off value that separate both patients. The 
closer the ROC curve comes to the upper left corner, the higher the overall accuracy, 
since sensitivity, and specificity reaches maximum values (100%). The area under the 
curve represents the effectiveness of the NTFET or the ELISA in discriminating the CVD 
risk group from the control group, and a value of area under curve of 1 represents the 
most accurate NTFET or ELISA, while values of the area under curve less than 0.5 
indicate no discrimination, that is, poor reliability, corresponding to the diagonal line in the 
ROC plot (Figure 5.19a). If there are significant differences between the areas under the 
curves, then the corresponding p value is less than 0.05. The statistical parameters 
obtained for the ROC curves of the NTFET and the ELISA are shown in Table 5.16. 
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Figure 5.19 a) ROC curves obtained for the salivary CRP determined by the NTFET and the 
ELISA technique and b) Plot of sensitivity and specificity vs. salivary CRP cut-off 
determined by the NTFET. 
 
 
From the ROC curves plotted in Figure 5.19a, the area under curve is 0.95 for the 
NTFET and 0.98 for the ELISA technique, as shown in Table 5.16, which means that both 
methodologies display similar performances as diagnostic tests for determination of the 
salivary CRP, with a slight advantage for the ELISA technique. Both methodologies could 
accurately distinguish the CVD risk patients from the control patients, since a area under 
curve higher than 0.96 indicates an excellent discriminatory ability, as stated by Fan et al. 
(2006). On the other hand, the ROC curve analysis shows that the NTFET achieved a    
70 % sensitivity (percentage of positive samples correctly identified) and 87 % specificity 
(percentage of negative samples correctly identified), demonstrating that the NTFET could 
be used as an accurate method for measuring the salivary CRP, as shown in Figure 
5.19a. 
From Table 5.16, it can be concluded that the two methodologies do not show a 
statistically significant difference (p = 0.29), obtained from the difference between the area 
under the ROC curves. From Figure 5.19b, where sensitivity and specificity curves are 
shown in function of cut-off values, a cut-off of approximately 1700 ng L-1 was found for 
the salivary CRP determined by the NTFET, which is the intersection between the 
sensitivity and the specificity curves, thus allowing to discriminate the control patients from 
the CVD risk patients. The cut-off found is similar to that obtained from Figure 5.18 (1900 
ng L-1), where the salivary CRP was plotted in function of the serum CRP.  
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Table 5.16 Statistical parameters obtained through ROC curves for the NTFET and the ELISA 
technique. 
Test variables 
Area 
under 
curve 
Standard 
error 
95% 
confidence 
intervals 
p value 
Sample size 
Control 
patients 
CVD risk 
patients 
NTFET 0.9533 0.03670 0.8814 to 1.025 1.6x10
-4
 15 10 
ELISA 0.9800 0.02268 0.9356 to 1.024 <1.0x10
-4
 15 10 
Comparison of ROC curve area 
                                                   Area difference                        - 0.0267 
                                          95% confidence intervals         - 0.0765 to 0.0232 
                                                        p value                                   0.2942 
 
 
Punyadeera et al. (2011) have established a saliva reference range with a 
homogeneous bead based assay, showing that the mean level of the CRP in the saliva of 
health human volunteers was 285 ng L-1, and in cardiac patients was 1680 ng L-1. Such 
results for healthy patients are approximately three times lower than that obtained in this 
work, where patients from control group with serum CRP lower than 3 mg L-1 (0.92 ± 0.67 
mg L-1) have salivary CRP concentrations of 814 ± 511 ng L-1, and patients from CVD risk 
group with serum CRP between 3 and 10 mg L-1 (4.6 ± 1.7 mg L-1) have salivary CRP 
concentrations of 2460 ± 771 ng L-1. In turn, Ouellet-Morin et al. (2011) have obtained 
salivary CRP values of 1188 ng L-1 for healthy patients, which are different than that 
obtained by Punyadeera et al. (2011), but more similar than that obtained in this work. 
Thus, the determination of the salivary CRP in different works show an expected 
variability in their estimate of critical values, mostly due to the conditions of saliva 
sampling, that is, the period during the day, the time of collection, the effectiveness of 
brushing teeth (which should be made one hour prior the collection), or the rinsing of 
mouth before collection. For example, Out et al. (2012) have found that the salivary CRP 
is, on average, higher in the morning than in the evening. However, taking into account 
the various estimative of the salivary CRP, this thesis contributes with the most 
acceptable values due to the statistical control of the results reported along this work. 
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5.4.3.4. Correlation of the CRP concentrations in serum samples with other risk 
factors for the development of cardiovascular diseases (CVD) 
 
In order to find a possible correlation between the serum CRP from the volunteer 
patients and other risk factors for the development of the CVD, Pearson correlation 
coefficients were determined with the data reported in Appendix IV. Thus, the age, the 
total cholesterol, the LDL cholesterol, the HDL cholesterol, the triglycerides, the BMI, and 
the serum CRP were correlated, together with Framingham risk score, which is an 
estimation of the percent probability of having a coronary heart disease in 10 years 
(NCEP, 2001). The calculation of Framingham score includes as risk factors the age, 
gender, total cholesterol, systolic blood pressure, treatment for hypertension, and 
cigarette consumption. According to the reference values for each risk factor, and 
associate Framingham score, the total points are calculated and the total risk score, that 
is, the 10-year risk is then estimated for myocardial infarction and coronary deaths. This 
current strategy for global risk assessment may have the potential to increase the 
accuracy of cardiovascular risk prediction, as studied by Ridker et al. (2003b). 
Furthermore, the Framingham score was also calculated for each patient of the population 
under study, as shown in Appendix VIIa, where the data to calculate the Framingham 
score for each patient is present, based on Tables of Appendixes VIIb and VIIc, which 
identify the reference values to calculate the Framingham score for the estimate of        
10-year risk for men, and for women, respectively. It should be highlighted that the systolic 
blood pressure was considered with the minimum score for each patient, since the 
patients were not provided their blood pressure in the questionnaires, and thus, the       
10-year risk percentages are displayed by default and not by excess. 
The application of the t-test to quantitative parameters obtained from the control 
patients (N = 15) and from the CVD risk patients (N = 10) allowed to establish a 
statistically significant difference for total cholesterol (p = 0.002), LDL cholesterol             
(p = 0.001), Framingham risk score (p < 0.001), and triglycerides (p = 0.018) between the 
two groups of patients. For HDL cholesterol (p = 0.266) and body mass index (p = 0.087), 
there is no statistically significant difference between the two groups of patients. 
Correlations between all quantitative parameters were also determined by Pearson 
correlation coefficients to measure the extent to which each pair of variables is linearly 
related, and Table 5.17 shows the results obtained for the control group and the CVD risk 
group of patients. According to Table 5.17, and for the control patients, only correlations 
between total cholesterol and LDL cholesterol (73.4 %, p = 0.002), Framingham score and 
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triglycerides (67.2 %, p = 0.006), as well as Framingham risk score and age                
(70.7 %, p = 0.003) are significant. Regarding the group of CVD risk patients, the CRP 
levels were found to be strongly correlated with total cholesterol (80.5 %, p = 0.005), and 
LDL cholesterol (74.2 %, p = 0.014). Recently, the CRP and the LDL cholesterol have 
been identified as equally strong predictors of cardiovascular risk, being both equally 
important for quality clinical care, as stated by Ridker et al. (2013), which can explain the 
results of Table 5.17. 
 
 
Table 5.17 Correlation coefficients (R) and respective p values for each pair of parameters 
obtained from serum samples of the control patients and the CVD risk patients (the 
bold values are statistically significant at the p = 0.05). 
Control patients 
R 
p values 
Serum 
CRP 
Total 
chol. 
HDL 
chol. 
LDL 
chol. 
Triglycerides Age BMI 
Total chol. 
0.183 
0.515 
      
HDL chol. 
0.042 
0.882 
0.470 
0.077 
     
LDL chol. 
0.132 
0.639 
0.734 
0.002 
-0.163 
0.561 
    
Triglycerides 
0.092 
0.745 
-0.035 
0.901 
-0.344 
0.209 
-0.147 
0.602 
   
Age 
-0.307 
0.266 
0.025 
0.929 
-0.063 
0.825 
-0.077 
0.784 
0.399 
0.141 
  
BMI 
0.371 
0.174 
0.017 
0.953 
0.239 
0.390 
-0.148 
0.598 
-0.076 
0.788 
0.151 
0.590 
 
Framingham 
score 
0.000 
1.000 
0.065 
0.818 
-0.250 
0.369 
0.012 
0.965 
0.672 
0.006 
0.707 
0.003 
-0.271 
0.328 
CVD risk patients 
R 
p values 
Serum 
CRP 
Total 
chol. 
HDL 
chol. 
LDL 
chol. 
Triglycer. Age BMI 
Total chol. 
0.805                         
0.005 
      
HDL chol. 
-0.054 
0.882 
0.217 
0.547 
     
LDL chol. 
0.742 
0.014 
0.954 
0.000 
0.241 
0.503 
    
Triglycerides 
0.342 
0.334 
0.203 
0.573 
-0.527 
0.118 
-0.061 
0.868 
   
Age 
-0.178 
0.623 
-0.049 
0.892 
0.661 
0.037 
0.111 
0.760 
-0.766 
0.010 
  
BMI 
0.130 
0.721 
-0.061 
0.867 
-0.459 
0.183 
-0.050 
0.891 
0.182 
0.614 
-0.632 
0.050 
 
Framingham 
score 
0.224 
0.534 
0.154 
0.671 
0.202 
0.671 
0.070 
0.847 
0.148 
0.684 
0.377 
0.283 
-0.544 
0.104 
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According to Ledue and Rifai (2003), the main sources of variability which affect the 
CRP results are the race and the ethnicity, the age and gender, lifestyle factors such as 
physical activity, smoking, alcohol, anti-inflammatory drugs, and hormone therapy 
influence. In this way, it is recommended, for accurate practice, that the interpretation of 
the CRP concentrations should be made in the context of the medical history of patients, 
as stated by Suarez (2004). Thus, besides the correlation between quantitative 
parameters, as shown in Table 5.17, it is important to know how the interaction between 
quantitative parameters (such as serum CRP, total cholesterol, HDL cholesterol, LDL 
cholesterol, triglycerides, BMI, age, and Framingham score) and qualitative parameters 
(such as gender, stress, hypertension, dyslipidemia, diabetes mellitus, family history of 
CVD, physical activity, as well as the consumption of tobacco, alcohol, and coffee) could 
explain the differences of clinical characteristics between the control and the CVD risk 
patients. Thus, a categorical principal components analysis (CATPCA) was performed 
with SPSS software (SPSS, 2012) to study both quantitative and qualitative parameters 
that is, using both nominal and ordinal parameters. Linting et al. (2007) reviewed this 
specific type of principal components analysis, mostly used in social and behavioural 
sciences, where each observed value is referred to a category, and a large number of 
variables can be reduced to a much smaller number of uncorrelated linear combinations 
of these variables, called components loadings, that reproduce as much variance from the 
variables as possible. Appendix IV shows the set of results, obtained for each patient of 
the control and the CVD risk group, and used to perform the CATPCA. For each variable, 
here called parameter, eigenvalues are calculated as a measure of describing the 
variance explained by each parameter. Then, the higher variance explained by such 
parameters occurred when the eigenvalues attained the unit, as shown in Table 5.18, 
where the eigenvalues obtained from the CATPCA performed with the 18 parameters, and 
corresponding variance are shown. 
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Table 5.18 Eigenvalues obtained from the 18 parameters measured and corresponding 
variance in the data. 
Principal 
components 
Eigenvalues Variance (%) 
Cumulative 
variance (%) 
1 4.82 26.8 26.8 
2 3.07 17.0 43.8 
3 1.93 10.7 54.5 
4 1.91 10.6 65.1 
5 1.42 7.9 73.0 
6 1.11 6.1 79.1 
7 0.91 5.1 84.2 
8 0.80 4.4 88.6 
9 0.59 3.3 91.9 
10 0.39 2.1 94.0 
11 0.29 1.6 95.6 
12 0.23 1.3 96.9 
13 0.18 1.0 97.9 
14 0.16 0.9 98.8 
15 0.10 0.5 99.3 
16 0.05 0.3 99.6 
17 0.04 0.19 99.8 
18 0.02 0.11 99.9 
Total 18 100  
 
 
Table 5.18 shows that the data can be explained by six components, since their 
eigenvalues are higher than the unit, accounting for about 79% of the total variance. The 
two first components were used to produce a biplot, according to the coefficients shown in 
Table 5.19 for components loadings, which explain 44 % of the total variance of the data 
(Table 5.18). The component loadings are measures obtained from the parameters and 
they are equal to the correlation coefficients between the principal component and the 
parameter. According to Table 5.19, the higher contributions (component loadings > |0.5|) 
to the first component are observed for the CRP, total cholesterol, LDL cholesterol, BMI, 
age, hypertension, dyslipidemia, and Framingham score at positive level, as well as by 
physical activity at negative level. On the other hand, triglycerides, stress, alcohol 
consumption, and coffee consumption contribute positively, and dyslipidemia contributes 
negatively to the second component. 
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Table 5.19 Coefficients obtained for the object points and the components loadings. 
Sample 
N. º 
Object points 
Parameters 
Component loadings 
Component 1 Component 2 Component 1 Component 2 
1 1.298 2.204 CRP 0.788 0.354 
2 0.973 0.875 Tot_Chol 0.631 0.310 
3 1.176 -1.594 HDL_Chol -0.170 -0.426 
4 0.886 0.291 LDL_Chol 0.536 0.210 
5 0.104 -0.159 Triglyc 0.455 0.575 
6 1.008 -0.117 BMI 0.510 0.052 
7 0.828 0.174 Age 0.623 -0.468 
8 1.960 1.158 Gender -0.419 -0.400 
9 1.307 -1.030 Stress -0.322 0.529 
10 0.867 -0.152 Hypertension 0.756 -0.224 
11 -0.664 0.500 Dyslipidemia 0.661 -0.589 
12 -0.272 0.449 Diab_mell 0.482 -0.252 
13 -1.316 -0.414 Fam_Hist -0.235 -0.333 
14 -1.252 0.993 Phys_Activ -0.656 0.367 
15 -1.288 0.959 Tobacco -0.007 0.144 
16 -1.032 0.497 Alcohol -0.091 0.756 
17 -0.624 -0.061 Coffee 0.198 0.536 
18 -1.104 0.478 Framing_score 0.756 0.203 
19 -0.156 1.015    
20 -1.068 -0.777    
21 -1.418 -0.838    
22 -0.839 0.248    
23 0.204 -1.023    
24 0.090 -1.111    
25 0.333 -2.563    
 
 
The dispersion of the object points, which correspond to the 15 control patients and to 
the 10 CVD risk patients, is shown in Figure 5.20a, according to the coefficients calculated 
for each component, and the biplot with the object points and with the component loadings 
is displayed in Figure 5.20b. 
From Figure 5.20, the two groups of patients are separated, since the patients who 
have similar clinical characteristics have similar components loadings, that is, they lie 
close to each other in the space defined by the parameters measured. Thus, the various 
CVD risk patients are included in the right quadrants of the biplot, where the parameters 
triglycerides, serum CRP, total cholesterol, LDL cholesterol, BMI, Framingham score, 
hypertension, dyslipidemia, and diabetes mellitus are the most strongly associated with 
such patients. These results reflect the association of CVD risk patients with the 
parameters which are considered as risk factors for the development of a CVD, which 
allows concluding that the determination of the serum CRP also contributes as a predictor 
of the risk to develop a CVD in association with other risk factors. It should be pointed that 
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the patient 5 of the CVD group is slightly detached from the other patients of this group 
(Figure 5.20a), but its characteristics do not justify its exclusion from the group. Thus, as 
shown in Figure 5.20 containing the results obtained from the CATPCA, the patient 5 is 
also included in the oval form which groups the CVD risk patients. 
 
 
Figure 5.20 Results obtained from CATPCA: a) plot of the object points, which correspond to the 
CVD risk patients (number from 1 to 10) and the control patients (points from 11 to 25) 
and b) biplot for the two first components with different patients and measured 
parameters (component loadings). 
 
 
According to the National Institutes of Health (NCEP, 2001), diabetes mellitus is 
regarded as a high risk contributor to develop a coronary heart disease, and the major risk 
factors that are associated with high LDL cholesterol, known as the major cause for 
coronary heart diseases, are the tobacco consumption, hypertension, family history of 
CVD, and age, also conferring higher risk to develop CVD in 10 years, determined by the 
Framingham score. In this way, and also taking into account the conclusions of the 
American Heart Association (Ridker, 2003a), where the CRP levels are considered to be 
increased by a positive history of smoking, elevated BMI, elevated triglycerides, and 
diabetes mellitus, it should be highlighted that the results obtained in this work, mainly 
from the biplot of Figure 5.20b, could contribute to the elucidation of the association of the 
CRP with the CVD risk factors. Only the family history of CVD does not contribute to the 
separation between the control and the CVD risk patients. For example, Albert et al. 
(2003) have reported the relation of the plasma concentration of the CRP and the 
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calculated Framingham score, indicating that individuals in the lowest CVD risk were at 
least half of those individuals in the highest CVD risk category. When BMI increases, an 
increase in adipocytes occurs with elevation of interleukin-6 (IL-6), and thus increasing the 
CRP, since IL-6 is one of the cytokines that cause an increase in acute-phase reactants, 
such as the CRP, according to the findings of Ford (1999). In turn, Rawson et al. (2003) 
concluded that an elevated CRP is associated with both high BMI and low physical activity 
in cross sectional studies. In fact, in this work, the physical activity is not expressed as 
significant parameter for the CVD risk patients, contrarily to the BMI. Although CRP levels 
are affected by obesity, as referred by Gupta et al. (2012), they have been concluded that 
the association between CRP and atherosclerosis decreases in obese individuals. 
 
 
5.5. Conclusions 
 
The NTFET were developed for biosensing of the CRP in clinical samples that is, blood 
serum and saliva, using SWCNT networks as transduction components. The assemblage 
of the NTFET was performed with a uniform and stable SWCNT dispersion, which was 
obtained after 60 minutes of sonication, and 5 minutes of centrifugation at 2000 × g, and 
with the FET fabricated with 100 nm of gold layer, a distance between electrodes of 2.5 
µm, and 10 electrodes. 
According to the results obtained, the NTFET were capable of quantifying the CRP 
concentrations over a large linear range between 10-4 and 102 mg L-1, using a log-log 
regression model with a strong determination coefficient (R2 = 0.992; p < 0.001). Thus, the 
residual levels of the CRP in healthy persons without any sign of inflammation (with the 
CRP levels below 3 mg L-1), as well as critical levels of the CRP responsible for 
pathological evidences (that is, higher than 3 mg L-1) could be detected with the NTFET. 
The cost-effectiveness of analysis as well as the rapid, label-free, and simple use 
associated with the disposable NTFET makes them much more fit for purpose and 
advantageous than the currently available analytical systems. 
When applied to clinical samples, the NTFET provided analytical results comparable 
with those obtained by a traditional ELISA methodology, taking into account the similar 
CRP levels in blood and saliva samples from volunteer patients, since there was no 
statistically significant difference between the two methodologies (p = 0.912). 
Furthermore, as a strong correlation was found between the salivary and the serum CRP 
both determined by the NTFET and the ELISA, it is suggested that the developed NTFET 
constitute an alternative for the use of point-of-care testing methodology to detect the risk 
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of developing a CVD, based on a non-invasive sampling, and also leading to the 
establishment of a new range of CRP levels in saliva samples. 
From this work, it was also found that triglycerides, serum CRP, total cholesterol, LDL 
cholesterol, BMI, Framingham score, hypertension, dyslipidemia, and diabetes mellitus, 
known as risk factors to develop a CVD, are the parameters responsible for the separation 
of the control and the CVD risk patients used in this study, when an optimized principal 
components analysis was performed. 
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In this thesis, disposable NTFET were developed to be used as immunosensors for the 
biosensing of the CRP in clinical samples that is, blood serum and saliva, using a SWCNT 
network as transduction components. The assemblage of the NTFET was performed with 
uniform and stable SWCNT dispersions in SC, which were obtained after 60 minutes of 
sonication, and 5 minutes of centrifugation at 2000 × g, and with the FET fabricated with a 
gold layer of 100 nm, a distance between electrodes of 2.5 µm, and 10 electrodes. 
 
The developed NTFET were capable of detecting concentrations of the CRP over a 
linear range between 10-4 and 102 mg L-1, with an analytical error of 3.6 % and an 
acceptable reproducibility of less than 15 %, when applied to standard solutions of CRP.  
 
The NTFET showed a very low LOD of 100 ng L-1, which is comparable with that 
obtained with ELISA technique for the determination of salivary and serum CRP. The best 
calibration model was based on a log-log curve with an acceptable value for the R2 of 
0.9924 and for the adjusted R2 of 0.9910. 
 
The cost-effectiveness of the analysis, the simple use associated with the disposable 
and label-free NTFET, and the need for low sample volumes (of about 1 μL) makes this 
biosensor much more fit for purpose and advantageous for the determination of the CRP 
than the currently and readily available analytical systems, such as the ELISA technique. 
 
When applied to clinical samples, the NTFET also provided analytical results 
comparable with those obtained with a traditional ELISA methodology, taking into account 
the similar CRP levels in blood and saliva samples from volunteer patients. Thus, the 
residual levels of CRP in healthy persons without any sign of inflammation, that is, with 
the CRP levels in serum below 3 mg L-1, as well as critical levels of the CRP responsible 
for pathological evidences, that is, higher than 3 mg L-1, could be detected with the 
NTFET. 
 
A strong correlation was found between the salivary and the serum CRP, both 
determined by the NTFET and the ELISA, which suggests that the developed NTFET is 
appropriate and can be suggested as a real alternative to point-of-care testing for 
detecting the risk of CVD. The successful application and performance of the NTFET for 
the determination of the CRP in saliva makes it suitable for non-invasive testing, with the 
possibility of becoming useful for the self point-of-care testing at home. 
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The correlation between the salivary and the serum CRP allowed to establish a new 
range of CRP levels in saliva associated with: a) patients with the salivary CRP below 700 
ng L-1 and consequently with low risk to develop a CVD (corresponding to the serum CRP 
below 1 mg L-1), b) patients with the salivary CRP levels between 700 ng L-1 and 1900    
ng L-1, and consequently with a moderate risk to develop a CVD (corresponding to the 
serum CRP between 1 and 3 mg L-1), and finally c) patients with the salivary CRP higher 
than 1900 ng L-1, and consequently with a high risk to develop a CVD (corresponding to 
the serum CRP higher than 3 mg L-1). 
 
Finally, the triglycerides, serum CRP, total cholesterol, LDL cholesterol, BMI, 
Framingham risk score, hypertension, dyslipidemia, and diabetes mellitus, known as risk 
factors contributing to the development of CVD, were found to be the parameters 
responsible for the separation of the data obtained in this study for the control and the 
CVD risk patients. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix I 
 
 
Consent form and information 
provided to volunteer patients 
before sample collection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DECLARAQAO DE CONSENTIMENTO
considenndo a "Decrarageo de Hersinquia,'da Associagilo M^dica Mundial(Helsinquia 1964; T6quio 1975; veneza 1983; Hong Kong lggg; somersei west tssi e EJinourgo zocnl
Designagflo do Estudo (em portugu6s):
Desenvolvimento de um Nanosensor para Detecado de Risco de Doengas
Cardiovasculares (CARDTOSENSOR)
Eu, abaixo-assinado, (nome completo)
Responsivel pelo doente (nome completo)
, declaro
que o mesmo nao participa em nenhum outro projecto de investigagio durante este
internamento, tendo compreendido a explicagdo que me foi fornecida acerca. da sua
situagao clinica e da investigagSo que setenciona realizar. Foi-me ainda dada oportunidade
de fazer as perguntas que julguei necessdrias, e de todas obtive resposta satisfatoria.
Tomei conhecimento de que, de acordo com as recomendagoes da Declarag6o de
Helsinquia, a informagio ou explicag6o que i'ne foi prestada 
.versou os objectivos, os
m6todos, os beneffcios previstos, os riscos potenciais e o eventual desconforto. Al6m disso,
foi-me afirmado que tenho o direito de recusar a todo o tempo a sua participag6o no estudo,
sem que isso possa ter como efeito qualquer prejuizo na assist€ncia que lhe 6 prestada.
Por isso, consinto que lhe seja aplicado o m6todo, o tratamento ou o inqu6rito proposto pelo
investigador.
Data: I t2o1L
Assinatura do Respons 6vet pelo doente:
O lnvestigador responsdvel:
Nome,' Paulo Manuel Barreiros de castro chaves
Assinatura:
comissdo de Efico do cenlro Hospilolor de s, Jo6o 
- 
Modelo cE02
 
tNFoRMAeAo no pARTtctpANTE
Titulo do estudo: Desenvolvimento de um Nanosensor para Detecgio de Risco de DoengasCardiovasculares (CARDTOSEN SOR)
lnvestigador responsfvel: paulo Manuel Barreiros de castro chaves
contacto do lnvestigador responsivel: g 1 3740955; pchaves@med. up. pt
Obiectivo da investigag&o:
Actualmente, a Protefna C Reactiva {PCR)e medida no sangue usando imunoturbidimetria,
ensaios imunoelectrofor6ticos, ELISA ou ensaios imunofluorescentes. Contudo, estes ensaios
sdo t6cnicas invasivas de avaliagdo do risco cardiovascular. O desenvolvimento de um
nano,sensor para determinagSo dos niveis da PCR na saliva permitird efectuar o seudoseamento de uma forma simples e ndo invasiva.
O presente projecto tem os seguintes objectivos:
- desenvolvimento e validagdo de um nanosensor para determinagio da pcR;
- comparagdo dos dados obtidos utilizando um ensaio de ELI$A no sangue (m€todo invasivo) e
um nanosensor no sangue e saliva (invasivo e n5o invasivo);
- comparagSo do metodo de ELI$A e do nanosensor em individuos em risco
cardiovasculares;
de eventos
- desenvolvimento de um prot6tipo para aplicag*o da metodologia do nanosensor em servigosde sa0de.
Metodologia a utilizar:
De forma a atingir os objectivos expostos acima. seri feito um inqu6rito para colheita de dadospessoais e cllnicos relativos ao doente em causa. Proceder-se-d em seguida A colheita de-.uma
amostra de sangue por pung8o em veia perif6rica e a uma colheita de siliva por *ri*iao. n*
amostras ser5o em seguida processadas e analisadas.
Beneficios esperados e riscos possiveis:
Este projecto desenvt:lverd um rloVo n&nosensor para determinagao do risco cardiovascularque serd sensivel e seiectivo a PCR e que aliar6 o re.Cuzido temp* de andlise a ngo
necessidade de pretratamento das amostras e fornecerd resultadrs in-situ, coniiicuino, pur*
aumentar a qualidade dos diagnosticos m6dicos.
lnc6modos derivados cla participagf,o:
o do desconforto associado drs colheitas de sangue por venipunctura.
Outras informag6es a prestar ao participante:
Relativamente a participasfio neste projecto e importante $ublinhar
- a participas&o tem caracter voluntdrio;
- seri* fcrnecido ternpo para reflectir sobre o pedido de papticipaggo,
opini$o de familiares e/ou amigos;
os seguintes a$psctos:
inclu$ive poder ouvir
- havera total liberdade para decidir sobre a participagio no projecto;
- haver6, em qualquer momento, possibilidade de retirada do estudo sem que se comprometa orelacionamento com o medico nem o respeito pelos direitos i assistencia rjue rn* e o*"uiou;
- haverd total garantia de privacidade e confidencialidade;
-a investigagSo foisubmetida e aprovada pela Comissio de Etica para a Safde do CentroHospitalar de S. Jodo - EPE.
O lnvestigador Responsave!,
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix II 
 
 
Questionnaire provided to 
volunteer patients before 
sample collection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix III 
 
 
Results obtained from the 
questionnaires provided from 
each volunteer patient 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample Age Gender Weight Height Stress Hypertension Dyslipidemia Diabetes Family Physical Tobacco Alcohol Coffee CVD
Number  (kg)  (cm) mellitus history of CVD activity  Consumption  Consumption  Consumption type
34 59 M 55 174 N N N N N Y Ex-Smoker >2x/week Daily -
30 47 M 75 166 N N N N N N Ex-Smoker >2x/week Occasional -
23 38 F 59 155 Y N N N Y Y N N Daily -
22 36 M 82 181 Y N N N N Y N Occasional Daily -
20 34 M 61 164 Y N N N N Y N Occasional Daily -
19 50 M 72 168 Y N N N N Y N >2x/week Daily -
16 51 M 62 164 Y Y N N Y N Ex-Smoker >2x/week Daily -
15 41 F 85 155 Y N N N N Y N Occasional N -
14 58 M 74 173 Y N N Y Y Y N Occasional Occasional -
4 48 F 66 164 Y N N N N N N N N -
5 30 F 58 163 Y N N N Y N N N Daily
67 50 M 85 178 Y N Y N Y Y Ex-Smoker >2x/week Daily CHD
55 52 M 82 167 N Y Y Y N N Ex-Smoker >2x/week Daily CH
45 57 M 62 158 N Y Do not know N Y N N N Occasional CHD
41 82 F 65 148 N Y Do not know Y Y N N N N CHD
Medical history and lifestyle factors of each volunteer patient
C
o
n
t
r
o
l
 
P
a
t
i
e
n
t
s
(cont.)
2 48 M 77 164 Y Y N N N N Y Occasional Occasional -
8 56 M 78 170 Y Y Y N N N Y >2x/week Occasional -
62 79 M 72 166 N Y Do not know Y N N N N N CHD
56 73 M 60 160 Y Y Do not know N N N Ex-Smoker N N CH
51 49 F 80 156 Y Y Do not know N Y N N N Occasional CHD
53 52 M 122 186 Y Y Y Y N N N >2x/week Daily TIA
44 52 F 67 160 Y N Y N Y N Y N N CHD
S24 49 M 91 173 Y Y Do not know Y Y N Y >2x/week N CHD
S30 61 M 71 167 Y Y Y Y Y N Ex-Smoker >2x/week Occasional CHD
S6 62 M 74 155 N Y Y N N N N Occasional Occasional CHD
S7 54 M 84 184 Y Y Y N Y N Y N Occasional TIA
S13 53 M 95 165 Y Y Y Y N N N >2x/week Occasional CHD
S15 75 M 74 160 N Y Do not know N N N N N N CH
S33 83 M 45 155 N N Y N N N Y N Occasional CHD
S35 73 M 70 165 N N Y N Y N Ex-Smoker >2x/week Occasional CH
C
V
D
 
R
i
s
k
 
P
a
t
i
e
n
t
s
CVD - Cardiovascular Disease; CHD - Coronary Heart Disease; TIA - Transient Ischemic Attack; CH - Cerebral Hemorrhage; N - No; Y - Yes; M - Male; F - Female
Sample Total Cholesterol HDL Cholesterol LDL Cholesterol Triglycerides CRP Ref. Lab. Total / HDL Col. BMI Framingham Score
Number (mg dL
-1
) (mg dL
-1
) (mg dL
-1
) (mg dL
-1
) (mg L
-1
)  (kg m
-2
) (% 10-year CVD risk)
34 173 42 94.8 181 0.48 4.1 18.17 8
30 190 42 130.6 87 0.82 4.5 27.22 1
23 189 60 120.2 44 0.74 3.2 24.56 1
22 145 39 86.8 96 0.81 3.7 25.03 1
20 163 48 95.2 99 0.89 3.4 22.68 1
19 169 53 89 135 0.22 3.2 25.51 3
16 147 42 84 105 0.46 3.5 23.05 3
15 158 52 79.8 131 2.59 3.0 35.38 1
14 196 47 122 135 2.16 4.2 24.73 8
4 161 56 88.4 83 0.50 2.9 24.54 1
5 166 71 83.2 59 1.55 2.3 21.83 1
67 150 39 90 104 0.74 3.8 26.83 4
55 190 88 81 103 0.70 2.2 29.40 3
45 133 38 73 108 0.8 3.5 24.84 6
41 163 59 85 95 0.23 2.8 29.67 5
Medical history and lifestyle factors of each volunteer patient
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(cont.)
2 210 37 117.4 278 6.73 5.7 28.63 20
8 205 51 114 200 3.53 4.0 26.99 16
62 169 51 103 74 4.04 3.3 26.13 12
56 169 43 100 131 22.30 3.9 23.44 12
51 222 52 136 171 12.50 4.3 32.87 1
53 184 46 101 184 3.50 4.0 35.26 5
44 217 39 141 186 4.14 5.6 26.17 4
S24 187 39 109 196 3.80 4.8 30.41 12
S30 205 41 115 244 11.10 5.0 25.46 10
S6 191 50 129 61 3.50 3.8 30.80 8
S7 244 27 158 297 10.40 9.0 24.81 20
S13 295 46 214 173 8.40 6.4 34.89 10
S15 189 41 130 88 3.30 4.6 28.91 16
S33 257 59 174 122 5.70 4.4 18.73 20
S35 182 57 108 85 21.80 3.2 25.71 10
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Total Cholesterol HDL Cholesterol LDL Cholesterol Triglycerides CRP Ref. Lab. Total / HDL Col.
c
BMI (kg m
-2
)
d
(mg dL
-1
)
a
(mg dL
-1
)
a
(mg dL
-1
)
a
(mg dL
-1
)
a
(mg L
-1
)
b
Desirable High (Low Risk) Optimal Normal Low Risk Optimal Underweight
< 200 > 60 < 100 < 150 < 1.0 ratio of 3.5:1 < 18.50
Borderline High Low (High Risk) Above optimal Borderline High Moderate Normal Normal range
200-239 < 40 100-129 150-199 1.0 to 3.0 ratio < 5:1 18.50 to 24.99
High Borderline High High High Risk High Overweight
> 240 130-159 200-499 3.0 to 10 ratio > 5 > 25.00
High Very High Obese
160-189 > 10 > 30.00
Very High
> 190
Classification of risk parameters according to several references a, b, c, and d
a based on ATP III from National Cholesterol Education Program guidelines;
b based on Ridker et al., 2003. Circulation 107, 363-369;
c based on The American Heart Association
Available at: http://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/What-Your-Cholesterol-Levels-Mean_UCM_305562_Article.jsp
d based on The International Classification of World Health Organization
Available at: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix IV 
 
 
Data used in the SPSS 
software, and coded from the 
data reported in Appendix III 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample Number Sample CRP
a Total Cholesterol HDL Cholesterol LDL Cholesterol Triglycerides BMI Framingham
in SPSS software Number (mg L
-1
) (mg dL
-1
) (mg dL
-1
) (mg dL
-1
) (mg dL
-1
)  (kg m
-2
) Score (%)
1  2 6.76 210 37 117 278 28.63 48 20
2  8 3.49 205 51 114 200 26.99 56 16
3 62 4.18 169 51 103 74 26.13 79 12
NA 56 21.81 169 43 100 131 23.44 73 12
NA 51 12.54 222 46 101 184 35.26 49 5
4 53 3.41 184 46 101 184 35.26 52 5
5 44 4.27 217 39 141 186 26.17 52 4
6 S24 3.36 187 39 109 196 30.41 49 12
NA S30 11.91 205 41 115 244 25.46 61 10
7 S6 3.79 191 50 129 61 30.80 62 8
NA S7 11.42 244 27 158 297 24.81 54 20
8 S13 8.42 295 46 214 173 34.89 53 10
9 S15 3.44 189 41 130 88 28.91 75 16
10 S33 5.20 257 59 174 122 18.73 83 2
NA S35 21.58 182 57 108 85 25.71 73 10
11 34 0.42 173 42 95 181 18.17 59 8
12 30 0.82 190 42 131 87 27.22 47 1
13 23 0.70 189 60 120 44 24.56 38 1
14 22 0.82 145 39 87 96 25.03 36 1
15 20 0.76 163 48 95 99 22.68 34 1
16 19 0.23 169 53 89 135 25.51 50 3
17 16 0.45 147 42 84 105 23.05 51 3
18 15 2.51 158 52 80 131 35.38 41 1
19 14 2.28 196 47 122 135 24.73 58 8
20 4 0.52 161 56 88 83 24.54 48 1
21 5 1.54 166 71 83 59 21.83 30 1
22 67 0.72 150 39 90 104 26.83 50 4
23 55 0.74 190 88 81 103 29.40 52 3
24 45 0.83 133 38 73 108 24.84 57 6
25 41 0.19 163 59 85 95 29.67 82 5
NA - Not Applicable;
The data of these patients were used for the application of the t -test, but they were not used for the Categorical Principal Components Analysis;
a
The CRP values are the means of the CRP values obtained by the NTFET and the ELISA technique for each patient
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Age
Sample Number Sample Diabetes Family history Physical Tobacco Alcohol Coffee
in SPSS software Number mellitus of CVD Activity Consumption Consumption Consumption
1  2 1 2 2 1 1 1 1 2 3 3
2  8 1 2 2 2 1 1 1 2 2 3
3 62 1 1 2 3 2 1 1 1 1 1
NA 56 1 2 2 3 1 1 1 3 1 1
NA 51 2 2 2 3 1 2 1 1 1 2
4 53 1 2 2 2 2 1 1 1 2 2
5 44 2 2 1 2 1 2 1 2 1 1
6 S24 1 2 2 3 2 2 1 2 2 1
NA S30 1 2 2 2 2 2 1 3 3 3
7 S6 1 1 2 2 1 1 1 1 3 3
NA S7 1 2 2 2 1 2 1 2 1 3
8 S13 1 2 2 2 2 1 1 1 2 3
9 S15 1 1 2 3 1 1 1 1 1 1
10 S33 1 1 1 2 1 1 1 2 1 3
NA S35 1 1 1 2 1 2 1 3 3 3
11 34 1 1 1 1 1 1 2 3 2 2
12 30 1 1 1 1 1 1 1 3 2 3
13 23 2 2 1 1 1 2 2 1 1 2
14 22 1 2 1 1 1 1 2 1 3 2
15 20 1 2 1 1 1 1 2 1 3 2
16 19 1 2 1 1 1 1 2 1 2 2
17 16 1 2 2 1 1 2 1 3 2 2
18 15 2 2 1 1 1 1 2 1 3 1
19 14 1 2 1 1 2 2 2 1 3 3
20 4 2 2 1 1 1 1 1 1 1 1
21 5 2 2 1 1 1 2 1 1 1 2
22 67 1 2 1 2 1 2 2 3 2 2
23 55 1 1 2 2 2 1 1 3 2 2
24 45 1 1 2 3 1 2 1 1 1 3
25 41 2 1 2 3 2 2 1 1 1 1
Codification of qualitative parameters:
Gender: 1 = Male, and 2 = Female
Stress, Hypertension, Diabetes mellitus , family history of CVD, and physical activity: 1 = No, and 2 = Yes
Dyslipidemia: 1 = No, 2 = Yes, and 3 = Do not know                  Tobacco comsumption: 1 = No, 2 = Yes, and 3 = Ex-Smoker
Alcohol comsumption: 1 = No, 2 = more than 2x in a week, and 3 = Occasional     Coffee comsumption: 1= No, 2 = Daily, and 3 = Occasional
Stress Hypertension Dyslipidemia
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Appendix V 
 
 
Database of the serum and the 
salivary CRP concentrations 
determined by NTFET and 
ELISA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample N.º
Mean (mg L
-1
) SD (mg L
-1
) CV (%) Mean (mg L
-1
) SD (mg L
-1
) CV (%) Mean (ng L
-1
) SD (ng L
-1
) CV (%) Mean (ng L
-1
) SD (ng L
-1
) CV (%)
34 0.41 0.01 2.1 0.44 0.08 17.7 477.73 8.55 1.8 486.26 21.44 4.4
Appendix Va: Mean and standard deviation (SD) of the CRP levels for each patient obtained by the NTFET and by the ELISA technique
Determination of the serum CRP Determination of the salivary CRP
NTFET 
1
ELISA technique
2
NTFET 
1
ELISA technique
2
30 0.81 0.02 2.8 0.82 0.14 17.2 824.57 8.18 1.0 834.71 199.50 23.9
23 0.71 0.05 6.9 0.69 0.06 8.8 641.72 5.83 0.9 645.71 124.32 19.3
22 0.82 0.01 1.6 0.83 0.03 3.2 871.20 11.20 1.3 893.04 155.29 17.4
20 0.78 0.03 3.8 0.74 0.05 7.2 1008.92 4.94 0.5 1017.49 229.10 22.5
19 0.21 0.04 17.7 0.25 0.04 16.0 185.30 1.62 0.9 184.92 30.59 16.5
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16 0.42 0.03 7.1 0.48 0.02 3.5 278.69 2.44 0.9 273.66 72.30 26.4
15 2.34 0.09 3.9 2.68 0.39 14.4 1707.77 16.95 1.0 1711.99 350.90 20.5
14 2.30 0.16 6.8 2.27 0.21 9.3 1722.77 16.78 1.0 1637.33 361.80 22.1
4 0.49 0.04 8.4 0.55 0.12 22.5 536.86 9.37 1.7 546.44 37.07 6.8
5 1.55 0.05 3.0 1.53 0.03 1.9 1655.75 29.68 1.8 1671.87 341.16 20.4
67 0.67 0.03 4.4 0.77 0.06 7.5 578.07 13.00 2.2 584.06 116.83 20.0
C
o
n
t
r
o
l
 
P
a
t
i
e
n
t
s
55 0.70 0.06 9.2 0.77 0.04 4.7 620.14 8.86 1.4 638.37 156.86 24.6
45 0.79 0.03 3.3 0.87 0.17 19.3 915.72 3.33 0.4 916.68 162.15 17.7
41 0.17 0.03 18.9 0.21 0.06 29.9 172.83 3.01 1.7 170.67 12.47 7.3
0.88 ± 0.67 0.93 ± 0.70 813.20 ± 520.35 814.21 ± 512.10
2 6.46 0.10 1.6 7.07 0.24 3.4 3241.01 106.46 3.3 3271.07 583.63 17.8
8 3.36 0.04 1.1 3.61 0.12 3.3 1683.11 44.10 2.6 1770.28 314.80 17.8
62 4.27 0.06 1.5 4.08 0.13 3.1 1794.39 18.77 1.0 1802.33 360.12 20.0
56 23.52 0.23 1.0 20.09 0.07 0.3 11112.64 493.59 4.4 11691.26 2316.19 19.8
51 12.44 0.18 1.5 12.65 0.94 7.4 6121.66 13.99 0.2 6077.71 1225.74 20.2
53 3.41 0.27 7.8 3.41 0.11 3.2 1703.94 58.92 3.5 1752.12 360.63 20.6
C
V
D
 
R
i
s
k
 
P
a
t
i
e
n
t
s
44 4.24 0.09 2.1 4.30 0.31 7.3 2743.69 41.74 1.5 2764.30 363.55 13.2
S24 3.55 0.17 4.8 3.17 0.15 4.9 2744.06 70.13 2.6 2760.59 386.92 14.0
S30 12.82 0.36 2.8 11.00 0.48 4.3 7106.98 18.68 0.3 7003.98 913.01 13.0
S6 3.50 0.12 3.4 4.08 0.32 7.8 1555.02 8.60 0.6 1542.65 360.73 23.4
S7 11.93 0.81 6.8 10.92 0.60 5.5 5053.58 15.57 0.3 5036.50 1997.18 39.7
C
V
D
 
R
i
s
k
 
P
a
t
i
e
n
t
s
S13 8.52 0.14 1.7 8.32 0.00 0.0 3390.27 57.02 1.7 3474.78 305.62 8.8
S15 3.48 0.06 1.7 3.39 0.44 12.9 2050.13 22.01 1.1 2044.09 217.67 10.6
S33 5.30 0.21 4.0 5.10 0.03 0.6 3577.16 61.35 1.7 3597.63 409.88 11.4
S35 21.77 0.83 3.8 21.39 0.21 1.0 10695.75 236.17 2.2 10674.22 2706.95 25.4
8.57 ± 6.68 8.17 ± 5.99 4304.89 ± 3149.38 4350.90 ± 3218.47
C
V
D
 
R
i
s
k
 
P
a
t
i
e
n
t
s
1Mean, standard deviation (SD), and coefficients of variation (% CV) for three individual NTFET. For each NTFET, three measurements were performed, and the results are shown in Appendix Vb.
2Mean, standard deviation (SD), and coefficients of variation (% CV) for two ELISA microplates. For each microplate, duplicates were performed, and the results are shown in Appendix Vc.
 
Mean SD CV (%) Mean SD CV (%) Mean SD CV (%)
2 6.54 0.37 5.6% 6.35 0.40 6.3% 6.50 0.32 4.9%
NTFET #3NTFET #1 NTFET #2
Serum samples
Appendix Vb: Mean and standard deviation (SD) of the three measurements for each NTFET (cont.)
8 3.33 0.43 12.9% 3.40 0.32 9.5% 3.34 0.17 5.1%
62 4.22 0.10 2.5% 4.34 0.13 3.0% 4.25 0.02 0.5%
56 23.52 0.18 0.8% 23.76 0.88 3.7% 23.29 0.98 4.2%
51 12.50 0.86 6.9% 12.59 0.90 7.2% 12.24 1.64 13.4%
53 3.46 0.44 12.7% 3.12 0.10 3.1% 3.64 0.28 7.6%
C
V
D
 
r
i
s
k
 
p
a
t
i
e
n
t
s
44 4.22 0.19 4.5% 4.33 0.12 2.9% 4.16 0.15 3.5%
S24 3.74 0.26 7.0% 3.48 0.37 10.6% 3.43 0.33 9.5%
S30 13.16 1.20 9.1% 12.87 0.98 7.6% 12.45 1.41 11.4%
S6 3.57 0.31 8.5% 3.36 0.05 1.6% 3.56 0.12 3.2%
S7 12.86 1.01 7.9% 11.52 0.83 7.2% 11.40 1.35 11.8%
C
V
D
 
r
i
s
k
 
p
a
t
i
e
n
t
s
S13 8.44 0.35 4.2% 8.68 0.25 2.9% 8.44 0.38 4.5%
S15 3.50 0.23 6.7% 3.53 0.44 12.3% 3.42 0.29 8.6%
S33 5.18 0.15 2.8% 5.17 0.15 2.9% 5.54 0.33 5.9%
S35 21.74 1.77 8.2% 20.95 0.76 3.6% 22.62 1.73 7.6%
C
V
D
 
r
i
s
k
 
p
a
t
i
e
n
t
s
34 0.41 0.07 16.5% 0.41 0.09 22.5% 0.40 0.08 19.5%
30 0.78 0.03 3.4% 0.81 0.03 3.6% 0.83 0.01 1.3%
23 0.71 0.06 8.0% 0.75 0.05 6.9% 0.65 0.05 7.1%
22 0.84 0.03 3.6% 0.81 0.06 7.8% 0.81 0.05 6.5%
20 0.78 0.08 9.9% 0.80 0.08 10.3% 0.74 0.04 5.0%
19 0.21 0.05 21.5% 0.24 0.04 17.0% 0.17 0.04 21.0%
16 0.39 0.08 19.9% 0.44 0.05 10.5% 0.41 0.05 10.9%
15 2.24 0.36 15.9% 2.36 0.18 7.6% 2.43 0.26 10.7%
14 2.23 0.20 9.0% 2.19 0.10 4.4% 2.48 0.21 8.4%
4 0.52 0.04 7.5% 0.52 0.07 13.0% 0.45 0.01 2.7%
C
o
n
t
r
o
l
 
P
a
t
i
e
n
t
s
5 1.54 0.13 8.4% 1.51 0.09 6.2% 1.60 0.05 2.9%
67 0.67 0.10 14.2% 0.64 0.04 6.4% 0.70 0.08 12.0%
55 0.71 0.02 2.8% 0.76 0.03 4.4% 0.63 0.03 5.0%
45 0.76 0.03 3.7% 0.79 0.08 9.6% 0.81 0.03 4.3%
C
o
n
t
r
o
l
 
P
a
t
i
e
n
t
s
41 0.19 0.07 37.4% 0.18 0.04 23.6% 0.13 0.04 29.9%
Mean SD CV (%) Mean SD CV (%) Mean SD CV (%)
2 3174.72 165.16 5.2% 3184.50 158.60 5.0% 3363.80 73.26 2.2%
Saliva samples
NTFET #1 NTFET #2 NTFET #3
Appendix Vb: Mean and standard deviation (SD) of the three measurements for each NTFET
8 1677.53 26.21 1.6% 1729.74 23.60 1.4% 1642.07 26.33 1.6%
62 1811.19 49.50 2.7% 1774.14 88.24 5.0% 1797.85 55.71 3.1%
56 11538.99 191.90 1.7% 10571.90 484.23 4.6% 11227.03 550.50 4.9%
51 6137.19 37.13 0.6% 6110.04 23.73 0.4% 6117.75 58.96 1.0%
53 1746.71 55.16 3.2% 1636.73 38.48 2.4% 1728.38 50.92 2.9%
C
V
D
 
r
i
s
k
 
p
a
t
i
e
n
t
s
44 2749.02 48.50 1.8% 2699.54 130.75 4.8% 2782.51 72.26 2.6%
S24 2803.92 61.95 2.2% 2761.36 67.24 2.4% 2666.90 57.70 2.2%
S30 7087.35 75.61 1.1% 7109.07 62.66 0.9% 7124.52 36.23 0.5%
S6 1559.01 58.98 3.8% 1545.14 30.87 2.0% 1560.89 77.06 4.9%
S7 5046.98 31.87 0.6% 5071.36 28.68 0.6% 5042.39 39.75 0.8%
C
V
D
 
r
i
s
k
 
p
a
t
i
e
n
t
s
S13 3358.84 91.96 2.7% 3456.09 7.88 0.2% 3355.87 162.87 4.9%
S15 2041.36 49.90 2.4% 2075.17 3.75 0.2% 2033.85 35.03 1.7%
S33 3534.90 176.75 5.0% 3549.04 142.31 4.0% 3647.52 99.79 2.7%
S35 10564.27 194.36 1.8% 10554.58 891.13 8.4% 10968.39 589.12 5.4%
C
V
D
 
r
i
s
k
 
p
a
t
i
e
n
t
s
34 474.46 19.84 4.2% 471.31 14.75 3.1% 487.43 13.04 2.7%
30 833.93 16.78 2.0% 821.01 1.83 0.2% 818.78 13.45 1.6%
23 640.39 16.92 2.6% 648.10 2.41 0.4% 636.67 15.58 2.4%
22 874.76 14.17 1.6% 880.19 27.28 3.1% 858.65 25.20 2.9%
20 1003.24 4.05 0.4% 1012.13 11.80 1.2% 1011.41 7.89 0.8%
19 186.38 0.96 0.5% 186.07 1.77 0.9% 183.44 2.90 1.6%
16 276.74 13.95 5.0% 277.91 6.42 2.3% 281.43 11.55 4.1%
15 1707.51 61.75 3.6% 1690.95 74.43 4.4% 1724.85 58.74 3.4%
14 1737.05 57.63 3.3% 1726.97 66.10 3.8% 1704.29 58.59 3.4%
4 526.04 3.45 0.7% 541.90 17.18 3.2% 542.64 17.40 3.2%
C
o
n
t
r
o
l
 
P
a
t
i
e
n
t
s
5 1622.00 13.89 0.9% 1667.51 66.10 4.0% 1677.75 54.94 3.3%
67 592.56 8.54 1.4% 567.41 20.68 3.6% 574.25 18.11 3.2%
55 626.61 15.02 2.4% 610.04 3.07 0.5% 623.75 10.00 1.6%
45 912.21 7.67 0.8% 918.83 13.68 1.5% 916.13 7.37 0.8%
C
o
n
t
r
o
l
 
P
a
t
i
e
n
t
s
41 169.38 2.01 1.2% 174.90 6.06 3.5% 174.20 4.80 2.8%
Salivary CRP determined by ELISA technique Regression equation (Plate #1)
x=(y-0.0556)/0.0003
OD (at 450 nm) Samples [CRP] (ng L-1) Mean (ng L-1) SD (ng L-1) CV
0.829 High Control 2577.33 2484.17 131.76 5.3%
0.773 High Control 2391.00
0.104 Low Control 160.80 159.92 1.25 0.8%
0.103 Low Control 159.03
Appendix Vc: Mean and standard deviation (SD) of duplicates for each ELISA microplate     (cont.)
0.152 2 321.87 329.62 10.95 3.3%
0.157 2 337.36
0.109 8 176.70 178.59 2.68 1.5%
0.110 8 180.49
0.109 62 178.33 178.55 0.31 0.2%
0.109 62 178.77
0.385 56 1097.33 1159.52 87.94 7.6%
0.422 56 1221.70
0.253 51 657.67 600.95 80.21 13.3%
0.219 51 544.23
0.107 53 169.60 172.62 4.27 2.5%
0.108 53 175.63
0.152 44 320.67 289.17 44.55 15.4%
0.133 44 257.67
0.132 S24 253.67 286.83 46.90 16.4%
0.152 S24 320.00
CV
D
 
R
is
k 
Pa
tie
n
ts
0.267 S30 703.20 733.33 42.61 5.8%
0.285 S30 763.47
0.100 S6 148.63 148.43 0.28 0.2%
0.100 S6 148.23
0.182 S7 421.00 418.02 4.22 1.0%
0.180 S7 415.03
0.175 S13 398.50 375.73 32.20 8.6%
0.162 S13 352.97
CV
D
 
R
is
k 
Pa
tie
n
ts
0.121 S15 218.00 217.98 0.02 0.0%
0.121 S15 217.97
0.163 S33 357.67 381.50 33.71 8.8%
0.177 S33 405.33
0.378 S35 1075.67 1010.33 92.40 9.1%
0.339 S35 945.00
0.070 34 47.67 54.33 9.43 17.4%
0.074 34 61.00
0.079 30 77.67 79.93 3.21 4.0%
0.080 30 82.20
0.074 23 62.47 64.37 2.69 4.2%
0.076 23 66.27
0.083 22 92.07 90.37 2.40 2.7%
0.082 22 88.67
0.088 20 106.30 98.65 10.82 11.0%
0.083 20 91.00
0.061 19 18.60 18.88 0.40 2.1%
0.061 19 19.16
0.064 16 26.67 25.65 1.44 5.6%
0.063 16 24.63
0.105 15 162.67 168.76 8.61 5.1%
0.108 15 174.84
0.103 14 158.43 159.38 1.34 0.8%
0.104 14 160.33
0.073 4 56.33 59.98 5.16 8.6%
Co
n
tr
o
l P
at
ie
n
ts
0.075 4 63.63
0.105 5 165.63 165.02 0.87 0.5%
0.105 5 164.40
0.073 67 57.77 57.83 0.08 0.1%
0.073 67 57.89
0.073 55 58.33 60.85 3.56 5.8%
0.075 55 63.37
0.083 45 89.33 92.42 4.36 4.7%
0.084 45 95.50
0.061 41 18.67 18.72 0.07 0.4%
0.061 41 18.77
x=(y-0.0371)/0.0004
OD (at 450 nm) Samples [CRP] (ng L-1) Mean (ng L-1) SD (ng L-1) CV
0.832 High Control 1987.42 1859.42 181.02 9.7%
0.730 High Control 1731.42
0.092 Low Control 136.17 143.23 9.99 7.0%
0.097 Low Control 150.29
0.141 2 259.92 323.17 89.45 27.7%
0.192 2 386.42
Salivary CRP determined by ELISA technique               Regression equation (Plate #2)         (cont.)
0.109 8 180.67 174.83 8.25 4.7%
0.105 8 168.99
0.109 62 180.09 180.50 0.59 0.3%
0.109 62 180.92
0.486 56 1121.92 1169.54 67.35 5.8%
0.524 56 1217.17
0.271 51 584.92 609.29 34.47 5.7%
0.291 51 633.67
0.107 53 173.89 176.09 3.11 1.8%
0.108 53 178.29
0.152 44 288.42 265.04 33.06 12.5%
0.134 44 241.67
0.132 S24 238.10 266.34 39.94 15.0%
0.155 S24 294.59
0.326 S30 722.92 671.15 73.20 10.9%
0.285 S30 619.39CV
D
 
R
is
k 
Pa
tie
n
ts
0.100 S6 157.88 157.72 0.23 0.1%
0.100 S6 157.56
0.247 S7 524.54 565.89 58.48 10.3%
0.280 S7 607.24
0.172 S13 336.47 323.89 17.78 5.5%
0.162 S13 311.32
0.107 S15 175.41 192.82 24.63 12.8%
0.121 S15 210.24
CV
D
 
R
is
k 
Pa
tie
n
ts
0.170 S33 331.40 341.03 13.62 4.0%
0.177 S33 350.67
0.476 S35 1097.67 1104.53 9.71 0.9%
0.482 S35 1111.40
0.055 34 44.44 44.01 0.61 1.4%
0.055 34 43.59
0.071 30 85.42 85.54 0.18 0.2%
0.071 30 85.67
0.064 23 68.33 64.47 5.47 8.5%
0.061 23 60.60
0.071 22 85.60 88.10 3.54 4.0%
0.073 22 90.60
0.079 20 103.59 103.59 0.00 0.0%
0.079 20 103.59
0.044 19 17.42 18.13 1.00 5.5%
0.045 19 18.84
Co
n
tr
o
l P
at
ie
n
ts
0.049 16 29.09 28.56 0.74 2.6%
0.048 16 28.04
0.104 15 167.08 172.03 7.00 4.1%
0.108 15 176.98
0.103 14 165.39 166.06 0.95 0.6%
0.104 14 166.73
0.060 4 56.24 50.25 8.47 16.9%
0.055 4 44.26
0.104 5 166.40 167.78 1.96 1.2%
Co
n
tr
o
l P
at
ie
n
ts
0.105 5 169.17
0.060 67 57.84 58.57 1.04 1.8%
0.061 67 59.31
0.063 55 65.60 65.79 0.27 0.4%
0.063 55 65.98
0.073 45 90.42 90.50 0.12 0.1%
0.073 45 90.59
0.043 41 15.75 15.75 0.00 0.0%
0.043 41 15.75
x=(y+0.0086)/0.0022
OD (at 450 nm) Samples [CRP] (ng L-1) Mean (ng L-1) SD (ng L-1) CV
0.1487 High Control 71.48 72.28 1.12 1.6%
0.1522 High Control 73.07
0.0223 Low Control 14.06 15.54 2.09 13.4%
0.0288 Low Control 17.02
x50000 [CRP] (mg L-1)
Serum CRP determined by ELISA technique               Regression equation (Plate #1)         (cont.)
0.3047 2 142.39 7119500.00 7.12 7.24 0.17 2.3%
0.3152 2 147.16 7358136.36 7.36
0.1546 8 74.17 3708636.36 3.71 3.70 0.02 0.4%
0.1536 8 73.72 3685909.09 3.69
0.1966 62 93.26 4663181.82 4.66 4.17 0.69 16.6%
0.1536 62 73.72 3685909.09 3.69
0.8776 56 402.80 20139954.55 20.14 20.14 0.00 0.0%
0.8775 56 402.75 20137681.82 20.14
0.5758 51 265.64 13281818.18 13.28 13.31 0.04 0.3%
0.5785 51 266.84 13342227.27 13.34
0.1366 53 65.99 3299545.45 3.30 3.34 0.05 1.5%
0.1397 53 67.43 3371268.18 3.37
0.1875 44 89.12 4455863.64 4.46 4.52 0.10 2.1%
0.1934 44 91.83 4591363.64 4.59
0.1425 S24 68.70 3435045.45 3.44 3.28 0.22 6.6%
0.1291 S24 62.61 3130500.00 3.13
CV
D
 
R
is
k 
Pa
tie
n
ts
0.4604 S30 213.16 10658136.36 10.66 10.66 0.00 0.0%
0.4605 S30 213.21 10660409.09 10.66
0.1801 S6 85.75 4287681.82 4.29 4.30 0.02 0.4%
0.1812 S6 86.25 4312681.82 4.31
0.4983 S7 230.39 11519500.00 11.52 11.34 0.25 2.2%
0.4829 S7 223.39 11169500.00 11.17
0.3596 S13 167.35 8367727.27 8.37 8.32 0.06 0.8%
0.3557 S13 165.57 8278590.91 8.28
CV
D
 
R
is
k 
Pa
tie
n
ts
0.1503 S15 72.21 3610409.09 3.61 3.70 0.13 3.6%
0.1585 S15 75.94 3796772.73 3.80
0.2166 S33 102.35 5117727.27 5.12 5.13 0.01 0.3%
0.2174 S33 102.73 5136495.45 5.14
0.9014 S35 413.62 20680863.64 20.68 21.24 0.79 3.7%
0.9506 S35 435.98 21799045.45 21.80
0.0089 34 7.96 397859.09 0.40 0.38 0.02 5.5%
0.0076 34 7.36 368240.45 0.37
0.0367 30 20.61 1030500.00 1.03 0.92 0.15 16.2%
0.0274 30 16.37 818636.36 0.82
0.0271 23 16.25 812318.18 0.81 0.73 0.11 15.4%
0.0201 23 13.06 653227.27 0.65
0.0271 22 16.23 811722.73 0.81 0.84 0.05 5.4%
0.0299 22 17.52 875954.55 0.88
0.0259 20 15.70 785045.45 0.79 0.78 0.01 1.7%
0.0251 20 15.34 766863.64 0.77
0.0033 19 5.42 271231.82 0.27 0.28 0.01 2.2%
0.0037 19 5.60 279868.18 0.28
0.0130 16 9.84 491863.64 0.49 0.50 0.01 1.2%
0.0134 16 10.01 500454.55 0.50
0.1036 15 50.98 2549045.45 2.55 2.40 0.21 8.6%
0.0908 15 45.16 2258136.36 2.26
0.0825 14 41.39 2069500.00 2.07 2.12 0.07 3.1%
0.0866 14 43.27 2163313.64 2.16
0.0191 4 12.61 630500.00 0.63 0.64 0.01 2.0%
0.0199 4 12.97 648681.82 0.65
Co
n
tr
o
l P
at
ie
n
ts
0.0616 5 31.90 1595000.00 1.60 1.51 0.12 8.1%
0.0540 5 28.44 1421772.73 1.42
0.0274 67 16.38 819136.36 0.82 0.81 0.01 1.2%
0.0268 67 16.11 805500.00 0.81
0.0256 55 15.56 778227.27 0.78 0.80 0.02 3.1%
0.0272 55 16.25 812681.82 0.81
0.0352 45 19.89 994500.00 0.99 0.99 0.00 0.0%
0.0351 45 19.88 994222.73 0.99
0.0030 41 5.28 264186.36 0.26 0.26 0.01 2.9%
0.0026 41 5.07 253590.91 0.25
x=(y+0.0061)/0.0022
OD (at 450 nm) Samples [CRP] (ng L-1) Mean (ng L-1) SD (ng L-1) CV
0.170 High Control 80.20 78.89 1.86 2.4%
0.165 High Control 77.57
0.015 Low Control 9.68 9.42 0.36 3.9%
0.014 Low Control 9.17
x50000 [CRP] (mg L-1)
Serum CRP determined by ELISA technique               Regression equation (Plate #2)
0.300 2 138.91 6945454.55 6.95 6.90 0.07 0.9%
0.295 2 137.06 6852840.91 6.85
0.149 8 70.38 3518750.00 3.52 3.53 0.02 0.5%
0.150 8 70.84 3542045.45 3.54
0.160 62 75.66 3783068.18 3.78 3.99 0.30 7.5%
0.179 62 84.11 4205568.18 4.21
0.891 56 407.55 20377272.73 20.38 20.04 0.48 2.4%
0.861 56 394.06 19702840.91 19.70
0.550 51 252.73 12636397.73 12.64 11.98 0.92 7.7%
0.492 51 226.59 11329431.82 11.33
0.154 53 72.75 3637500.00 3.64 3.49 0.21 6.0%
0.141 53 66.84 3342045.45 3.34
0.172 44 80.73 4036363.64 4.04 4.08 0.06 1.5%
0.175 44 82.50 4124886.36 4.12
0.128 S24 60.88 3043750.00 3.04 3.06 0.03 1.0%
0.130 S24 61.70 3085227.27 3.09
CV
D
 
R
is
k 
Pa
tie
n
ts
0.492 S30 226.30 11314772.73 11.31 11.33 0.03 0.2%
0.494 S30 227.09 11354545.45 11.35
0.165 S6 77.77 3888636.36 3.89 3.85 0.05 1.4%
0.162 S6 76.25 3812500.00 3.81
0.422 S7 194.80 9739772.73 9.74 10.50 1.08 10.3%
0.490 S7 225.27 11263636.36 11.26
0.360 S13 166.25 8312500.00 8.31 8.33 0.02 0.2%
0.361 S13 166.75 8337500.00 8.34
CV
D
 
R
is
k 
Pa
tie
n
ts
0.129 S15 61.48 3073977.27 3.07 3.08 0.01 0.4%
0.130 S15 61.83 3091715.91 3.09
0.225 S33 104.82 5240909.09 5.24 5.08 0.23 4.4%
0.210 S33 98.43 4921704.55 4.92
0.957 S35 437.56 21878181.82 21.88 21.53 0.49 2.3%
0.926 S35 423.75 21187500.00 21.19
0.015 34 9.61 480340.91 0.48 0.49 0.02 3.5%
0.016 34 10.09 504431.82 0.50
0.025 30 14.20 709886.36 0.71 0.72 0.02 2.7%
0.026 30 14.75 737500.00 0.74
0.022 23 12.98 648977.27 0.65 0.65 0.00 0.5%
0.022 23 12.88 644204.55 0.64
0.029 22 16.16 807954.55 0.81 0.81 0.00 0.2%
0.029 22 16.10 805113.64 0.81
0.025 20 14.11 705681.82 0.71 0.70 0.01 1.0%
0.025 20 13.91 695454.55 0.70
0.003 19 4.14 207045.45 0.21 0.22 0.02 8.1%
0.004 19 4.64 232159.09 0.23
0.016 16 9.93 496590.91 0.50 0.47 0.03 7.2%
0.014 16 8.97 448295.45 0.45
0.120 15 57.16 2857954.55 2.86 2.95 0.13 4.4%
0.128 15 60.80 3039772.73 3.04
0.100 14 48.25 2412613.64 2.41 2.41 0.00 0.1%
0.100 14 48.33 2416250.00 2.42
0.014 4 9.35 467386.36 0.47 0.46 0.01 1.1%
0.014 4 9.20 460113.64 0.46
Co
n
tr
o
l P
at
ie
n
ts
0.063 5 31.39 1569318.18 1.57 1.55 0.03 1.7%
0.061 5 30.63 1531477.27 1.53
0.026 67 14.61 730681.82 0.73 0.73 0.00 0.0%
0.026 67 14.62 730795.45 0.73
0.027 55 15.10 754886.36 0.75 0.74 0.02 2.1%
0.026 55 14.65 732693.18 0.73
0.029 45 15.97 798511.36 0.80 0.76 0.06 8.1%
0.025 45 14.25 712500.00 0.71
0.001 41 3.25 162264.77 0.16 0.17 0.01 5.3%
0.002 41 3.50 174920.45 0.17
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix VI 
 
 
Database of the serum and the 
salivary CRP concentrations 
determined by the ELISA 
technique: calibration study 
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Appendix VII 
 
 
Calculations of Framingham 
Risk Score for the serum 
samples of volunteer patients, 
and tables with reference 
values for their calculation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tobacco Total Cholesterol HDL Cholesterol Estimate of 10-year risk
Sample N.º Age Genre Consumer  (mg dL
-1
)  (mg dL
-1
) Age Total Ch. HDL Ch. Tob. Cons. Total Points (%)
34 59 M Ex-smoker 173 42 8 0 2 1 11 8
30 47 M Ex-smoker 190 42 0 0 3 1 4 1
23 38 F N 189 60 -3 0 4 -1 0 1
22 36 M N 145 39 -4 0 0 2 -2 1
20 34 M N 163 48 -9 0 4 1 -4 1
19 50 M N 169 53 6 0 2 0 8 3
16 51 M Ex-smoker 147 42 6 0 0 1 7 3
15 41 F N 158 52 0 0 0 0 0 1
14 58 M N 196 47 8 0 2 1 11 8
4 48 F N 161 56 3 0 3 0 6 1
5 30 F N 166 71 -7 0 4 -1 -4 1
67 50 M Ex-smoker 150 39 6 0 0 2 8 4
55 52 M Ex-smoker 190 88 6 0 2 -1 7 3
45 57 M N 133 38 8 0 0 2 10 6
41 82 F N 163 59 16 0 1 0 17 5
2 48 M Y 210 37 3 5 5 2 15 20
8 56 M Y 205 51 8 3 3 0 14 16
62 79 M N 169 51 13 0 0 0 13 12
56 73 M Ex-smoker 169 43 12 0 0 1 13 12
51 49 F N 222 52 3 0 6 0 9 1
53 52 M N 184 46 6 0 2 1 9 5
44 52 F Y 217 39 6 4 4 2 16 4
S24 49 M Y 187 39 3 5 3 2 13 12
S30 61 M Ex-smoker 205 41 10 0 1 1 12 10
S6 62 M N 191 50 10 0 1 0 11 8
S7 54 M Y 244 27 6 3 4 2 15 20
S13 53 M N 295 46 6 0 5 1 12 10
S15 75 M N 189 41 13 0 0 1 14 16
S33 83 M Y 257 59 13 1 1 0 15 20
S35 73 M Ex-smoker 182 57 12 0 0 0 12 10
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Appendix VIIa: Data to calculate the Framingham score for each patient
 
Appendix VIIb: Framingham Point Scores for Estimate of 10-year risk for men (Source: National 
Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of 
Health and Human Services). 
 
Appendix VIIc: Framingham Point Scores for Estimate of 10-year risk for women (Source: 
National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. 
Department of Health and Human Services). 
 
 
